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ABSTRACT

Investigation of Methionine and Lysine Derivatives as a Source of Rumen-Protected
Amino Acids for Lactating Dairy Cows
by
Mark Avila Fagundes, Doctor of Philosophy
Utah State University, 2021

Major Professor: Dr. Jeffery O. Hall
Department: Animal, Dairy, and Veterinary Sciences

The N-acetyl amino acids, such as N-acetyl-L-methionine (NALM), ƐN-acetyl-Llysine, and Nα, ε-acetyl-L-Lysine are amino acid (AA) derivatives and developmental
forms of rumen-protected (RP) AAs for dairy cows (CJ CheilJedang). The AA derivates
are produced via N-acetylation of the L-Met α-amino, L-Lys α-amino or ε-amino group,
respectively. Three independent studies were conducted to investigate the use of Met and
Lys acetylation derivatives as sources of RPAAs for lactating dairy cows. The initial
study investigated production responses and ruminal fermentation characteristics of
lactating dairy cows when supplemented with NALM as a source of RPMet in
metabolizable protein (MP) -deficient or MP-adequate diets. Supplementation of NALM
increased milk fat concentration and yield and 3.5% fat-corrected milk (FCM) yield and
tended to increase energy-corrected milk (ECM) yield regardless of MP difference.
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Dietary treatments had similar effects on ruminal fermentation characteristics and
microbial protein yield. Results from the first study suggest that NALM exerted minor
influence on ruminal metabolism, but increased milk fat concentration, resulting in
increases in milk fat yield and feed efficiency.
The subsequent study investigated lactational performance of dairy cows when
supplemented with N-acetyl-L-Lysine (NALL), N, -acetyl-L-Lysine (diNALL), or
AjiPro-L (AP) as a source of RPLys to a control diet. Feeding the diNALL and AP diets
decreased dry matter intake. Stage of lactation may have altered DMI in cows fed the
diNALL and AP diets because energy requirements decrease during mid-lactation and
control of feed intake is regulated by hepatic oxidation. Milk yield was not altered by
RPLys supplementation. Findings from the study indicate that supplementing N, acetyl-L-Lysine in mid to late lactation dairy cows decreases DMI and maintained milk
yield leading to improved milk production efficiency (milk yield/DMI).
The final study evaluated the bioavailability (BA) and lactational performance of
lactating dairy cows supplemented with NALM at two different supplementation rates.
Overall, production parameters were not influenced by NALM supplementation.
Bioavailability, as assessed by plasma appearance of Met was higher for the 30g NALM
dose compared with 60g NALM and control, suggesting that optimal supplementation
rate for NALM is 30 g/cow/d. Residue of NALM was not detected in plasma, milk, liver
or muscle samples. Overall, findings suggest that NALM is deacetylated before reaching
central circulation, increases plasma Met concentrations, therefore supplying lactating
dairy cows with a BA source of RPMet.
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(208 pages)

PUBLIC ABSTRACT

Investigation of Methionine and Lysine Derivatives as a Source of Rumen-Protected
Amino Acids for Lactating Dairy Cows

Mark Avila Fagundes

Cows have a protein requirement for growth, maintenance, and lactation. In order to
meet those protein requirements, dairy farmers can supplement or feed cattle with
specific amino acids, the building blocks that make-up protein. However, in order for the
amino acid product to be effective it must avoid degradation in the rumen and be
delivered in the small intestine for absorption. Lysine and methionine have traditionally
been recognized as the most limiting amino acids for lactating dairy cows. Therefore,
nutrition companies have focused on finding ways to encapsulate or protect lysine and
methionine from rumen microbes. The N-acetyl-L-methionine and N-acetyl-L-lysine are
amino acid derivatives and developmental forms of amino acids for dairy cows. Three
separate nutrition studies were conducted to investigate the use of lysine and methionine
acetylated derivatives as sources of amino acids for lactating dairy cows. The initial study
investigated milk production responses of lactating dairy cows when supplemented with
N-acetyl-L-methionine. Supplementation of N-acetyl-L-methionine increased milk fat
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concentration and yield and 3.5% fat-corrected milk yield. Results from the first study
suggest that N-acetyl-L-methionine did not impact rumen metabolism, but increased milk
fat concentration by providing methyl donors to the mammary gland, resulting in
increases in milk fat yield. The second study investigated lactational performance of
dairy cows when supplemented with N-acetyl-L-lysine, N, -acetyl-L-lysine, or
AjiPro-L as a source of rumen-protected lysine. Feeding the N, -acetyl-L-lysine and
AjiPro-L diets decreased dry matter intake. Milk yield was not altered by rumenprotected lysine supplementation. Findings from the study suggest that supplementing
N, -acetyl-L-lysine to dairy cows decreases dry matter intake, but maintained milk
yield leading to improved milk production efficiency. The final study evaluated the
bioavailability and lactational performance of dairy cows supplemented with N-acetyl-Lmethionine. Overall, milk production parameters were not affected by N-acetyl-Lmethionine supplementation. Bioavailability was higher for diets with N-acetyl-Lmethionine compared with the control diet. Residue of N-acetyl-L-methionine was not
detected in plasma, milk, liver, or muscle samples. Overall, findings suggest that Nacetyl-L-methionine is deacetylated and absorbed as methionine into the bloodstream of
cows, supplying lactating dairy cows with a bioavailable source of rumen-protected
methionine.

vii

ACKNOWLEDGMENTS

First, I would like to thank all the employees of the Caine Dairy Research Center,
veterinary staff of the USU Clinical Veterinary Services and students in the ruminant
nutrition lab for aiding in sample collections, maintaining animal health, and feeding of
experimental animals. A special thanks is given to both the USU School of Veterinary
Medicine and CJ Bio for financial support. Upmost gratitude is expressed to all
committee members for accepting the task to direct me through graduate school at USU. I
appreciate the time given by Dr. Rood, Young, and Villalba attending committee
meetings and mentoring me in your areas of expertise. Dr. Hall, I am grateful for your
willingness to take me on as your graduate student, partway through my program, which I
know has not always been the most convenient with your busy schedule. To this day your
mineral course is one of the best I have taken in my academic career and I have enjoyed
our discussions of veterinary medicine. Dr. Eun, I am especially appreciative that you
accepted me as your graduate student. Over the last few years, you have not only
provided mentorship, but you have become a great friend. Although, you are over 5,000
miles away that doesn’t prevent you from having an active role in my graduate program.
This willingness speaks to your passion, thoughtfulness, and leadership in advising
students to help them succeed. Lastly, I would like to give a special thanks to my wife,
friends, and family members who have supported me throughout this process.
Mark Avila Fagundes

viii

CONTENTS

Page
ABSTRACT……………………………………………………………………………...iii
PUBLIC ABSTRACT………………………………………………………………….....v
ACKNOWLEDGMENTS………………………………………………………….…....vii
LIST OF TABLES………………………………………………………………………..xi
LIST OF FIGURES……………………………………………………………………..xiii
LIST OF ABBREVIATIONS………………………………….………………………..xiv
INTRODUCTION……………………………………………………………………..….1
REVIEW OF LITERATURE…………………………………………………………......3
AA…………….………………………………………………………………..….3
AA Nutrition in Dairy Cows………………….……………….……..…....3
Structural Configuration and Biological Functions of Met and Lys………7

RPMET and RPLYS..…………………………………………………………......9
RPMet Supplements………………………………………………….…...9
RPLys Supplements………………..…………………………………….14
Effects on Intake………………………………………………..………..17
Effects on Milk Yield and Composition………...…………........…….....20
Effects on Immunity………………………...……………………….…..26
INTESTINAL ABSORPTION OF AA…...……………………………………..30
MET METABOLISM……………………………………...…...…………….....32
MAMMARY GLAND AA METABOLISM………………….....……………...34
Lys….……………………..……………………………...……………...34

ix

Met……………………………………………………………………….35
MAMMALIAN TARGET OF RAPAMYCIN (mTOR) PATHWAY……….….36
BA…………………..……………………………………………………………37
Current Approaches and Limitations………………………...………......37
RPMet……………………………………………………………………39
RPLys………………...…………………………………………………..41
CONCLUSIONS………………………..............……………………………….41
REFERENCES…………………………………………………………………..43
CHAPTER 1. INFLUENCE OF SUPPLEMENTING A METHIONINE
DERIVATIVE, N-ACETYL-L-METHIONINE IN DAIRY DIETS ON
PRODUCTION AND RUMINAL FERMENTATION BY LACTATING
COWS DURING EARLY TO MID-LACTATION……..………………………65
ABSTRACT……………………………………………………………………...65
INTRODUCTION……………………………………………………………….66
MATERIALS AND METHODS…………………………………………...…....68
RESULTS AND DISCUSSION……..…………………………….………….....75
CONCLUSIONS…………………………………………………………….…..83
ACKNOWLEDGMENTS…………………………...…………………………..84
REFERENCES…………….……………………………………...……………..84
CHAPTER 2. EFFECTS OF SUPPLEMENTING THREE DIFFERENT
FORMS OF RUMEN-PROTECTED LYSINE ON LACTATIONAL
PERFORMANCE OF MID TO LATE LACTATION DAIRY COWS...……..104
ABSTRACT……………………………………………………………………104
INTRODUCTION……………………………………………..……………….105
MATERIALS AND METHODS…………………………………………….…107

x

RESULTS AND DISCUSSION…………………………..……………………113
CONCLUSIONS….…………………………………………………………....121
ACKNOWLEDGMENTS…………………………………….…………...…...122
REFERENCES…………………………………...……..…………………...…122
CHAPTER 3. BIOAVAILABILITY AND LACTATIONAL
PERFORMANCE OF DAIRY COWS SUPPLEMENTED
WITH N-ACETYL-L-METHIONINE AT DIFFERENT DOSES………...…..140
ABSTRACT…………………………………………………………………….140
INTRODUCTION……………………………………………..……………….141
MATERIALS AND METHODS…………………………………………….…144
RESULTS AND DISCUSSION…………………………..……………………151
CONCLUSIONS….…………………………………………………………....161
ACKNOWLEDGMENTS…………………………………….…………...…...162
REFERENCES…………………………………...……..……………………...163
CONCLUSIONS……………………………………………………………………….182
REFERENCES…………………………………...……..……………………...186
CURRICULUM VITAE……………………………………………………………….188

xi

LIST OF TABLES

Table

Page

1-1.

Ingredient and chemical composition of the experimental diets without
or with N-acetyl-L-Met (NALM) at 2 different levels of MP fed to
lactating Holstein dairy cows (n = 4)…………………………….………….…..94

1-2.

Intake, milk production, feed efficiency, and net energy utilization of
lactating Holstein dairy cows supplemented without or with
N-acetyl-L-Met (NALM) at 2 different levels of MP……………………………97

1-3.

Plasma AA concentrations (µmol/L) of lactating Holstein dairy cows
supplemented without or with N-acetyl-L-Met (NALM) at 2 different
levels of MP …………..........................................................................................99

1-4.

Ruminal fermentation characteristics of lactating Holstein dairy cows
supplemented without or with N-acetyl-L-Met (NALM) at 2 different
levels of MP………………………………………………..…………………...101

2-1.

Ingredient and chemical composition of the experimental diets
supplemented with rumen-protected lysine fed to lactating Holstein dairy
cows (n = 40)………...........................................................................................129

2-2.

Dry matter intake, productive performance, body weight (BW) change,
and net energy utilization of mid to late lactation Holstein dairy cows
supplemented with rumen-protected lysine…..………………………………...132

2-3.

Plasma AA concentrations (µmol/L) of mid to late lactation Holstein dairy
cows supplemented with rumen-protected lysine…………...………………….135

2-4.

Utilization of N by mid to late lactation Holstein dairy cows supplemented
with rumen-protected lysine……………………………………………………137

2-5.

Ruminal fermentation characteristics of mid to late lactation Holstein dairy
cows supplemented with rumen-protected lysine………………………...….....139

3-1.

Ingredients and chemical composition of the basal diet……………………..…170

3-2.

Energy and protein supply and AA balance of the basal diet supplemented
with N-acetyl-L-Met (NALM) at 2 different doses…………………...……..…172

xii

3-3.

Intake, milk production, and feed efficiency of lactating Holstein dairy
cows supplemented with N-acetyl-L-Met (NALM) at 2 different doses…….....174

3-4.

Plasma AA concentrations (µmol/L) of lactating Holstein dairy cows
supplemented with N-acetyl-L-Met (NALM) at 2 different doses……..……....176

3-5.

Determination of bioavailability and kinetic parameters in lactating Holstein
dairy cows supplemented with N-acetyl-L-Met (NALM) at 2 different
doses…………………………………………………………………………….178

3-6.

Residue potential in lactating Holstein dairy cows supplemented with
N-acetyl-L Met (NALM) at 2 different doses………………………………….180

xiii

LIST OF FIGURES

Figure

Page

1.

Biological functions of Met and hepatic Met metabolism. BHMT =
Betaine-homocysteine methyltransferase; CBS = cystathionine-β-synthase;
CSE = cystathionase; DMG = dimethylglycine; GSH = glutathione;
GNMT = glycine N-methyltransferase; HCY = homocysteine; MAT1A =
Met adenosyltransferase 1A; MTR = Met reductase; MT =
methyltransferase; 5-MTHF = 5-methyltetrahydrofolate; SAH = Sadenosylhomocysteine; SAHH = SAH hydrolase; SAM = S-adenosylMet and THF = tetrahydrofolate. Adapted from Zhang and White, (2017)……..64

1-1.

Proposed mechanism of N-acetyl-L-Met (NALM) on its potential effects
on milk fat and milk production. SAM = S-adenosyl-Met; VLDL = very
low-density lipoprotein (Nelson and Cox, 2013)………………………….…....103

3-1.

Plasma Met concentration (µM) versus time plot for lactating Holstein
dairy cows abomasally infused with N-acetyl-L-Met (NALM) at 2
different supplementation doses……………………….……………………….181

xiv

LIST OF ABBREVIATIONS

AA = amino acid
ADF = acid detergent fiber
AP = AjiPro-L
AUC = area under the curve
BA = bioavailability
BCAA = branched chain amino acids
BW = body weight
CL = control
CNCPS = cornell net carbohydrate and protein system
CP = crude protein
DIM = days in milk
diNALL = Nα, Ɛ-acetyl-L-lysine
dLys = digestible lysine
DM = dry matter
dMet = digestible methionine
DMI = dry matter intake
EAA = essential amino acid
ECM = energy corrected milk
εNALL = ƐN-acetyl-L-lysine
FCM = fat corrected milk

xv

His = histidine
HMB = DL-2-hydroxy-4-(methylthio)-butanoic acid
HMTBa = DL-2-hydroxy-4-(methylthio)-butanoic acid
HMBi = isopropyl ester of 2-hydroxy-4-(methylthio)-butanoic acid
Ile = isoleucine
KMB = 2-keto-4-(methylthio) butanoic acid
Leu = leucine
LFI = liver functionality index
LPS = lipopolysaccharide
Lys = lysine
MCP = microbial crude protein
ME = metabolizable energy
Met = methionine
MHA = methionine hydroxy analogue
MP = metabolizable protein
MPA = metabolizable protein adequate
MPD = metabolizable protein deficient
mTOR = mammalian target of rapamycin
MUN = milk urea nitrogen
N = nitrogen
NALL = N-acetyl-L-lysine
NALM = N-acetyl-L-methionine

xvi

NAM = N-acetyl-DL-methionine
NDF = neutral detergent fiber
NEAA = non-essential amino acids
NEFA = non-esterified fatty acid
NEL = net energy for lactation
NFC = non fiber carbohydrates
NH3-N = ammonia nitrogen
NRC = national research council
OM = organic matter
PD = purine derivatives
PMNL = polymorphonuclear leukocytes
RDP = rumen degradable protein
RP = rumen-protected
RPAA = rumen-protected amino acid
RPLys = rumen-protected lysine
RPMet = rumen-protected methionine
RUP = rumen undegradable protein
SAM = S-adenosyl-methionine
TMR = total mixed rations
Val = valine
VFA = volatile fatty acids
VLDL = very low-density lipoproteins

INTRODUCTION

Lysine (Lys) and methionine (Met) have traditionally been recognized as the most limiting
amino acids (AA) for lactating dairy cows fed corn-based diets (Schwab et al., 1992; NRC,
2001). Protein nutrition of dairy cows in recent years has shifted from the use of dietary crude
protein (CP) towards meeting the ammonia and AA needs for ruminal fermentation in order to
maximize microbial protein (MCP) synthesis (Schwab and Broderick, 2017). Another nutritional
shift seen recently is the balancing of individual AA in metabolizable protein (MP) as a method
to deliver bioavailable AAs to the small intestine. However, in order for an AA product to reach
the small intestine for absorption, it must be protected from rumen microbial degradation.
Protection of free AAs from ruminal degradation dates to the 1960s (Schwab and Broderick,
2017) and numerous rumen-protected AA (RPAA) products, have been developed using a
variety of technologies. In terms of Met, encapsulation of a Met molecule with coating materials,
such as carbohydrates or polymer allows RPAA products to avoid ruminal degradation (Schwab
and Ordway, 2003). Altering the structural configuration of AAs to avoid microbial degradation
is another method to escape rumen degradation. Methionine analogues utilize a hydroxyl group
to protect them from ruminal degradation and are converted to useable Met by enzymatic
reactions (Schwab and Ordway, 2003). Rumen-protected Lys (RPLys) products are often coated
by a series of lipid or fatty acid calcium-based salts (Ji et al., 2016). Encapsulated rumenprotected Met (RPMet) and Met analogues can impact milk yield, but their effects tend to be
more prominent in altering milk fat and protein composition (Patton, 2010; Zanton et al., 2014).
Encapsulated RPLys supplementation has minimal impact on production parameters, unless
RPLys is supplemented with a RPMet product (Robinson, 2010). Lactational responses to both
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supplemental RPMet and RPLys in the literature are inconsistent and require further research.
Inconsistent findings may be related to AA protection methods, varying supplementation rates,
or metabolizable protein concentrations in the diets.
The N-acetyl-L-Met (NALM), ƐN-acetyl-L-Lys (εNALL), and Nα, ε-acetyl-L-Lys
(diNALL) are AA derivatives and developmental forms of RPAAs for lactating dairy cows.
Based on prior research, it is thought that the acetyl group acts as a barrier to block the
hydrolysis of the AA N-terminal (Wallace, 1992). However, to our knowledge there is limited
production and bioavailability data available on the supplementation of acetylated AA
derivatives to lactating dairy cows (Amaro et al., 2019; Digenis et al., 1974; Liang et al., 2019;
Windschitl and Stern 1988).
Therefore, a series of lactation studies were performed to investigate the use of acetylated
Met and Lys derivatives as a source of RPAAs for lactating dairy cows. Three independent
studies were conducted, and it was hypothesized that; for study 1) increased Met from NALM
would increase milk protein synthesis and milk yield, but the degree of the response would be
dependent upon the MP supply in the diets; for study 2) increased post-ruminal Lys from
developmental NALL products would increase milk protein synthesis and milk yield compared
with the control diet and for study 3) Met from abomasal infusion of NALM would increase
plasma Met concentration, and the bioavailability of NALM would be greater for each dose
compared with the control leading to a dose response, while lactational performance would be
similar across all treatments due to the short study length.
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REVIEW OF LITERATURE

Methionine and Lys are recognized as the 2 most limiting AAs for milk protein synthesis and
milk production in lactating dairy cows. Individual or combined supplementation of RPAAs in
ruminant diets is not a new concept, but in recent years has become more popular due to the
beneficial effects of RPLys and RPMet on lactational performance (Robinson, 2010; Zanton et
al., 2014). Supplementation of RPMet can improve milk fat (Overton et al., 1998; Samuelson et
al., 2001) and protein yield (Rulquin and Delaby, 1997; Patton, 2010), while RPLys tends to
exert its beneficial effects on milk protein yields (Robinson, 2010). As the dairy industry
continues to find solutions to reduce environmental impact, nitrogen (N) efficiency can be
improved by reducing protein concentrations in ruminant diets with strategic supplementation of
RPAAs. For these reasons, feeding RPAAs has gained popularity in the dairy industry. This
literature review will cover the common RPLys and RPMet products available for use in
ruminants, as well as their effects on feed intake, milk and milk component production,
immunity, metabolism, intestinal absorption of AA, mammary gland AA metabolism, and
bioavailability. Main focus will be placed on encapsulated RPAAs, Met analogues, and AA
derivatives, specifically NALM and N-acetyl-L-Lys (NALL).

AA

AA Nutrition in Dairy Cows
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In recent decades, significant progress has been made in understanding the AA nutrition of
dairy cows. Ruminal protein metabolism and the discovery of bacterial protein synthesis have
been comprehensively researched (Wegner et al., 1940). Dairy cows can utilize nonprotein N
(e.g., urea) and free ammonia from ruminal AA degradation for MCP synthesis. Ruminal MCP is
the major form of MP supplied to (50-80%) and absorbed from the small intestine of dairy cows
(Storm and Ørskov, 1983). Microbial protein is considered a high-quality protein for dairy cows
because of its high digestibility and favorable AA composition (Schwab and Broderick, 2017).
However, MCP synthesis requires large amounts of energy with the efficiency of energetic
transformations for protein synthesis from AA being less than 75% (Wu, 2013). Therefore, much
attention has been placed on the development of RPAAs to escape rumen degradation and supply
high-quality, systemically available AAs in ruminant diets.
Historically, AA dietary formulations for dairy cows have been based on the single-limiting
AA theory (Mitchell and Block, 1946), which was adapted from the law of the minimum
proposed by von Lieberg (1863; Liu et al., 2017). Recently, the single-limiting AA theory has
been refuted (Appuhamy et al., 2012; Liu et al., 2017). A revised conceptual framework with the
NRC (2001) model that represents the individual and additive effects of all 10 essential AA
(EAA) is believed to improve model accuracy compared with the single-limiting AA model in
ruminants (Liu et al., 2017). Thus, when a ration is formulated based on the single-limiting AA
theory, the additive effects of EAA for lactational AA requirements are ignored, and production
responses may be altered. Balancing rations for EAA requirements of dairy cows and for
multiple-limiting AAs may help to reduce overfeeding of protein, improve post-ruminal AA
absorptive efficiency, reduce N excretion, and improve lactational performance (Liu et al.,
2017).
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Of the 20 primary AAs that occur in proteins, 10 are classified as being ‘‘essential’’ (or
indispensable) (NRC, 2001). Essential AAs cannot be synthesized by animal tissues or if they
can (arginine and histidine), not at rates sufficient to meet requirements at early stages of growth
or for high levels of production (NRC, 2001). Lysine and Met have been identified as the 2 mostlimiting EAAs for lactating dairy cows, with current evidence suggesting that histidine (His)
may be limiting in grass silage-based diets (Vanhatalo et al., 1999; Giallongo et al., 2016). Since
His concentrations are lower in ruminal MCP compared with milk protein and common
feedstuffs (NRC, 2001), His may be a limiting EAA for lactating cows fed MP-deficient diets.
This is of most significance when MCP provides or encompasses most of the MP supplied to
ruminants (Patton et al., 2014; Giallongo et al., 2016).
Branched chain amino acids (BCAA) are used by the mammary gland for cellular, milk
protein synthesis and comprise 50% of the EAA in milk proteins (Mackle et al., 1999). It has
been suggested that BCAAs may be as limiting as Met and Lys in high producing dairy cows
(Appuhamy et al., 2011), because of obligate use of BCAAs (isoleucine (Ile), leucine (Leu), and
valine (Val)) by intestinal tissue as energy sources. A meta-analysis was performed (Lean et al.,
2018) to predict the effects of metabolizable AAs on dairy cattle performance. The researchers
found a positive association of Cornell Net Carbohydrate and Protein System estimated
metabolizable Leu with milk protein and milk yield responses, suggesting that Leu should be
given greater consideration as a potential co-limiting AA (Lean et al., 2018). However, the
effects of BCAA supplementation on dairy cow production is varying and further evidence is
needed to determine if BCAAs should be considered as limiting AAs in dairy diets for
incorporation into a multiple-limiting AA model.
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Methionine and Lys are the most researched AAs in regards to dairy cattle nutrition. They are
considered the most limiting EAA for the synthesis of milk and milk protein in the highproducing dairy cow (Schwab et al., 1992; Rulquin et al., 1993). Methionine is one of 4 sulfurcontaining AAs and along with cysteine is proteogenic (Brosnan and Bronson, 2006). In
ruminants, Met is not only used for protein synthesis, but serves multiple biological roles (Figure
1). Milk protein synthesis by lactating dairy cattle can be altered if Met is in the shortest dietary
supply of available dietary AAs requirements based on the single-limiting AA theory (Mitchell
and Block, 1946). Methionine functions as a methyl donor and precursor to antioxidant and
lipotropic compounds including carnitine, choline, creatine, cysteine, glutathione,
metallothionine, taurine and S-adenosyl methionine (SAM) (Lehninger, 1977; Seymour, 2016;
Figure 1).
Previously, research has focused on the role of Met as a co-limiting AA for milk protein and
fat synthesis, and maintaining metabolic balance (Polan et al., 1991; Seymour, 2016). Recently,
the metabolic functions of Met such as its role in supporting liver function, oxidative balance,
and immunity have been assessed (Osorio et al., 2013). Methionine deficiency in non-ruminants
produces fatty liver disease, a reduction in cellular antioxidants, reduced methyl donors, and
generalized hepatic inflammation and fibrosis (Schugar and Crawford, 2012). Unlike the
variability of Met’s biological functions, the predominant biological function of Lys is protein
synthesis (milk protein, growth, pregnancy, and maintenance) (NRC, 2001). It is evident that
Met and Lys are essential for milk and milk component production and serve many biological
roles. However, the chemical form of AA fed to dairy cattle can alter the absorption, utilization
efficiency, and subsequent production response to AA supplementation.
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Structural Configuration and Biological Functions of Met and Lys

Methionine and all protein AAs, except glycine, can have both D- and L-isomers. L-AAs are
physiological isomers in organisms and account for greater than 99.98% of the total AAs in the
body (Wu, 2013). In dairy cows, the D-isomer is not bioavailable (Lapierre et al., 2012). The Disomer must be converted to the L-isomer before it can be incorporated into mammalian proteins.
Supplementation of the L-isomer of Met can be utilized directly for protein synthesis without
conversion to any other isoforms. Since chemical synthesis of AAs results in a racemic mixture
of the D- and L-enantiomers of Met, the bioavailability (BA) of the D- isomer of Met in dairy
cows depends on the rate of transformation into the L-isomer (Lapierre et al., 2012).
For ruminants, BA data of D-Met are limited and somewhat unclear. In small ruminants,
lower utilization of D-Met than L-Met has been described (Doyle, 1981), while the utilization of
D-Met and L-Met appear to be equally effective for supporting wool growth (Doyle, 1981; Reis
et al., 1989). In growing steers, D- and L-Met produced similar increases in N retention
(Campbell et al., 1996), although this tended to be lower with DL-Met infusion compared with
an equimolar dose of L-Met (Titgemeyer and Merchen, 1990). In both bovine studies, plasma
total Met concentrations (D plus L) were greater when either D- or DL-Met was provided
compared with similar supplementation of the L-enantiomer (Lapierre et al., 2012). Lobley et al.,
(2001) found that feeding RPMet with the 2 enantiomers (D- and L-) to dairy cows results in
accumulation of plasma D-Met, which could be an indication of poorer systemic utilization of DMet. From this research, it seems that both enantiomers increase D-Met plasma concentration,
but is D-Met utilized by the dairy cow?
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To date, the research by Lapierre et al., (2012) is the most thorough to determine the BA of
D-Met in dairy cows. The researchers sought to quantify the conversion of D-Met to the Lisomer, proportion of D-Met plasma removal, and L-Met conversion, and determine if the
conversion of D- to L-Met occurs in the mammary gland of dairy cows (Lapierre et al., 2012).
The findings from this study indicate that the D-enantiomer of Met, constituting half of the Met
in rumen-protected products, is transformed to the L-enantiomer in dairy cows. The whole body
rate of disappearance of D-Met is, however, much slower than that of L-Met, with the half-life of
D-Met being 6 to 7 times longer than that of L-Met (Lapierre et al., 2012). The non-utilization of
D-Met by the mammary gland and a lower hepatic extraction of D-Met compared with L-Met
would contribute to the slower rate of disappearance (Lapierre et al., 2012). The longer half-life
of D-Met could be useful as it offers the opportunity to delay the clearance of the absorbed Met
or act as a reservoir for L-Met synthesis (Lapierre et al., 2012).
The diversity of AAs is influenced by structural configuration (e.g., side chains), which
determines a specific AAs chemical property, such as reactivity, solubility, stability, and taste
(Wu, 2013). The R-group of Met contains a methyl group covalently bonded to a sulfur atom.
Methionine is among the most hydrophobic of the AAs and its electrophilic qualities are
attributed to the terminal methyl group and sulfur atom (Brosnan et al., 2007). This means that
most of the Met residues in globular proteins are found in the interior hydrophobic core, in
membrane-spanning protein domains, and Met is often found to interact with the lipid bilayer
(Brosnan and Brosnan, 2006). Methionine must bind to initiator tRNA in order for the preinitiation complex to form during the beginning of protein synthesis in eukaryotes (N-formylMet in bacteria) and it is believed that the hydrophobic nature of Met is essential for protein
synthesis (Drabkin et al., 1998).
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Lysine is a basic AA characterized by the presence of an amino group at the end of a 4carbon aliphatic side chain and bears a positive charge at physiological pH (Tomé and Bos,
2007). This structure makes Lys a reactive component in different chemical reactions including
carbonyl-amine interactions. As a consequence, a segment of Lys can be degraded, and another
part can become unavailable in different food systems because of its involvement in different
interactions with AA side chains or with other components including carbohydrates or lipids
(Tomé and Bos, 2007). As a result, its ε-amino group side chain easily forms covalent bonds
with other AAs and reducing sugars known as the Maillard reaction (Ordway and Aines, 2010).
Even when Lys is incorporated into peptides or proteins, its ε-amino group remains reactive and
can still form covalent bonds (Nursten, 2005). Although all AA, peptides, and proteins can
participate in the Maillard reaction, Lys is the most common and prevalent AA that participates
(Ordway and Aines, 2010).

RPMet and RPLys

RPMet Supplements

Protection of free AAs from ruminal degradation dates back to the 1960s when researchers
began to understand the importance of balancing AA in order to meet dairy cows AA
requirements (Schwab and Broderick, 2017). The first RPMet supplement was developed by
Delmar Chemicals (LaSalle, QC, Canada). This product consisted of a core of 20% DL-Met,
colloidal kaolin, and tristearin (Schwab and Broderick, 2017). The encapsulated DL-Met product
when fed to lactating cows at 5, 15 and 45 g/d had no effect on milk production or milk
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component yields (Broderick et al., 1970). However, plasma Met concentrations were increased
at the higher supplementation rates (Broderick et al., 1970). Abomasal infusion of the
encapsulated DL-Met product to lactating cows increased both milk protein yield and
concentration. Plasma AA concentrations were altered when casein plus the encapsulated DLMet were abomasally infused. These results suggest that the Delmar product was a successfully
developed commercial RPMet product (Broderick et al., 1970); however, it was later found to
have poor intestinal digestibility (Grass and Unangst, 1972). These findings highlighted the
reality that developing encapsulated products with both high rumen protection and intestinal
release was not an easy task.
Since this initial RPMet research, many approaches have been investigated to increase
ruminal protection of Met products. In the 1980s and 1990s, Met analogues and derivatives were
screened to find alternatives to encapsulation. Methionine analogues and derivatives provide the
precursors for enzymatic conversion to Met. However, the screening was unsuccessful, and
attention was again focused on improving encapsulation technologies (Schwab and Broderick,
2017). Today RPAA products are marketed as being either; physically encapsulated or protected
AA, AA analogues, or AA derivatives. The most popular RPMet products currently fed to dairy
cows are physically protected and Met analogues. A brief review will be given on the 2 popular
physically protected RPMet products, and special attention will be given to Met analogues in this
review as they are structurally and functionally similar to Met derivatives.
Physical protection approaches have been utilized other than lipid coating to protect Met with
a surface coated carbohydrate (Mepron M85®, Evonik Inc., Kennesaw, GA). The Mepron®
pellets consist of an 85% DL-Met core and are coated with several thin layers of ethylcellulose
and stearic acid. Rumen enzymatic digestion of ethyl cellulose is negligible; therefore,
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degradation of the products occurs through physical action and abrasion. This results in minimal
rumen degradation and slow release of DL-Met in the small intestine (Schwab and Ordway,
2003). Smartamine® M (Adisseo Inc., Alpharetta, GA) is a lipid/pH-sensitive polymer coated
product. The core contains 75% DL-Met and is covered with ethylcellulose, stearic acid, and a
small droplet of 2-vinylpyridine-co-styrene. This copolymer arrangement allows the product to
escape ruminal degradation and become solubilized at the low abomasal pH of 2, thus allowing
free DL-Met to be released in the abomasum (Schwab and Ordway, 2003).
The Met analogues currently used in the dairy industry are Met hydroxy analogue (MHA or
HMTBa) (ALIMET®, Novus International Inc., St. Louis, MO), calcium bis MHA (MFP®,
Novus International Inc.), the isopropyl ester of 2-hydroxy-4-methylthiobutanoic acid (HMBi)
(MetaSmart® Liquid, Adisseo Inc.) and butanoic acid, 2-hydroxy-4-(methylthio)-1-methylethyl
ester (MetaSmart® Dry, Adisseo Inc.). The ALIMET® is a liquid 2-hydroxy-4methylthiobutanoic acid (HMB) product with the substitution of the α-amino group of Met with
a hydroxyl group. The manufacturers’ data sheet does not state a minimum L-Met or DL-Met
hydroxy analogue percentage (Novus International Inc. 2015). The minimum Met activity as a
percent of DM in beef and dairy is 100%. The minimum activity is 88% in all other species. The
product has a chemical formula of C5H10O3S. The ALIMET® is a light brown to brown liquid
with a characteristic sulfur odor. The pH of the product is less than 1. Boiling point is observed
at 121°C and the flash point using Pensky-Martens Closed Cup is greater than 116°C. The vapor
pressure is 16 mm Hg at 25°C. The material density is heavier than water, but is completely
soluble. Shelf life is a minimum of 2 years when stored as directed (Novus International Inc.
2015).
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The MFP® is the dry-pelleted HMB calcium with substitution of the α-amino group of Met
with a hydroxyl group (Novus International Inc. 2015). The product has a minimum DL-Met
hydroxy analogue calcium content of 95%. The minimum Met activity is 84%. The product has a
chemical formula of C5H10O3S . ½ Ca. The MFP® is a light tan to tan granular powder with a
cherry odor/flavor and a pH of 11 at 5% solution. The MFP® has a solubility of 74 g/kg at 25°C,
and the material density is 800-850 kg/m3 (loose). The MFP® is not oxidative and has dust
explosion class ST1 (weak explosion). The shelf life is a minimum of 5 years when stored as
directed (Novus International Inc. 2015).
The MetaSmart® Liquid (Adisseo Inc. 2018) is a liquid HMBi (95%) product with the
substitution of the α-amino group of Met with an isopropyl ester group. The product has a
chemical formula of C8H16O3S. It has a colorless to brown liquid appearance and a pH of 3.6. It
has a melting/freezing point of -35.2°/-30.4°C. The product degrades prior to boiling. The flash
point using Pensky-Martens Closed Cup is 115°C. The vapor pressure (Pa) is 0.6% at 25°C. The
specific gravity is 1.07 at 20°C and has a solubility in water of 25.1 g/L at 30°C (Adisseo Inc.
2018).
The MetaSmart® Dry is a dry HMB product with the substitution of the α-amino group of
Met with an ester group (Adisseo Inc. 2018). The product has a chemical formula of C6H12O3S.
It is free-flowing, cream to beige-colored powder, consisting of butanoic acid, 2-hydroxy-4(methylthio)-1-methylethyl ester (50-75% by weight) adsorbed onto a silicon dioxide carrier (2550% by weight). The product has a flash point of > 93°C. The specific gravity is 0.75 g/cm3
(loose), 0.80 g/cm3 (packed), and the product is insoluble in water (Adisseo Inc. 2018).
The first Met analogue extensively studied was MHA (DL-α-hydroxy-γ-mercaptobutyrate) or
more appropriately called HMB (Schwab and Ordway, 2003). The HMB is more resistant to

13

ruminal degradation than free Met and its production is less expensive than that of DL-Met
protected supplements such as Smartamine M (Wilson et al., 2008). Estimated bypass rates of
HMB range from 99 (Jones et al., 1988) to 6% (Noftsger et al., 2005). Supplementation of HMB
has a moderate effect on increasing plasma Met concentrations in dairy cows (Koenig et al.,
1999; Koenig et al., 2002). In order for the body to utilize HMB as useable Met, HMB must be
converted to L-Met in a two-step process. In the first step, HMB is enzymatically converted to 2keto-4-(methylthio) butanoic acid (KMB). In the second step, transamination of KMB yields
useable body Met (L-Met) (Dibner and Knight, 1984).
Several esters of HMB have been developed in an attempt to increase its rumen protection.
Comparing microbial degradation of several HMB esters, HMBi was estimated to have 60%
protection, but methyl, ethyl, butyl, and cyclohexyl esters were more readily hydrolyzed to HMB
in the rumen (Robert et al., 2001). The ability of HMBi to avoid hydrolysis suggests that
isopropyl esters present a steric hindrance of ruminal bacterial esterases. In order for HMBi to be
converted to useable body Met, HMBi must be hydrolyzed to HMB and isopropanol. Then,
HMB is converted to KMB and L-Met (Dibner and Knight, 1984).
Methionine derivatives are the least studied form of RPMet. A Met derivative is a free Met
molecule with a chemical blocking group added to the α-amino group or a Met molecule in
which the acyl group has been modified (Schwab and Ordway, 2003). Methionine derivatives
add a chemical tail to the α-amino group, while Met analogues change the structural
configuration of the α-amino group. There are 2 enzymes capable of converting AA derivatives
to their corresponding AAs, to be utilized as body AAs. The enzyme aminoacylase I is present in
multiple mammalian organs (small intestine, liver, and kidney) (Giardina et al., 1997). The
bovine liver contains the enzyme, α-N-acylamino acid hydrolase which is capable of hydrolyzing
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α-N-acylated AAs to yield acetate and the corresponding AAs (Met or Lys) (Gade and Brown,
1981).
Digenis et al. (1974) screened 31 nitrogenous compounds with possible Met activity. The
compounds were screened in vitro with rumen microbes and compounds not supporting cellulose
digestion were included in studies to confirm resistance to rumen microbial degradation. Nacetyl-DL-Met (NAM) and DL-homocysteine thiolactone hydrochloride were the most stable
toward microbial degradation (Digenis et al., 1974).
Windschitl and Stern (1988) reported that Met flowing out of continuous cultures increased
with NAM supplementation without a change in bacterial Met flow, which was attributed to
greater escape (67%) of the NAM from bacterial degradation. Daabees et al., (1984)
supplemented NALM to young pigs and revealed that plasma Met concentration increased, but
no NALM was present in either portal or vena caval plasma at any sampling time, thus indicating
NALM deacetylation to Met in the intestinal lumen or mucosal cells with release of free Met to
the plasma. Additionally, Amos et al. (1974) abomasally infused sheep with NAM and found
that plasma Met concentration increased 1 h post infusion compared with the control treatment.
Based on the prior data, it seems that NAM can bypass the rumen and that both NAM and
NALM can increase plasma Met concentrations. However, research for NALM has not reported
the BA of NALM fed to lactating dairy cows. These in vitro and in vivo findings revealed the
potential use of Met derivatives as a RPMet source to lactating dairy cows; however, it was not
until the past few years that interest in these products has grown.

RPLys Supplements
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Extensive research has focused on RPMet products. However, there are limited publications
on RPLys products. This is primarily due to difficulties with development and production of
rumen stable and efficacious RPLys products. As previously discussed, the Lys side chain is
highly reactive and can react with encapsulation materials, such as polymer. Encapsulated Lys
has a lack of resistance to TMR mixing and ruminant mastication (Swanepoel et al., 2010).
Product stability of RPLys in wet TMR has been overlooked in recent years. A study conducted
by Ji et al. (2016) assessed whether mechanical mixing of TMR or TMR with low or high
moisture content alters Lys release from 6 RPLys products. The authors concluded that
mechanical feed mixing, dietary moisture content, and exposure of RPLys to other feed
ingredients in the TMR over time may damage the protective coating and reduce efficacy of
RPLys products (Ji et al., 2016). Although differences in Lys release among RPLys products
were found, inferences about RPLys product BA is cautioned, as altered protection of Lys does
not determine free Lys delivery to the plasma and systemic availability to the cow (Block and
Jenkins, 1994; Ji et al., 2016).
Inconsistent post-ruminal polymer degradation and high production costs have also limited
the development of RPLys products (Swanepoel et al., 2010). However, there has been success
since the early 1990s in developing rumen stable AA matrixes and a number of RPLys products
have become available for commercial use (Robinson, 2009b). Available commercial RPLys
products use encapsulation, matrix technology, or a combination of both to protect a Lys core
from ruminal degradation (Ji et al., 2016). These RPLys products are often coated by a series of
lipid or fatty acid calcium-based salts (Ji et al., 2016). Wu and Papas (1997) found that RPLys
coating protection efficacy in the rumen depends on coating composition, pellet surface
smoothness, inner core pellet strength, pellet solubility, and pellet size (Wu and Papas, 1997).
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Because the majority of RPLys products are lipid-coated, questions have arisen about the
rumen environment (i.e., water content and acidity) and stability of lipid coated RPLys products.
Acid can catalyze the hydrolysis of triglycerides to fatty acids and glycerol (Bender et al., 1961;
Carey, 2003), and acid-catalyzed hydrolysis occurs in environments with high water
concentrations, such as in the rumen (Bender et al., 1961; Carey, 2003). Thus, Reiners et al.
(2018) sought to determine the effects of acidity and silage source on Lys retained by 2 RPLys
products and to estimate ruminal degradation of Lys retained by RPLys after mechanical mixing
with alfalfa or corn silage with different amounts of acidity (pH). The authors concluded that
physical and chemical dietary characteristics can affect Lys provided to ruminants from RPLys
products (Reiners et al., 2018). They state that Lys concentration was reduced from the two
RPLys products when mixed in silage-based diets before cows consume the diet (Reiners et al.,
2018). Because chemical and physical dietary factors along with on-farm feeding practices
(mixing times) can impact RPLys efficacy, additional research is needed to find ways to
minimize Lys loss. The most popular RPLys products currently fed to dairy cows are physically
protected. A brief review will be given on 2 popular physically protected lipid RPLys products.
AjiPro-L® (Ajinomoto Co. Inc., Tokyo, Japan) is a small white oval bead composed of L-Lys
monohydrochloride (50% minimum) core, vegetable oil (49%) and lecithin (1%). The
hydrogenated vegetable oil matrix in AjiPro-L resists physical damage while its hydrophobic
layer prevents the microbial breakdown of Lys (Reiners et al., 2018). USA Lysine® (Kemin
Industries, Des Moines, IA) is a beige to light brown particle composed of a L-Lys
monohydrochloride (65% minimum) core. It is manufactured by extrusion of L-Lys-HCl and
lipid (vegetable oil) into small particles and subsequently the Lys lipid particles are coated with
multiple layers of a lipid matrix (Reiners et al., 2018).
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Lysine derivatives, like Met derivatives are the least studied form of RPLys. A Lys derivative
is a free Lys molecule that has a chemical blocking group added to either the α-amino or ε-amino
group. The focus of this dissertation is on AA derivatives, specifically NALM and NALL. For
now, the review will focus on production responses of lactating dairy cows to encapsulated AA
supplementation, Met analogue supplementation, and briefly cover NALM supplementation. To
our knowledge, NALL supplementation to lactating dairy cows has not been described in the
literature and therefore only encapsulated RPLys production responses will be discussed.

Effects on Intake

Dry matter intake (DMI) is the amount of feed an animal consumes that does not include
moisture content. Dry matter intake is significant in nutrition, because it determines the amount
of nutrients available to an animal for health, production, and other physiologic processes (NRC,
2001). Actual or estimated DMI is important for the formulation of diets to prevent underfeeding
or overfeeding of nutrients and to promote efficient nutrient use (NRC, 2001). A variety of
factors can influence DMI including forage quality, TMR nutrient balance, feeding delivery,
feeding method, TMR palatability, ration dry matter (DM), environmental conditions, housing
facilities, and managerial practices.
Amino acids, especially His have been shown to increase DMI in lactating dairy cows (Lee et
al., 2012b; Giallongo et al., 2016). The exact mechanism of increased DMI is unknown, but it is
speculated that His and other EAA regulate DMI via a direct effect in the anterior prepyriform
cortex of the brain (Rudell et al., 2011). Methionine on the other hand if overfed can have a
negative impact on DMI (Benevenga, 1974). A meta-analysis conducted by Zanton et al. (2014)
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reported that DMI response was affected by supplemental Met source (Smartamine, Mepron,
HMTBa, and DL-Met). Cows fed Smartamine had higher DMI, while cows fed Mepron had
lower DMI compared to control cows. Supplementation of HMBTa and DL-Met did not affect
DMI compared to control cows (Zanton et al., 2014).
Responses to supplementation of RPMet and HMBi on DMI in the literature have been
inconsistent. Kung and Rode (1996), Leonardi et al. (2003), and Chen et al. (2011) found that
RPMet supplementation did not improve DMI. Limited studies have shown an increase in DMI
with RPMet supplementation (Broderick et al., 2009; Zanton et al., 2014), whereas Ordway et al.
(2009) and Zanton et al. (2014) reported decreases in DMI. Supplementation of HMBi may
increase DMI (Osorio et al., 2014) because of the potential stimulatory effect of HMBi on
cellulolytic bacteria and the subsequent increase in ruminal passage rate and DMI (Lee et al.,
2015).
Lee et al. (2012b) assessed supplementation of RPMet products in MP-deficient diets. The
authors reported that MP-deficient diets below 15% of the NRC requirements decreased DMI.
However, the authors observed that a treatment supplemented with a combination of 3 RPAA
consisted of Lys (100 g/cow), Met (30 g/cow), and His (50 g/cow) increased DMI (Lee et al.,
2012b). In contrast, Lee et al. (2015) found that supplementation with RPLys and RPMet in MPdeficient diets (−256 to −305 MP g/d) did not affect DMI. Recent research suggests that
transition cows may benefit from balancing for limiting EAA (Zhou et al., 2016). Supplementing
Lys adequate diets with RPMet resulted in increases in DMI (Osorio et al., 2013; Zhou et al.,
2016). Improved DMI during the transition period leads to better postpartum performance in
dairy cows supplemented with RPMet (Zhou et al., 2016).
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Responses to supplementation of NALM on feed intake is scarce, but a recent study by Liang
et al. (2019) supplemented mid-lactating cows with 0, 15, 30, or 60 g/d of NALM. Dry matter
intake was not affected by NALM supplementation. This finding is in agreement with Amaro et
al. (2019), in which dosage rates of 0, 15, 30, and 45 g/d of NALM were fed to 60 multiparous
Holstein dairy cows in early lactation (27 ± 4.3 DIM) and the dose did not affect DMI. However,
a study by Gresenti (2017) supplemented mid to late lactating cows with 0, 15, 30, or 60 g/d of
NALM. Increasing NALM supplementation linearly increased DMI, which the research group
speculated may potentially be related to a linear increase in rumen MCP yield (Gresenti, 2017).
However, the potential stimulatory effects of NALM supplementation on rumen microbiota
needs to be further investigated. Contrasting results from Met supplementation may be due to
differences in length of feeding of RPMet, varying Met supplementation amounts or rates (based
on % DM), Met products, stage of lactation, or a combination of factors (Osorio et al., 2013).
Research of RPLys and its effect on DMI is limited. However, RPLys supplementation does
not appear to affect DMI of lactating dairy cows (Paz et al., 2014). These findings of RPLys and
no effect of DMI are in agreement with Blauwiekel et al. (1997) and Robinson et al. (2011).
Swanepoel et al. (2010) found that supplementation of RPLys did not influence DMI in midlactation cows (77 ± 3.2 DIM). However, the late lactation group (262 ± 6.70 DIM) had a
tendency toward lower DMI with addition of RPLys (Swanepoel et al., 2010). Recently, Girma
et al. (2019) investigated providing transition cows with an increased level of energy and
supplementing RPLys to improve both pre- and post-partal DMI. Supplementation of the TMR
with RPLys improved DMI in postpartum cows and RPLys supplementation of the close-up diet
increased DMI of cows compared to control animals (Girma et al., 2019). The authors contribute
the findings of increased DMI to the endogenous synthesis of carnitine from RPLys
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supplementation. The authors state that supplementing RPLys is an efficient strategy to increase
the supply of Lys that serves as the carbon backbone for carnitine synthesis (Vaz and Wanders,
2002; Robinson et al., 2006). Carnitine is the methylated form of Lys (Shug et al., 1982) that
buffers acetyl residues from lipid mobilization, reduces ketone body formation, and plasma βhydroxybutyrate concentrations (Jacobs, 2002). Carnitine is important for oxidation of longchain fatty acids, regulation of ketosis, support of the immune system, and enhancement of the
antioxidant system (Citil et al., 2009; Pirestani et al., 2011). As previously mentioned, DMI is
controlled by many factors, so further research needs to be completed to fully understand RPAA
(RPLys and RPMet) supplementation and DMI regulation.

Effects on Milk Yield and Composition

The adoption of the multiple component pricing system by the Federal Milk Marketing
Administration (2000) changed the method by which producers are compensated for their milk.
The system adjusted the pricing structure to pay producers based on the amounts of milk fat,
protein and solids in milk. Milk was previously priced based on total fluid milk volume.
Economically, milk protein and fat are the most important milk components to dairy farmers. As
the value of milk protein continues to increase, there is greater interest among dairy farmers to
find alternative feeding strategies such as RPAA supplementation to increase milk protein yields
(Vyas and Erdman, 2009). Not only are productive responses important (i.e., increasing milk fat
and protein yield), reducing environmental pollution by improving dietary N conversion into
milk protein is of concern in the dairy industry (Lapierre et al., 2005). As mentioned previously,
Liu et al. (2017) suggest the incorporation of a multiple-limiting AA concept to improve milk
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and milk protein yield model predictions, thus allowing modification of diets to increase postabsorptive N efficiency and reduced N excretion by dairy cows.
Encapsulated RPMet products, especially Smartamine and Mepron have been extensively
studied in the literature (Patton., 2010). The evidence for one product being more effective than
the other is inconclusive, as milk yield responses to supplemental RPMet products is variable.
Patton (2010) reported increased milk production for both RPMet products (0.43 kg/d for
Mepron and 0.14 kg/d for Smartamine) based on a meta-analysis from 36 studies with 17 studies
evaluating Mepron and 18 evaluating Smartamine. Zanton et al. (2014) evaluated the lactational
performance of dairy cows to supplemental Met sources. The authors assessed HMTBa provided
as either a liquid or Ca salt form (17 papers with 34 control diets and 46 treatment comparisons),
Mepron (18 papers with 35 control diets and 42 treatment comparisons), and Smartamine (20
papers with 30 control diets and 39 treatment comparisons). Overall, milk yield did not respond
to any form of Met supplementation; however, it tended to increase for HMTBa and Mepron
supplementation (Zanton et al., 2014).
Although there is variability in milk yield responses to supplemental Met products, strategic
supplementation of RPAAs to low CP diets is becoming more popular. The observed production
responses to supplementation of RPMet in cows fed low CP diets (i.e., MP-deficient diets) have
been inconsistent and marginal (Arriola Apelo et al., 2014a; Sinclair et al., 2014). Milk yield was
not improved when a low CP diet (15.0%) was fed alone or in combination with RPMet
supplementation (Arriola Apelo et al., 2014b). However, further research with MP-deficient diets
(ranging 5–10% below MP requirement) have sustained milk yield (Lee et al., 2015; Giallongo et
al., 2016). Peri-partal RPMet supplementation has been shown to improve post-partal
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performance. Osorio et al. (2013) and Zhou et al. (2016) found that cows supplemented with a
RPMet source increased milk yield in the subsequent lactation.
A Met analogue, HMTBa, is converted to Met in the body and used as a supplemental Met
source in dairy production. Results of published studies assessing the effects of supplementing
Met sources, including HMTBa, on performance variables are inconsistent as well. A recent
meta-analysis was performed to summarize the accumulated results of HMTBa supplementation
on animal performance (Feng et al., 2018). Supplementation of HMTBa had no effect on milk
yield, which was in agreement with the meta-analysis done by Zanton et al. (2014). Noftsger et
al. (2005) reported no difference in milk production when cows were supplemented with HMBi
at 0.13% DM. However, St-Pierre and Sylvester (2005) showed an increase in milk yield (2.9
kg/d) to cows supplemented with HMBi at 0.15% DM. Lee et al. (2015b) found that
supplementing HMB (the unprotected form), numerically decreased milk production when %
DM inclusion rate of dietary HMB increased. Alternatively, HMB supplementation increased
milk production in a quadratic manner (Piepenbrink et al., 2004).
Supplementation of NALM to mid lactation dairy cows improved milk yield in a quadratic
manner, with 30 g/d of NALM seeming to be the optimal supplementation rate for milk yield
under the experimental conditions (Liang et al., 2019). Amaro et al. (2019) found that milk yield
of early lactation Holstein dairy cows tended to be greater (P = 0.07) with intermediate
concentrations (15 and 30 g/d) of NALM compared to control animals. The authors noted that
NALM supplementation at 30 g/d resulted in the highest milk yield (Amaro et al., 2019), which
is in agreement with Liang et al. (2019). Encapsulated RPMet, Met analogues, and Met
derivatives can impact milk yield, but their effects tend to be more prominent in altering milk
composition (milk fat and protein).

23

Supplementing RPLys to pre-calving cows during the close-up period (-21 to 0 d) at a rate of
40 g/cow/d had no effect on post-partum milk yield (Girma et al., 2019). These results agree with
Swanepoel et al. (2010) who observed that supplementing dairy cows with RPLys (41 g/cow/d)
did not affect milk yield in early lactation. Paz and Kononoff (2014) did not observe a difference
in milk yield when RPLys was supplemented to diets with altering inclusion rates of low-fat
distillers dry grains. Cows supplemented with RPLys (37 g/cow/d) after peak lactation showed
no improvement in milk yield (Bernard et al., 2014). In contrast, Robinson et al. (2011) observed
a 2 kg increase in milk yield when RPLys was supplemented to deliver 15 to 21 g of MP Lys.
Historically, HMB/HMBTa and HMBi supplementation tends to exert their effects on milk
fat production in lactating dairy cows (Zanton et al., 2014). Supplementation of HMTBa had no
effect on milk yield, fat percent, protein percent, or protein yield, but increased milk fat yield
(Feng et al., 2018). Zanton et al. (2014) reported HMTBa supplementation increased milk fat by
5.38 g/g of MP Met from HMTBa, whereas Feng et al. (2018) reported HMTBa supplementation
increased milk fat by 5 g/g of MP Met. A meta-analysis by Zanton et al. (2014) concluded
HMTBa supplementation increases milk fat yield by 45 g/d and milk protein yield by 13 g/d. StPierre and Sylvester (2005) observed a 166 g/d increase of milk fat yield with HMBi
supplementation.
The beneficial effects of HMTBa supplementation on milk fat have been investigated (Polan
et al., 1970; Wang et al., 2010). Patton et al. (1970) reported that in vitro HMTBa
supplementation can stimulate polar lipid formation and the authors suggest that the polar lipid
class may increase with rumen protozoal growth. Increased ruminal biohydrogenation
intermediates of the alternative pathway (e.g., trans-10 C18:1) exert antilipogenic effects in the
mammary gland of ruminants which can lead to milk fat depression (Shingfield and Griinari,
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2007). Baldin et al. (2018) witnessed that HMTBa supplemented to either high-producing (44.1
± 4.50 kg/d) or low-producing (31.4 ± 4.30 kg/d milk yield) lactating dairy cows at 0.1% of diet
DM maintained lower concentrations of the biohydrogenation intermediates, trans-10 C18:1 in
milk samples. This finding suggests that HMTBa may stabilize ruminal biohydrogenation and
help prevent the shift to the alternative biohydrogenation pathway (Baldin et al., 2018).
Therefore, it is speculated that supplemental HMTBa exert their effects on milk fat production
by shifting ruminal biohydrogenation intermediates.
Physically encapsulated RPMet products and Met derivatives generally do not increase milk
fat concentrations, because, unlike Met analogues, they lack a ruminal mode of action. However,
encapsulated forms of RPMet have been shown to increase milk fat yield. Chen et al. (2011)
found trends (P = 0.08) for increased milk fat concentration and yield when lactating dairy cows
were supplemented with approximately 15 g of RPMet (Smartamine M) at 0.06% on a DM basis.
Recently, Toledo et al. (2017) evaluated the effects of daily top-dressing a TMR with 21.2 g of
RPMet from 30 ± 3.0 to 126 ± 3.0 DIM on productive performance in lactating dairy cows. The
group found that top-dressing RPMet to multiparous cows increased milk fat percentages (3.45
vs. 3.14%), although no effects were seen in primiparous cows. Based on limited data in the
literature, NALM supplementation to either mid or early lactating dairy cows has failed to
exhibit beneficial effects on milk fat concentrations (Amaro et al., 2019; Liang et al., 2019).
Lactational performance of dairy cows in response to feeding RPLys has been researched
over the past 30 yr, but sufficient data are lacking for beneficial effects of single AA
supplementation of Lys in dairy rations. Supplementing combinations of Met and Lys is a much
more common practice in the dairy industry. Swanepoel et al. (2010) reported reduced milk fat
synthesis to feeding a RPLys product to high-producing dairy cows. Třináctý et al. (2009) fed a
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RPLys tablet to high-producing Holstein dairy cows (33.5 kg/d); milk protein concentration
increased, while milk fat concentration and fat yield declined. However, according to Robinson
(2010) the results described above for Lys supplementation on milk fat are inconsistent with the
literature of post-ruminal Lys supplementation. A review of literature by Robinson (2010)
reported that RPLys supplementation generally resulted in minimal negative DMI and
production responses, possibly due to an AA imbalance or poor AA delivery to the intestinal
absorptive site. Productive benefits of RPLys supplementation is disappointing and overall
lactational performance effects can only be judged as negligible (Robinson, 2010).
Less convincing evidence exists for the effect of L-Lys fed to lactating cows, but when L-Lys
was deleted from a mixture of abomasal infused AAs, milk and milk protein production was
reduced in the Lys-deficient infusion (Weeks et al., 2006). The exact relationship of L-Lys to AA
deficiencies has yet to be established (Patton et al., 2014). However, increased L-Lys supply
appears important in early lactation when microbial synthesis is reduced because of lower DMI,
to help drive milk and milk protein production (Robinson et al., 2011).
Although RPLys has minimal effects on production performance, increases in milk protein
yield are one of the most likely observed responses due to supplementation with RPMet (Zanton
et al., 2014). As previously described, Zanton et al. (2014) evaluated the lactational performance
in dairy cows receiving supplemental Met sources (HMTBa, Mepron, and Smartamine) or postruminal infusion of DL-Met. Milk protein yield was increased due to supplementation from all
Met sources or from infusion of DL-Met and protein concentration was greater for all
supplements or infusion of DL-Met, except for cows supplemented with HMTBa. Average milk
protein yield responses ranged from 13 g/d for cows supplemented with HMTBa to 35 g/d for
Mepron (Zanton et al., 2014). These results are in agreement with the meta-analysis by Patton
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(2010) who noted similar milk protein production responses when cows were supplemented with
RPMet (Mepron and Smartamine). Osorio et al. (2013) observed an increase in protein yield
post-partal for cows supplemented with Smartamine and MetaSmart (1.24 and 1.23 kg/d) versus
control cows (1.11 kg/d) during the transition period (-21 to 30 DIM). Supplementing RPMet can
also result in an increase in milk protein percentage (Osorio et al., 2013), but one study
(Benefield et al., 2009) reported a negative effect on milk protein concentration. Milk protein
concentration has been used to indicate the effectiveness of a Met source, leading to changes in
milk protein synthesis (Schwab et al., 2001). This is based on the idea that if milk yield is
unchanged, an increase in milk protein concentration will allow for an inference to be made on
milk protein yield and therefore efficacy of Met supplementation (i.e., bioavailability) (Zanton et
al., 2014). The take-home message is that if Met can escape ruminal degradation and be made
available post-ruminally, whether by supplementing RPMet products or Met analogues, milk
protein can be increased. Methionine, if not utilized by the cow for milk and milk component
production, can also potentially play a pivotal role in both cow and calf immunity.

Effects on Immunity

It is well-known that Lys and Met are the most limiting EAA for milk production, but these
EAAs also play a crucial role in immune function. Methionine and its derivate metabolites (e.g.,
glutathione, taurine, polyamines) are immunonutrients in nonruminants (humans), which aid and
improve immune functionality and activity (Vailati-Riboni et al., 2017). Recently, Vailati-Riboni
et al. (2017) supplemented dairy cows with RPMet at 0.08% DM (8 to 12 g/d DL-Met) during
the transition period (-21 to 30 DIM) to determine periparturient immune response using an ex
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vivo whole blood approach and the inflammatory response of the blood immune cells were tested
with a LPS challenge (Vailati-Riboni et al., 2017). Overall, Met supplemented cows had a lower
post-partum IL-1ß (pg/µL) concentration compared to the control cows. The Met treated cows
had a greater phagocytosis capacity of neutrophils and oxidative burst activity by both
monocytes and neutrophils. The authors suggest that the above results indicate that Met
supplementation improved immune functional activity, while dampening the innate immune
response to a LPS challenge (Vailati-Riboni et al., 2017). They also mention that Met probably
acts on the oxidative status of the animal or indirectly through an immunologically active
metabolite (e.g., taurine). Taurine is the most plentiful AA in the cytosol of neutrophils that can
trap hypochlorous acid to form taurine monochloramine (Vailati-Riboni et al., 2017). Greater
oxidative burst in neutrophils could be attributed to higher taurine monochloramine
concentrations, leading to peri-partal immune cell hyper-responsiveness. Therefore, Met may act
as an immunomodulator of the immune response in transition cows when cows undergo a period
of immunosuppression (Vailati-Riboni et al., 2017).
Zhou et al., (2017) investigated differences in liver functionality indexes (LFI) in peri-partal
dairy cows fed RPMet or choline. The LFI is a composite index that is used to determine changes
in plasma concentrations of blood biomarkers (albumin, cholesterol, and bilirubin) (Bertoni and
Trevisi, et al., 2013). The researchers retrospectively assigned cows to low (LFI < 0) and high
(LFI > 0) groups. Animals with a high LFI had greater liver functionality and are considered to
be at a lower risk for developing health/metabolic disorders during the transition period. The
liver regulates the metabolic activity aimed at mobilizing and directing nutrient flow to the
mammary gland and the gastrointestinal tract (Seymour, 2016). Therefore, any reduction in liver
function can impair lactational performance, reproductive efficiency, and immune status
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(Seymour, 2016). A larger number of Met-supplemented cows were in the high LFI group. The
high LFI cows had an overall greater liver functionality and decreased state of oxidative stress,
indicating that the high LFI cows had a better immunometabolic status during the transition
period (Zhou et al., 2017).
In dairy cows, Met can also have a large impact on cow health through a variety of reasons
other than immunomodulation or liver functionality (Figure 1). Methionine serves as a source of
cysteine for glutathione synthesis via homocysteine produced in the Met cycle (Martinov et al.,
2009). Liang et al. (2019) supplemented RPMet to transition cows (-28 d to 30 d) at a rate of
0.10% DM to determine if RPMet alters glutathione metabolism in peri-partal Holstein cows.
Adipose tissue biopsies were collected on d −10, 10, and 30, relative to parturition, from 7 cows
in each group to measure various proteins and genes related to glutathione metabolism. Overall,
increased mRNA abundance of 4 key glutathione metabolism-related genes and upregulation of
4 protein abundance components related to glutathione metabolism were found (Liang et al.,
2019). The authors state that RPMet supplementation may alter glutathione metabolism in
adipose tissue (Liang et al., 2019). Altered glutathione metabolism in adipose tissue may
contribute to reduced oxidative stress and inflammation during the transition period. However,
further research is needed to assess the impacts of adipose tissue glutathione metabolism on
immunity of dairy cattle.
Methionine plays a role in the liver as a lipotropic agent (Martinov et al., 2009). Methionine
is needed for synthesis of SAM, which is a key methyl donor necessary for the packaging of very
low-density lipoproteins (VLDL) for exportation out of the liver (Osorio et al., 2014).
Triglycerides, if not exported from the liver, can accumulate causing fatty liver disease in
ruminants. Sun et al. (2016) observed increased plasma non-esterified fatty acids (NEFA) and
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plasma VLDL concentrations in post-partum transition cows supplemented with RPMet. This
finding suggests that Met may affect hepatic lipid metabolism and exportation of VLDLs from
the liver (Sun et al., 2016).
Transition cows benefit from Met supplementation through lipotropic agent activity,
antioxidant substrate formation, immunomodulation and immune functionality. In addition,
maternal nutritional status may also benefit neonatal innate immune function (Jacometo et al.,
2016). Abdelmegeid et al. (2017) performed an in vitro study with neonatal Holstein calf
polymorphonuclear leukocytes (PMNL). Supplementation with either Met, choline, or taurine
altered the inflammatory response and affected oxidative stress, suggesting that Met and other
nutrients may be needed for an adequate immune response in calves (Abdelmegeid et al., 2017).
Jacometo et al. (2018) supplemented RPMet at 0.08% DM during the close-up period to
multiparous Holstein cows. Calves born to RPMet supplemented cows showed positive changes
in PMNL molecular pathways compared to control calves. Although the data are inconclusive,
maternal RPMet supplementation may play a role in neonatal calf immunity, but further research
is needed to identify the link between maternal AA supply and calf immunity.
Methionine’s role in ruminant immunity has been investigated more extensively in the
literature compared with that of Lys. However, Lys deficiency can impair both antibody
responses and cell-mediated immune responses in monogastric animals (Chen et al., 2003; Wu,
2013). Lysine deficiency limits animal immunity-related protein synthesis which includes
antibodies and cytokines that are necessary for normal immune function (Liao et al., 2015). Han
et al. (2018) reported that Lys deficiency in piglets impaired inflammatory responses in the liver,
kidney, and spleen by mediating serum antibody concentrations (i.e., IgG and IgM) and
inflammatory cytokines. Additionally, toll-like receptors, which are needed to active the
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inflammatory response were altered by Lys restriction in piglets (Han et al., 2018). It is apparent
that Lys is necessary for immune function in monogastrics (i.e., humans, swine, and fowl), but
data are lacking for the potential beneficial effects of Lys in ruminant immunology.

Intestinal Absorption of AA

The absorption of AAs through the gastrointestinal tract of animals is an important biological
function because growth, lactation, reproduction, and maintenance requirements depend on the
adequate supply of AAs for protein synthesis. Amino acids that reach the small intestine can be
incorporated into proteins, converted into other AA for biosynthetic processes, oxidized to CO2,
or transported through enterocytes into the mesenteric portal vein (Stoll and Burrin, 2006).
Protein reaching the small intestine of the ruminant can come from a variety of sources:
including rumen undegradable protein (RUP), MCP, and endogenous proteins. Ruminants use
similar intestinal and pancreatic proteases as monogastric animals for protein breakdown.
Absorption rates of AAs differ by anatomical location of the small intestine (i.e., duodenum,
jejunum, and ileum), enterocyte maturity, and the site of AA absorption varies by species. In
monogastrics, the jejunum is believed to hold the greatest capacity for AA absorption (Webb,
1990). In ruminants, the majority of AA absorption increases with distance from the pylorus and
the majority of absorption occurs in the jejunum and ileum (William, 1969; Phillips et al., 1976).
Amino acid absorption site and rate can also be influenced by individual AA. Williams
(1969) observed that sheep absorbed the majority of their AAs in the ileum; however, the order
of absorption varied with anatomical location, suggesting that AA affinities for transport systems
vary among intestinal sites. Phillips et al. (1976) reported that the largest amount of threonine
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and valine absorption occurs in the ileum and Met absorption was similar between the jejunum
and ileum in sheep. Webb (1990) reported that total Met and Lys uptake was higher by ileal
brush border membrane vesicles than by jejunal brush border membrane vesicles. Webb (1990)
also reported that in ileal and jejunal tissue, Met transporters had lower affinities and higher
capacities for Met than the Lys transporter. This suggests that the mode of transportation and
mechanism of AA transport through the enterocytes can differ according to the individual AA
being absorbed.
Amino acid transport is affected by size, charge, and AA structural configuration (i.e., Rgroup side chains). Spencer et al. (1962) suggested that all transport carriers require the presence
of an amino/imino group and a carboxyl group. Hydrophilic small weight neutral amino acids are
taken up less readily than the larger weight hydrophobic amino acids and basic amino acid
transport is intermediate (Webb, 1990). The various carriers are located on the basolateral
membrane, brush border, or on both sides of the small intestine (Webb, 1990). To date many AA
transport systems have been identified in the small intestine. However, the exact number is
unknown, but the classification of amino acid transport systems is based on substrate preference
and is determined by kinetic and inhibition analysis measurements (Christensen, 1984).
The major mechanisms for AA transport from the intestinal lumen to the enterocytes occur
through simple diffusion, facilitated diffusion, or active transport (Wilson and Webb, 1990).
Active transport requires energy and is believed to be Na+-dependent, while facilitated diffusion
mechanisms are Na+-independent systems. The relative significance of each route is highly
dependent on the concentration of substrate present. The Na+-dependent systems require
metabolic energy to transport AAs against a concentration gradient. The Na+ gradient which has
high extracellular Na+ and low intracellular Na+ concentrations is regulated by Na+/K+-ATPase
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located in the basolateral membrane of the enterocyte (Webb, 1990). The Na+/K+-ATPase pump
co-transports Na+ and an AA into the cell and K+ out of the cell (Webb and Matthews, 1994).
The Na+-independent systems do not require metabolic energy to move along a concentration
gradient. Simple diffusion is the predominant form of transport, but when substrate
concentrations are low, facilitated diffusion and active transport will account for more transport
(Webb, 1990).

Met Metabolism

Metabolism of Met is divided into 3 pathways: transmethylation, remethylation, and
transsulfuration. Transmethylation is a sequence of reactions present in Met metabolism and is
universally present in cells. Transmethylation (i.e., Met metabolism) begins when Met is
converted to SAM by Met adenosyltransferase (Brosnan and Brosnan, 2006). Numerous
methylases comprise the user group for SAM that donates its methyl group to an acceptor to
produce S-adenosylhomocysteine (Brosnan and Brosnan, 2006). The S-adenosylhomocysteine is
hydrolyzed to adenosine and homocysteine in a reaction catalyzed by S-adenosylhomocysteinase
(Martinov et al., 2009).
Remethylation occurs when homocysteine is methylated back to Met by Met synthase, which
is ubiquitous in the body (Brosnan and Brosnan, 2006). Betaine homocysteine methyltransferase
which is present in the liver and kidneys of some species can also methylate homocysteine to
Met. Methionine synthase uses 5-methyl-tetrahydrofolate as a methyl donor, while betaine
homocysteine methyltransferase uses betaine, from the diet or betaine produced during choline
oxidation (Stead et al., 2006). Betaine homocysteine methyltransferase and Met synthase solely
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affect remethylation. The combined steps of transmethylation and remethylation makeup what is
called the Met cycle and these steps occur in most cells of the body (Brosnan and Brosnan,
2006). Methionine catabolism does not occur during transmethylation or remethylation.
In the transsulfuration pathway, homocysteine is converted to cysteine by cystathionine βsynthase and cystathionine γ-lyase. The transsulfuration pathway exists in most tissues except
muscle (including heart) and endothelium (Martinov et al., 2009). The conversion of Met to
cysteine is an irreversible process. Methionine metabolism plays a vital role in folate
assimilation. Methionine synthase converts 5-methyl-tetrahydrofolate to tetrahydrofolate,
making it free to support DNA synthesis and various biological functions (Brosnan and Brosnan,
2006). The transsulfuration pathway is responsible for the majority of Met catabolism in the
body. The transsulfuration is also vital for the production of glutathione and taurine through its
synthesis of cysteine. Glutathione synthesis is often limiting based on cellular cysteine
concentrations and the transsulfuration pathway provides half of the cellular cysteine
requirements (Mosharov et al., 2000).
It is important to remember that Met metabolism is dependent upon the availability of
coenzymes and enzymes. For animals to properly metabolize Met, dietary requirements for
vitamins and minerals must be met. Dietary intake of B vitamins, specifically B2, B9, and B12
are necessary for proper Met metabolism in the body. Methionine synthase uses the derivative of
vitamin B9 (folic acid), using 5-methyl-tetrahydrofolate as a methyl donor. 5-methyltetrahydrofolate donates a methyl group to homocysteine to regenerate Met and the enzyme Met
synthase catalyzes this step and utilizes vitamin B12 (cobalamin) as a cofactor (Locasale, 2013).
Vitamin B2 (riboflavin) is a cofactor for 5-methyl-tetrahydrofolate synthesis. In monogastrics,
Met metabolism can be altered if the diet is limiting in B-vitamins. Because rumen microbes can
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synthesize B vitamins, ruminants are usually able to meet B vitamin requirements once rumen
microbes reach the small intestine (NRC, 2001).

Mammary Gland AA Metabolism

Knowledge of mammary gland AA metabolism is just as important as body or hepatic AA
metabolism, as the mammary gland is responsible for milk protein synthesis and can impact
lactational performance. Historically, AA metabolism is classified by the balance between
arteriovenous uptake and milk casein-AA secretion (Manjarin et al., 2014), while catabolism is
represented by excessive AA uptake which is not available for milk protein synthesis. Complex
intracellular interactions exist within mammary tissue. Therefore, AA metabolism in the
mammary gland may give insight on mechanisms responsible for improved AA utilization in
lactating dairy cows. Thus, if molecular mechanisms can be targeted by AA supplementation,
then lactational responses may be regulated at the cellular level and add to the complexity of
lactation.

Lys

Lysine has one of the highest fractional extraction rates by the mammary gland in bovids,
ovids, and suids (Trottier et al., 1997; Mabjeesh et al., 2000; Manjarin et al., 2014). The primary
metabolic fate of Lys in the mammary gland is for milk protein synthesis. Mabjeesh et al. (2000)
described that the uptake of Lys in the mammary gland of dairy cows and goats is greater than
milk Lys output. Hurley et al. (2000) reported that a small proportion of Lys is oxidized by
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mammary tissue. Lapierre et al. (2009) assessed the responses to mammary and splanchnic
metabolism to altered Lys supply in dairy cows. Six catheterized dairy cows received a control
diet with low CP (15.0% DM) plus an abomasal infusion of AAs (560 g/d) without or with Lys
(at 50.3 g/d) (Lapierre et al., 2009). The researchers found that limiting Lys did not alter the
uptake of Lys by the mammary gland. The mammary uptake to milk output ratio of Lys
decreased from 1.37 to 1.12 without Lys in the infusion, but Lys was still in excess of mammary
supply (Lapierre et al., 2009). The excessive uptake of Lys points toward Lys serving roles, other
than milk protein synthesis. The swine NRC (2012) estimates the rate of post-absorptive Lys
utilization into milk protein to be 67%, leaving 33% of Lys to be utilized for other processes,
including oxidative losses (Manjarin et al., 2014). According to Manjarin et al., (2014), Lys must
be involved in other roles, such as utilization of Lys into nonessential AA synthesis and the
utilization rate of 67% is a gross underestimation for the amount of Lys used for milk protein
synthesis.

Met

Methionine extraction by the mammary gland, unlike Lys, closely matches the amounts
required for milk protein synthesis (Bequette et al. 1998). Methionine, as previously stated has
many biological functions (Figure 1) and Met can be utilized to synthesize phospholipids,
carnitine, creatine, and polyamines (Wu, 2013a). To date there is a clear deficit in the literature
on the understanding of Met’s role in mammary tissue except for its incorporation into milk
proteins (Manjarin et al. 2014). According to Manjarin et al. (2014), none of the catabolic
pathways of Met known to occur in other tissues and organs has been studied nor identified in
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mammary tissue. The swine NRC (2012) used a coefficient of utilization efficiency for Met of
66%. The utilization efficiency for Met of 66% is most likely underestimated based on the idea
that mammary extraction of Met matches the amount required for milk protein output in ovids
and suids (Bequette et al. 1998; Manjarin et al., 2014). Guan et al. (2004) estimated the
efficiency of Met incorporation into porcine milk protein as being closer to 95%. Lysine and Met
catabolic pathways in mammary tissues need to be further investigated in cattle to get a better
understanding of the function these EAAs play in the mammary gland and on lactation.

Mammalian Target of Rapamycin (mTOR) Pathway

The mammalian target of rapamycin (mTOR) pathway regulates cell cycle progression, cell
growth, and protein synthesis through its ability to integrate nutrient and growth factor signals to
increase protein translation (Manjarin et al., 2014). The effect of individual AA supplementation
on translational protein synthesis has become an important research focus in recent years. The
mTOR pathway in the mammary gland has been fully described, but the molecular mechanisms
that AA influence for mTOR activation to increase protein synthesis in monogastrics and
ruminants is unclear (Manjarin et al., 2014). It is believed that AA availability regulates the
mTOR signaling pathway, by controlling translational initiation rates and by suppressing the
inhibitory activity of eIF4E binding protein 1 (Arriola Apelo et al., 2014a). Amino acids may
also increase elongation rates by stimulating eukaryotic elongation factor 2 and enhance
ribosomal activity through activation of ribosomal protein S6 (Arriola Apelo et al., 2014a).
Eukaryotic elongation factor 2 has been thought to be a limiting factor for milk protein synthesis
(Christophersen et al., 2002).
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Recently, Ma et al. (2019) sought to evaluate the effect of supplementing RPMet around
parturition on the quantity and phosphorylation of mTOR related signaling proteins in post-partal
bovine mammary tissue. The researchers found lower phosphorylation of mTOR complex 1 and
were unable to find the exact mechanisms responsible for increased protein synthesis due to
RPMet supplementation (Ma et al., 2019). However, they attributed the increased milk protein
percentage post-partal to increased DMI which may increase AA flux into the mammary gland.
Increased protein synthesis could also be attributed to increases in AKT serine/threonine kinase 1
phosphorylation status and a cascade of intracellular events, leading to upregulation of AA and
glucose transporters (Ma et al., 2019). It is evident that the exact molecular mechanisms that AA
influence for mTOR activation is unclear and further research needs to be conducted. The
findings from such studies could lead to a better understanding of why production responses to
supplementation of RPAAs are inconsistent and how molecular mechanisms could potentially
influence milk protein responses in lactating dairy cows.

BA

Current Approaches and Limitations

Bioavailability of AA in dairy cows has been assessed in vivo by a few techniques which
include the production response approach (Schwab et al., 2001; Fleming et al., 2019), the areaunder-the-curve method (Graulet et al., 2005; Fleming et al., 2019), the plasma free AA doseresponse technique (Rulquin and Kowalczyk, 2003; Borucki Castro et al., 2008; Hanigan et al.,
2009), and the revised plasma free Lys dose-response technique (Whitehouse et al., 2017). The
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most recent technique described in the literature is the stable isotope-based approach which is
used for the assessment of intestinally absorbed AAs from individual feed ingredients (Estes et
al., 2018). Although each approach has been described in the literature, caution should be taken
when reviewing each BA method, because each approach has limitations as is discussed below.
The major limitation for the production response approach is being able to ensure an AA
deficiency, for all treatment animals on the trial, over the entire range of the treatment dosages
(Whitehouse et al., 2017). The complexity of AA interactions in the mammary gland,
specifically with the mTOR pathway, also limits the utility of the production response approach.
If animals respond to AA supplementation with a positive linear response in milk protein
concentration or yield, this could either be due the AA exerting its effect directly in the
mammary gland, through activation of a molecular pathway, or nutrient interactions to stimulate
milk protein synthesis. The AA deficiency is necessary in order to obtain a linear response to AA
supplementation in either milk protein concentration (%) or milk protein yield (kg/d)
(Whitehouse et al., 2017).
For the area-under-the-curve technique, animals receive a single pulse dose of the RPAA in
high quantities not normally encountered by rumen microbes, which may limit or alter the
ruminal RPAA degradation, thus affecting the amount of AA that reaches the small intestine for
absorption (Whitehouse et al., 2017). The limitation for the plasma dose-response technique was
that all trials that used this technique, prior to the revised Lys technique, failed to assign dietary
treatments simultaneously within the same Latin square, thus ignoring potential animal variation
(Whitehouse et al., 2017).
A stable isotope non-invasive method for measuring BA of AA has been studied in ruminants
(Borucki Castro et al., 2008; Estes et al., 2017). There are 2 isotope dilution techniques that

39

either utilize a bolus or constant rate infusion of the AA isotope of interest (Estes, 2016). The
isotopic measurements are used to estimate the total AA flux from the labeled AA infused
dosage and subsequent isotopic enrichment of the samples selected to represent the compartment
(i.e., pool) of interest (Estes, 2016). The bolus approach uses a single isotope dose delivered into
the compartment of interest (Estes, 2016). The constant infusion approach uses a similar
principal, but the infusion is continued until enrichment in the compartment of interest reaches a
steady state to calculate a rate of total entry into the compartment (Estes, 2016).
Borucki Castro et al. (2008) assessed the efficacy of a whole-body Lys net flux method to
determine BA of Lys in dairy cows fed 3 different forms of soybean meal. The whole-body net
flux method (i.e., isotopic method) was tested against the plasma dose-response technique and
duodenal flow/intestinal digestion method. Borucki Castro et al. (2008) found that the plasma
response method recovered 97% of the omasally infused Lys and the isotope method recovered
100% of the omasally infused Lys, suggesting that there was no loss of the infused dose. The
researchers concluded that the isotope method is sensitive and accurate in determining Lys
availability in dairy cattle, which could be beneficial in eliminating the use of cannulated animals
for BA studies (Borucki Castro et al., 2008). However, the plasma response curve yielded similar
results to the isotopic method and further research is needed to assess the validity of an isotope
approach.

RPMet

For RPMet products, the BA is generally calculated based on a positive or negative dietary
control. Most often, Smartamine M is the positive control of reference value with a known BA of
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80%. However, the equation to derive BA of AA will be dependent on the method used to
measure BA (e.g., production response approach, the area-under-the-curve method, the plasma
free AA dose-response technique, or the stable isotope-based approach). Before a reference BA
value for Smartamine M was established, Berthiaume et al. (2000) stated that RPMet BA should
be based on a product’s AA concentration, ruminal stability, and intestinal digestibility. Koenig
and Rode (2001) defined BA of RPMet as a combination of effective ruminal degradability and
intestinal disappearance with the calculation being equal to: (100 – effective ruminal
degradability) × intestinal digestibility. Koenig and Rode (2001) estimated the BA of Mepron to
be a 23.6% based on the above calculation. Recently, Abdi-Benemar (2016) reported a BA of
61% for Mepron, which is closer to that of Smartamine M.
Bioavailability of Smartamine M was first estimated to be 80% from nylon bag studies and
determination of its ruminal stability exceeding 90% at 24 h and intestinal release values close to
90% (Schwab and Ordway, 2003). Robert and Williams (1997), estimated that the BA of
Smartamine M falls somewhere between 75 to 97%, with an average BA value of 88%. Graulet
et al. (2005) determined the BA of Smartamine M to be 74%, while Schwab (1995) found the
BA to be 80%.
The BA of HMBi is between 40 and 58%, based on blood kinetics (Robert et al., 2001;
Robert et al., 2002) and milk true protein indices (Schwab et al., 2001). Bioavailability
determined by blood Met concentration was 53 and 74% for HMBi and Smartamine M (Graulet
et al., 2005). The measurements from Graulet et al. (2005) indicate BA of HMBi to be 71% of
that from Smartamine M, whereas another study indicated that BA of HMB was 50% of that of
Smartamine M (Robert et al., 2001).

41

RPLys

Limited data is available in the literature on the BA of RPLys products. However, the most
studied RPLys product is AjiPro-L and multiple generations of AjiPro-L have been developed
(i.e., generations 1-3). Recently, Whitehouse et al. (2017) estimated the BA of AjiPro-L 2G and
AjiPro-L 3G using the plasma free Lys dose-response method. The slope for the AjiPro-L 3G
was numerically greater than that for the AjiPro-L 2G, which resulted in a 12% improvement in
the BA (Whitehouse et al., 2017). Tucker et al. (2015) compared the BA of 3 commercially
available RPLys products using the plasma free Lys dose-response method (MetaboLys; H.J.
Baker & Bro., Inc., Westport, CT and Lysine USA; Kemin Industries Inc., Des Moines, IA
against the second generation AjiPro-L; Ajinomoto Heartland, Inc.). The BA of MetaboLys and
Lysine USA were estimated as 18.3 and 38.2% of the second generation AjiPro-L BA,
respectively (Tucker et al., 2015).

CONCLUSIONS

Methionine and Lys are recognized as the 2 most limiting AA for milk protein synthesis and
milk production in dairy cows. With this in mind, considerable advancements have been made in
both protein and AA nutrition of dairy cows. These include the development of RPAA sources
with varying encapsulation coatings, the development of Met analogues, and the development of
cost-effective Met and Lys derivatives. As prices of feed protein continue to rise and as
environmental issues remain a concern, producers and nutritionists will need to evaluate the
potential of feeding lower CP diets with strategic AA supplementation. Incorporation of a
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multiple limiting AA concept in an animal requirement model will likely add to the complexity
of feeding dairy cattle. Although not necessary for animal requirement models, molecular and
cellular mechanisms (i.e., mTOR pathway) can identify sources of variation in response to AA
supplementation of dairy cows and potential discrepancies in BA data. A sound approach to
determine BA of AA in lactating dairy cattle may not be practical, but the prospect of an in vivo
stable isotope-based method could help with precision feeding of cattle.
There is an overall insufficiency of information on Met and Lys derivatives in lactating
cattle. The dissertation emphasis will be on Met (NALM) and Lys (NALL) acetylated derivatives
supplemented to lactating dairy cows. Their impacts on lactational performance (NALM and
NALL) and BA of NALM in lactation cows will be assessed. It was hypothesized that increased
Met and Lys supply from the AA derivatives being fed (NALM and NALL) would improve
lactational performance by increasing milk yield; however, the degree of response would depend
upon the AA derivative supplemental dose in the dietary treatments. It was anticipated that
NALM will act as an effective source for delivering BA Met equivalents to the small intestine to
be absorbed, transported into the bloodstream, and utilized by the animal for various biological
functions.
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Figure 1. Biological functions of Met and hepatic Met metabolism. BHMT = Betainehomocysteine methyltransferase; CBS = cystathionine-β-synthase; CSE = cystathionase; DMG =
dimethylglycine; GSH = glutathione; GNMT = glycine N-methyltransferase; HCY =
homocysteine; MAT1A = Met adenosyltransferase 1A; MTR = Met reductase; MT =
methyltransferase; 5-MTHF = 5-methyltetrahydrofolate; SAH = S-adenosylhomocysteine;
SAHH = SAH hydrolase; SAM = S-adenosyl-Met and THF = tetrahydrofolate. Adapted from
Zhang and White, (2017).
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CHAPTER 1

Influence of supplementing a methionine derivative, N-acetyl-L-methionine in dairy diets
on production and ruminal fermentation by lactating cows during early to mid-lactation
-Journal of Dairy Science, 2018, Vol. 101, Issue 8, p7082-7094

ABSTRACT

The present study investigated production responses and ruminal fermentation characteristics
of lactating dairy cows when supplemented with N-acetyl-L-Met (NALM) as a source of rumenprotected Met in metabolizable protein (MP) -deficient (MPD) or MP-adequate diet (MPA).
Eight lactating dairy cows (53  10.4 d-in-milk, on average) were blocked by parity and days-inmilk, and the experiment was performed in a replicated 4 × 4 Latin square design. Within each
square, cows were randomly assigned to a sequence of 4 diets during each of the four 21-d
periods (14 d of treatment adaptation and 7 d of data collection and sampling). A 2 × 2 factorial
arrangement was used; MPD or MPA was combined without or with NALM: MPD without
NALM, MPD with NALM (MPD+NALM), MPA without NALM, and MPA with NALM
(MPA+NALM). A NALM product was supplemented in the MPD+NALM and the
MPA+NALM at 30 g/cow/d. Supplementation of NALM did not affect dry matter intake (DMI)
and milk yield regardless of MP concentration. In addition, supplementing NALM resulted in a
similar milk true protein concentration and yield. In contrast, NALM supplementation increased
milk fat concentration and yield and 3.5% fat-corrected milk (FCM) yield and tended to increase
energy-corrected milk (ECM) yield regardless of MP difference. Additionally, trends were
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observed for increased 3.5% FCM yield/DMI and ECM yield/DMI, and the positive effects were
greater under the MPA than the MPD diet, resulting in trends toward interactions between MP
and NALM. Dietary treatments had similar effects on ruminal fermentation characteristics and
microbial protein yield. Plasma concentration of Met increased under the MPD but not the MPA
diet, leading to an MP × NALM interaction. Overall results in the current study suggest that
NALM exerted minor influence on ruminal metabolism, but increased milk fat concentration,
resulting in increases in milk fat yield and feed efficiency. Yet, potential effects of NALM on
intermediary metabolism between the gastrointestinal tract, the liver, and the mammary gland
need to be explored to understand utilization efficiency for production of dairy cows.
Key Words: N-acetyl-L-methionine, feed efficiency, lactational performance, milk fat
concentration

INTRODUCTION

Dietary sources of N in lactation diets are inefficiently utilized by dairy cows, as they excrete
substantially more N in manure over milk, which increases milk production costs and
environmental N excretion (Noftsger et al., 2005). Optimizing the balance of total AA in MP has
been used as the most promising means to maximize lactational performance with minimal
dietary CP supply (Lee et al., 2012a). Studies have suggested that Lys and Met are the most
limiting AA, especially in high producing dairy cows fed alfalfa and corn silage-based
commercial diets typically used in the United States, and optimal concentrations of these limiting
AA in MP are required to increase milk protein synthesis (Schwab et al., 1976). Thus, balancing
for these AA is of practical significance as an effective approach to enhance milk protein
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production. With an increasing economic value of milk protein, there has been strong interest by
dairy producers and industries in nutritional modifications such as supplementation of rumenprotected AA that will increase milk protein yield (Arriola Apelo et al., 2014a).
Considerable research has been conducted over the past 3 decades to develop technologies to
protect AA from ruminal degradation, and consequently ruminally protected Met (RPMet)
products in different chemical forms have been developed and extensively used to alleviate Met
deficiencies in lactating dairy cows (Overton et al., 1998; Patton, 2010). However, attempts to
increase milk protein yield by increasing the supply of Met by addition of RPMet have given
mixed results mainly due to complex inter-organ metabolisms in the rumen, the liver, and the
mammary gland (Bequette et al., 2003) and substantial variations on DMI and CP concentration
in feeds (Sinclair et al., 2014; Zanton et al., 2014).
The N-acetyl-L-Met (NALM) is a Met derivative produced via protection of L-Met α-amino
group with an N-acetyl group. The cost of production for N-acetyl DL-Met by addition of an αamino N-acetyl group to DL-Met is economically infeasible, but a cost-effective method for
NALM production was recently developed (CJ CheilJedang, Seoul, South Korea) by addition of
an α-amino N-acetyl group to L-Met. The NALM has been shown to be bioavailable and capable
of replacing dietary Met in animals and humans according to Rotruck and Boggs (1975). In
addition, NALM was readily incorporated into tissue proteins and supported growth of rats
(Rotruck and Boggs, 1975). The NALM has also been used in foods as an approved food
additive (Baxter et al., 2002). Windschitl and Stern (1988) reported that Met flowing out of
continuous cultures increased with N-acetyl DL-Met administration without a change in bacterial
Met flow, which was attributed to greater escape (67%) of the N-acetyl DL-Met from bacterial
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degradation. In the literature, however, there is no research reported on the effects of
supplementing NALM in lactation diet on production and ruminal fermentation in dairy cows.
We conducted the present study to investigate lactational performance and nutrient utilization
by lactating dairy cows supplemented without or with NALM in MP-deficient (MPD) or MPadequate diet (MPA), according to NRC (2001). We hypothesized that increased Met supply
from NALM would increase milk protein synthesis and milk yield, but the degree of the response
would depend upon the MP supply in the diets.

MATERIALS AND METHODS

The dairy cows used in the present study were cared for according to the Live Animal Use in
Research Guidelines of the Institutional Animal Care and Use Committee at Utah State
University. The study was conducted at the Caine Dairy Research Center (Wellsville, UT), Utah
State University from May to July, 2016.

Cows, Experimental Design, and Diets

Eight multiparous lactating Holstein cows were used during this trial. Cows began the
experiment averaging 53 ± 10.4 DIM, producing 39.2 ± 5.13 kg/d of milk yield, consuming 24.2
± 3.51 kg/d of DMI and an average BW of 696 ± 66.2 and 721 ± 57.3 kg at the beginning and the
end of the experiment, respectively. The experiment was performed in a replicated 4 × 4 Latin
square design. Within each square, cows were randomly assigned to a sequence of 4 diets during
each of the four 21-d periods (14 d of treatment adaptation and 7 d of data collection and
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sampling). Although primary production parameters were measured in the present study, caution
needs to interpret the data due to the short-term observation. Within each square, cows were
randomly assigned to a sequence of 4 dietary treatments with a 2 × 2 factorial arrangement: MPD
without NALM diet (MPD−NALM); MPD with NALM diet (MPD+NALM); MPA without
NALM diet (MPA−NALM), and MPA with NALM (MPA+NALM; Table 1-1).
The developmental NALM product from CJ CheilJedang was used as a supplemental source
of RPMet in this study. The NALM product was in powder form, and contained Met
concentration of 78.0%, with 99.5% purity. The NALM product was added at a rate of 0.13%
DM, and the rate was determined for cows to consume 30 g/cow/d of Met in order to supply 15.6
g of digestible Met to the small intestine according to manufacturer’s recommendation. This rate
was also based on the requirements of digestible Met for cows fed the MPD diet. The
recommendation of required digestible Lys and Met were assumed as 6.6 and 2.2% of the MP
requirements, respectively (NRC, 2001). The NALM product was top-dressed onto
corresponding experimental diets.
The chemical composition of alfalfa hay was 21.6, 38.9, and 27.9% DM for CP, NDF, and
ADF, respectively, whereas corn silage contained 5.32, 41.5, and 23.9% DM for CP, NDF, and
ADF, respectively. The diets had a forage-to-concentrate ratio of 61:39 (DM basis) on average
and were typical of high-producing dairy cows in the Intermountain West (i.e., Utah, Idaho,
Wyoming, Montana, and parts of Arizona and Nevada) with 44% of the forage coming from
good-quality alfalfa hay. Diets were formulated based on the NRC (2001) recommendations to
provide sufficient NEL, MP, vitamins, and minerals with an estimated intake of 25.0 kg/d to
produce 40 kg/d of milk with 3.5% fat and 3.0% true protein.
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Cows were housed individually in tie stalls fitted with rubber mattresses covered with straw,
allowing free access to water. Cows were individually fed twice daily for ad libitum intake at a
level of 110% expected daily intake with 70% of allotted feed fed at 0600 h and 30% fed at 1500
h. Feed offered and refused was recorded daily, and samples were taken during the sampling
week to determine DMI. Cows were milked twice daily at 0400 and 1600 h, and milk production
was recorded throughout the entire experiment.

Energy Partitioning Calculations

Energy partitioning was determined during treatment periods using data of milk yield, milk
composition, and BW of experimental animals. Cows were weighed for 2 consecutive d after the
a.m. milking and before the a.m. feeding at the beginning (d 1 and 2) and end (d 20 and 21) of
each period. These weights were used to calculate the mean BW of cows for each experimental
period. Energy used for maintenance was calculated as BW0.75× 0.08 (NRC, 2001). Energy of
BW change was assumed to be 5.114 Mcal/kg of gain or 4.924 Mcal/kg of loss (NRC, 2001).
Milk energy was calculated as (0.0929 × milk fat concentration) + (0.0563 × milk true protein
concentration) + (0.0395 × milk lactose concentration) (NRC, 2001). Estimated NEL value was
calculated by total net energy utilization (maintenance, BW gain, and milk) divided by DMI
(Neal et al., 2014).

Feed and Milk Samplings and Analyses
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Samples of alfalfa hay and corn silage were taken weekly to determine DM, and diets were
adjusted accordingly for change in DM concentration. Samples were composited by month,
ground to pass a 1-mm screen (standard model 4; Arthur H. Thomas Co., Swedesboro, NJ), and
stored for chemical analysis. Samples of TMR and orts were collected from individual cows on d
15 to d 21, composited, dried at 60°C for 48 h, and ground as previously described. The DM
concentrations of samples were used to calculate intakes of DM and nutrients.
Analytical DM concentration of samples was determined by oven drying overnight at 105°C,
and OM was determined by ashing at 550°C for 5 h (AOAC, 2000; method 942.05).
Concentration of CP was determined using an automated N combustion analyzer (Elementar,
Analysensysteme GmbH, Hanau, Germany; AOAC, 2000; method 968.06). Concentrations of
NDF and ADF were sequentially determined using a fiber analyzer (200/220, ANKOM
Technology, Macedon, NY) according to the methodology supplied by the company, which is
based on the methods described by Van Soest et al. (1991). Sodium sulfite was used in the
procedure for NDF determination and pre-treated with heat-stable amylase (Type XI-A from
Bacillus subtilis; Sigma-Aldrich Corporation, St. Louis, MO). Ether extract was measured using
a fat analyzer (XT20, ANKOM Technology; AOAC, 2000; method 2003.05). In addition,
samples of TMR were analyzed for starch by Dairyland Laboratories, Inc. (Arcadia, WI)
according to Knudsen (1997).
Milk was sampled for 2 consecutive days (d 15 and 16) during the a.m. and p.m. milkings
each period. Individual milk samples were analyzed by the Rocky Mountain DHIA Laboratory
(Providence, UT) for fat, true protein, lactose, and MUN. Milk composition was expressed on
weighted milk yield of a.m. and p.m. samples. Milk fat and protein yields were calculated by
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multiplying milk yield from the respective day by fat and true protein concentration of the milk
from an individual cow.

Blood and Urine Samplings and Analyses

Blood samples were collected immediately before the morning feeding as well as at 1000 and
1400 h into 10-mL plasma vacuum tubes from the coccygeal artery or vein on d 19 and 20 in
each period. Blood samples were centrifuged at 2,300 × g for 20 min, and plasma was collected
and stored at ‒40°C for subsequent AA analysis. The plasma samples were prepared for AA
analysis using the EZ:faast GC-FID Free (Physiological) Amino Acid Analysis Kit (Phenomenex
Inc., Torrance, CA). Concentrations of plasma free AA were determined in accordance with the
user manual provided with the kit. Extraction of free AA from the plasma consisted of a
combination of solid-phase extraction, derivatization, and liquid/liquid extraction. The organic
phase containing the AA in question were analyzed using a GC (model 5890, Hewlett-Packard
Lab) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZB-FAAP;
Phenomenex Inc., Torrance, CA) and flame-ionization detection.
On d 15 to 17, spot urine samples were collected from each cow at 0600 and 1800 h for a
total of 6 samples per cow (Holt et al., 2013). Using 4 M HCl urine samples were acidified to pH
< 4.0 and composited by cow per period. Samples were frozen and stored at –40°C. At a later
date, the samples were thawed in preparation for analysis and diluted with 39 parts diluent to 1
part urine. The diluent utilized consisted of 0.202% sodium 1-heptanesulfonate and 0.086%
ammonium dihydrogen phosphate (NH4H2PO4). The solution was brought to a pH of 2.1 using 4
M HCl. Utilization of the ratio of the urinary purine derivatives (PD) to creatinine is an accepted
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way to estimate the microbial protein (MCP) flow to the duodenum (Shingfield and Offer,
1998). The PD and creatinine were analyzed using an HPLC instrument (Waters Corp., Milford,
MA) according to the procedures set forth by Shingfield and Offer (1999). In order to estimate
urine volume, creatinine was used as a marker (Valadares et al., 1999), and an average creatinine
output of 28 mg/kg of BW as estimated by Whittet (2004) was assumed. Similar creatinine
outputs have been reported (25 to 30 mg/kg of BW daily) (McCarthy et al., 1983; Jones et al.,
1990). In order to estimate the relative differences in MCP production, the ratio of urinary PD
(allantoin and uric acid) to creatinine was used (Shingfield and Offer, 1998), and the supply of
MCP was estimated based on estimates of urinary excretion of PD according to the method of
Chen et al. (1990) and Janicek et al. (2008).

Ruminal Fermentation Characteristics

Ruminal fluid samples were obtained using a Geishauser probe at 0, 3, and 6 h after the
morning feeding on d 18 and 19 in each period. The fluid was collected with a solid, tube-like
probe with rows of small holes on the end (Geishauser, 1993). The first 100 mL of ruminal fluid
was discharged to avoid contamination from saliva, and then 10 mL was collected for analysis.
The pH of the ruminal fluid was measured within 5 min of collecting the samples using a
portable pH meter (Oakton pH 6; Oakton Instruments, Vernon Hills, IL). Five milliliters of the
ruminal fluid were mixed with 1 mL of 1% sulfuric acid and stored frozen (−40°C) for ammoniaN (NH3-N) analysis. Concentration of NH3-N in the ruminal contents was determined as
described by Rhine et al. (1998), using a plate reader (MRXe; Dynex Technologies Inc.,
Chantilly, VA). Another 5 mL of the ruminal fluid was collected and mixed with 1 mL of 25%
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metaphosphoric acid, and then stored at −40°C for VFA content determination. Ruminal VFA
were separated and quantified using a GLC (model 6890 series II; Hewlett-Packard Co.,
Avondale, PA) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZBFAAP; Phenomenex Inc., Torrance, CA) and flame-ionization detection. The oven temperature
was held at 170°C for 4 min, increased to 185°C at a rate of 5°C/min, then increased by 3°C/min
to 220°C, and held at this temperature for 1 min. The injector and the detector temperatures were
225 and 250°C, respectively, and the carrier gas was helium (Eun and Beauchemin, 2007).

Statistical Analysis

All data were analyzed as a 4 × 4 replicated Latin square with a factorial arrangement of
treatments using the Proc Mixed procedure of SAS (version 9.4; SAS Institute Inc., Cary, NC).
Data for intake, milk production, and energy partitioning were analyzed with a model that
accounted for effects of square, MP difference (MPD vs. MPA), supplementation of NALM
(−NALM vs. +NALM), day nested within period, and the interaction between MP, NALM, and
day as fixed effects and cow within square and period within square as random effects with day
included as a repeated measure. Data for ruminal pH, VFA, and NH3-N were analyzed using the
model described above except that time after feeding was included as the repeated option. For
each variable analyzed, 3 covariance structures (compound symmetry, autoregressive order 1,
and unstructured covariance) were evaluated. The covariance structure that resulted in the lowest
values for the Akaike information criterion and the Schwartz Bayesian criterion was used (Littell
et al., 1998). Kenward-Roger's option was used to calculate the denominator degrees of freedom.
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Residual errors were used to test main effects and interactions. Differences were considered
significant at P ≤ 0.05, and trends were discussed at 0.05 < P ≤ 0.10.

RESULTS AND DISCUSSION

To the best of our knowledge, this is the first time that the effects of supplementing NALM
in lactation dairy diets have been described. The lack of data in the literature regarding NALM
led us to indirectly compare our results with data reported for HMBi as well as traditional
polymer-protected Met (RPMet) products.
A continuous culture study estimated ruminal undegradability of N-acetyl-DL-Met at 67%
(Windschitl and Stern, 1988). Monogastric data involving young pigs supplemented with NALM
revealed that no NALM was present in either portal or vena caval plasma at any sampling time
(Daabees et al., 1984), which indicates hydrolysis of NALM to Met in the intestinal lumen and
mucosal cells. The research reported in this paper represents initial attempts to investigate
lactational performance and ruminal fermentation profiles of dairy cows fed with NALM as an
alternative RPMet source.

Characteristics of Diet Composition and Treatment

Ingredients and chemical composition of experimental diets are presented in Table 1-1. The
MPA diet provided adequate MP, whereas the MPD diet was 6% MP-deficient (-181 to -190
g/d). The MPD diet was formulated to contain less MP compared to the MPA diet by reducing
the amount of dietary concentrations of canola and soybean meal in the diets. The 6% MP
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deficiency was chosen for the MPD based on the result from Giallongo et al. (2016) who fed an
MP-deficient diet (5-10%) supplemented with RPMet. All diets supplied NEL in excess of
requirement (NRC, 2001). The MPA diet met or exceeded the MP, RDP, and RUP requirements,
while the MPD diet was deficient for MP, RDP, and RUP as expected.
The NRC (2001) model suggests that Lys and Met concentrations in MP for optimal milk
protein production are 7.2 and 2.4%, respectively. These concentrations are difficult to achieve
without feeding very high dietary concentrations of protein. Therefore, it is recommended that
the first step in balancing diets for Lys and Met is to maintain a Lys:Met in MP of 3.0 with more
practical concentrations of Lys and Met in MP being 6.6 and 2.2%, respectively (Schwab et al.,
2005). In this study, supplementing NALM (assuming 67% rumen undegradability) substantially
improved Met status, as indicated by the reduction of the predicted (NRC, 2001) digestible Lysto-digestible Met ratio in MP from 3.5 to 2.7 (Table 1-1). The digestible Lys-to-digestible Met
ratio for maximum milk and milk protein yield have traditionally been reported as a 3.00:1
(NRC, 2001, Whitehouse et al., 2009), but optimal ratios as low as 2.69:1 were reported by Van
Amburgh et al. (2015) when using the CNCPS model after calculating the optimum efficiency of
utilization of Lys and Met using data derived by Lapierre et al. (2007) and from a meta-analysis
of 40 published papers (Doepel et al., 2004).

Feed Intake, Productive Performance, and Net Energy Utilization

Intake of DM did not differ among dietary treatments, averaging 25.3 kg/d (Table 1-2). The
MPD and the MPA diet with supplementation of NALM increased CP intake with a greater
increase under the MPA diet, resulting in an MP × NALM interaction. Responses to

77

supplementation of polymer-coated RPMet and HMBi on feed intake and productive
performance in the literature have been quite variable. Kung and Rode (1996) found that rumenprotected AA supplementation did not improve DMI, which corresponds to the findings of other
studies performed by Leonardi et al. (2003) and Chen et al. (2011). A limited number of studies
have shown an increase in DMI with RPMet supplementation (Broderick et al., 2009; Zanton et
al., 2014), while Ordway et al. (2009) and Zanton et al. (2014) reported decreases in DMI.
Supplementation of HMBi has also increased DMI (Osorio et al., 2014) because of the potential
stimulatory effect of HMBi on cellulolytic bacteria and the subsequent increase in passage rate
and DMI (Lee et al., 2015). On the other hand, Lee et al. (2012b) assessed supplementation of
RPMet products to MP-deficient diets, as was explored in the current study and reported that
MP-deficient diets below 15% of the NRC requirements decreased DMI. However, the authors
observed that a treatment supplemented with a combination of 3 rumen-protected AA consisted
of Lys (100 g/cow), Met (30 g/cow), and His (50 g/cow) increased DMI (Lee et al., 2012b). An
additional study by the same group (Lee et al., 2015) found that supplementation with rumenprotected Lys and RPMet in MP-deficient diets (-256 to -305 MP g/d) did not affect DMI. In the
current study, stage of lactation may have interfered with a potential effect of NALM on DMI
under the MPA diet, because peak DMI typically tends to lag behind peak milk in early to midlactating cows that consume feed in order to meet energy needs.
Feeding the MPA diet increased milk yield by 2.2 kg/d relative to the MPD diet, resulting in
more efficient feed utilization for milk production (1.64 vs. 1.57; Table 1-2). Milk yield was not
affected by NALM supplementation, while yields of 3.5% FCM and ECM increased or tended to
increase (P = 0.06) with NALM addition. Noftsger et al. (2005) reported no difference in milk
production when cows were supplemented with HMBi at 0.13% DM. However, St-Pierre and
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Sylvester (2005) showed an increase in milk yield (2.9 kg/d) to cows supplemented with HMBi
at 0.15% DM. The observed production responses to supplementation of RPMet in cows fed
low-protein diets (i.e., MP-deficient diets) have been, in most cases, minimal and/or inconsistent
(Arriola Apelo et al., 2014a; Sinclair et al., 2014). No negative effect on milk yield was detected
by feeding a low CP diet (15%) alone or in combination with RPMet supplementation (Arriola
Apelo et al., 2014b). In the current study, a 6% MP-deficient diet decreased milk yield, while
previous research with MP-deficient diets (5-10% below MP requirement) have maintained milk
yield (Lee et al., 2015; Giallongo et al., 2016). In the present study, there was no improvement in
milk yield in response to NALM supplementation in both of the MPD and the MPA diet, thus
indicating that NALM was not utilized for milk production. Alternatively, NALM
supplementation increased yields of 3.5% FCM and ECM, suggesting a potential role on fatty
acid synthesis and delivery to the mammary gland possibly through a methyl donation
mechanism in the liver, which will be discussed later in this paper.
There was a tendency toward MP × NALM interaction on milk fat concentration (P = 0.10),
because NALM supplementation increased milk fat concentration under the MPA, but not the
MPD diet (Table 1-2). However, milk true protein concentration was similar across the diets.
Ordway et al. (2009) showed that HMBi did not increase milk fat concentration, but increased
milk protein concentration in comparison to the control diet. In contrast, milk fat concentration
increased with HMBi supplementation (Dalbach et al., 2011; Osorio et al., 2013). Supplementing
RPMet typically results in an increase in milk protein percentage (Rulquin and Delaby, 1997;
Samuelson et al., 2001; Lara et al., 2006), but one study (Benefield et al., 2009) reported a
negative impact on milk protein concentration. It has been well established that Met acts as a
methyl donor needed in the synthesis of milk fat (Osorio et al., 2016; Sun et al., 2016). The
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primary methyl carrier during bovine hepatic methyl metabolism is S-adenosyl-Met (SAM). It
works to donate methyl groups for the generation of phosphatidylethanolamine, acting as
phospholipids for cell membranes in the packaging of very low-density lipoprotein (VLDL;
Purohit et al., 2007). Once packaged, the VLDL consist of triglycerides, apolipoproteins B and
E, phospholipids, and cholesterol, and consequently Met plays a vital role in both the
development of apolipoproteins and phospholipids. The VLDL are then exported from the liver
to the mammary gland for milk fat synthesis (Figure 1-1). Thus, as a potential mode of action,
NALM after its digestion and absorption may have been involved in hepatic Met metabolism
pertaining to fatty acid trafficking, leading to the increased milk fat production in early to midlactation observed in the current study.
It has been reported that aminoacylase I is present in multiple mammalian organs (i.e., small
intestine, liver, and kidney; Giardina et al., 1997). The bovine liver contains the enzyme, α-Nacylamino acid hydrolase which is capable of hydrolyzing α-N-acylated AA to yield acetate and
the corresponding AA (Gade and Brown, 1981). However, it is unclear how cows utilize the
NALM into conversion of milk fat, once NALM was hydrolyzed by aminoacylase I and
absorbed in the small intestine as acetate and Met (Baxter et al., 2002) as was illustrated in the
Figure 1-1.
Feeding the MPA diet increased milk fat yield compared with the MPD diet, and
supplementing NALM further increased milk fat yield regardless of MP level (Table 1-2).
Although feeding the MPA diet increased milk protein yield compared with the MPD diet,
NALM supplementation did not influence milk protein yield. Noftsger et al. (2005) and St-Pierre
and Sylvester (2005) demonstrated an increase in milk protein yield with HMBi
supplementation. Supplementing HMBi and polymer-coated RPMet typically has more impact
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on milk protein vs. milk fat yield (Lara et al., 2006; Rulquin et al., 2006; Ordway et al., 2009).
This is most likely due to Met being the first-limiting essential AA in lactation dairy diets, and
consequently supplementation of HMBi or polymer-coated RPMet is first partitioned to improve
milk protein yield in dairy cows. Contradictory effects have been reported (Phipps et al., 2008
and Ordway et al., 2009) for HMBi on increased milk fat yield. Patton (2010) performed a metaanalysis on 35 studies evaluating production performance in lactating dairy cows supplemented
with various RPMet products to dairy diets and found increased production of true milk protein
both as a percentage (0.07%) and yield (27 g/d). However, NALM supplementation did not
increase milk protein yield, and thus NALM may have been used as a source of Met in methyl
donation toward VLDL production as previously discussed. Further research is needed to
determine the actual contribution of Met in NALM for VLDL formation and its impacts on milk
production parameters.
For the diets supplemented with NALM, the increased milk fat concentration and no change
in DMI resulted in a tendency toward MP × NALM interaction on 3.5% FCM yield/DMI and
ECM yield/DMI (P = 0.06; Table 1-2). A 12-wk study performed by Chen et al. (2011) showed
that supplementing HMBi to lactating cows averaging 143 DIM increased ECM yield/DMI. Feed
efficiency is a reasonable indicator evaluated on dairy farms, as it helps measure the relative
ability of cows to convert feed nutrients into milk or milk components. The increased feed
efficiencies observed in the current study suggest that NALM supplementation would be
economically favorable in early to mid-lactating cows, but only when fed a diet adequate in MP
concentration. However, caution should be exercised to extrapolate these benefits of NALM in
the current study due to the short length of data collection and, therefore, further investigation is
needed to confirm our data with a relatively long period of experiment.
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No changes were seen in either BW gain or net energy utilization with supplementation of
NALM in the diets (Table 1-2). However, feeding the MPA diet increased milk yield relative to
the MPD diet, leading to an increased net energy utilization for milk. Research on RPMet
supplementation on BW gain in ruminants is scarce, but some studies have reported increases in
BW gain upon RPMet supplementation (Deetz et al., 1985; Oke et al., 1986). Methionine is a
limiting AA in protein synthesis for growing cattle (Richardson et al., 1978), and therefore an
increase in available Met can support protein deposition in the body (Loest et al., 2002). The role
of Met in the formation of phospholipids through conversion of Met to SAM will also support fat
deposition in growing cattle (Obeid et al., 2009). In addition, acetate, a component of NALM, is
also recognized for its role as a lipogenic precursor (Bauman and Griinari, 2001). No effect on
BW gain due to NALM supplementation suggests that energy was partitioned for milk fat
production rather than BW gain in early to mid-lactation in the present study.

Plasma AA Profiles

Among EAA, feeding the MPA diet increased plasma concentrations of Ile and Leu
compared with the MPD diet, but supplementing NALM decreased those AA only under the
MPA diet, resulting in an interaction between MP and NALM (Table 1-3). Supplementing
NALM decreased plasma concentration of Val under the MPA but not the MPD diet, leading to a
MP × NALM interaction. In contrast, Noftsger et al. (2005) did not find any difference in Val
concentration when cows were supplemented with HMB, HMBi, or DL-Met. Similarly, St-Pierre
et al. (2005) supplemented a control diet with HMB, HMBi, or a combination of HMB and
HMBi, and the dietary treatments had no effect on free plasma amino acids, including Val.
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Plasma concentration of Met increased under the MPD but not MPA, leading to an MP × NALM
interaction. The no effect of NALM supplementation on plasma Met concentration in the MPA
diet observed in this study was unexpected, and its mechanism is difficult to explain. The liver
plays a central role in Met metabolism (Finkelstein, 1990); approximately 50% of Met
metabolism and up to 85% of all methylation reactions occur in the mammalian liver (Mato et
al., 2002). Hepatic gene regulation serves as an important regulatory point for controlling Met
metabolism (Finkelstein, 2003; Mato et al., 2008). However, effects of RPMet supplementation
on genes for Met metabolism in bovine hepatocytes in vivo has not been clearly understood in
lactating dairy cattle. Zhang et al. (2016) demonstrated decreased mRNA expression for genes
that catalyze regeneration of Met and showed the decreased need for cellular regeneration of Met
with increasing Met concentrations from 2-hydroxy-4-(methylthio)-butanoic acid (HMB) and
DL-Met on primary bovine hepatocytes. The authors described that increased Met supply from
HMB and DL-Met in primary bovine hepatocytes was not directed at increased glucose
synthesis, probably due to other metabolic priorities for Met (Zhang et al., 2016). Likewise, in
the current study it is speculated that increased Met supply from NALM supplementation in the
MPA diet may have been prioritized in the bovine hepatocyte to the primary methyl donor SAM,
allowing SAM to be used for increased VLDL synthesis and exportation to the mammary gland
for milk fat synthesis (Figure 1-1).

Ruminal Fermentation Characteristics

Ruminal pH decreased in the MPD relative to the MPA diet (6.24 vs. 6.37; Table 1-4), but
NALM supplementation did not influence ruminal pH. The mean ruminal pH from all dietary
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treatments were at least above 6.2, so even the effect of MP difference on overall microbial
physiology may have been minor. Concentration of VFA and their compositions were in general
not affected by MP level as well as NALM supplementation. Similarly, Noftsger et al. (2005)
and Lee et al. (2015) reported no effects of RPMet supplementation on ruminal pH and VFA
production. Concentration of NH3-N also did not differ across the dietary treatments, while MCP
yield increased due to feeding the MPA diet compared with the MPD diet, but NALM did not
affect MCP yield regardless of MP level (Table 1-4). Supplementation of RPMet traditionally
has not had an impact on microbial production, with the exception of Met analogues such as
HMBi because of its partial ruminal degradation and potential stimulatory effects on MCP
synthesis (Robert et al., 2001). Similarly, Lee et al. (2015) reported increased MCP yield with
polymer-coated RPMet supplementation. Although NALM is partially degraded in the rumen
(approximately 33%, Figure 1-1), the degraded fraction of the NALM would not contribute to
MCP synthesis under the experimental condition of our study. Further research is needed to
understand the mode of action of NALM on ruminal metabolism, particularly how the
aminoacylase I enzyme acts on NALM.

CONCLUSIONS

The current study investigated the production responses and ruminal fermentation profiles of
early to mid-lactating dairy cows supplemented without or with a developmental NALM product
in the MPD or the MPA diet. The NALM supplementation did not affect DMI, milk yield, and
milk protein yield or alter ruminal fermentation characteristics in either the MPD or the MPA
diet, suggesting that early to mid-lactating dairy cows tested in this study may have other
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metabolic priorities for Met. However, supplementation of NALM regardless of MP difference
increased both 3.5% FCM and ECM yields coupled with increased milk fat concentration which
was more impactful in the MPA diet, leading to better feed efficiencies with the MPA diet. Thus,
supplementing NALM, particularly in the MPA diet, in early to mid-lactation can be a good
approach to formulate an optimal dairy feeding program for improving feed efficiency. Yet, the
potential effects of NALM on intermediary metabolism between the gastrointestinal tract, the
liver, and the mammary gland needs to be explored to understand the metabolic impacts of
NALM on lactational and physiological parameters of dairy cows. Overall, the results in the
current study suggest that NALM exerted minor influence on ruminal metabolism, but increased
milk fat concentration possibly due to accelerated fatty acid delivery to the mammary gland,
resulting in sizable increases in milk fat yield and feed efficiency.
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Table 1-1. Ingredient and chemical composition of the experimental diets without or with Nacetyl-L-Met (NALM) at 2 different levels of MP fed to lactating Holstein dairy cows (n = 4)
Experimental diet1
MPD

MPA

−NALM

+NALM

−NALM

+NALM

Alfalfa hay

27.0

27.0

25.8

25.7

Wheat straw

2.49

2.49

2.38

2.38

Corn silage

32.5

32.5

31.0

31.0

Corn grain (steam-flaked)

11.6

11.6

11.1

11.1

Corn grain (high-moisture)

6.17

6.17

5.90

5.89

Cottonseed, whole

4.88

4.87

4.66

4.65

Canola meal

3.50

3.50

5.68

5.68

Soybean meal

3.25

3.24

5.27

5.27

Beet pulp, shreds

4.93

4.92

4.71

4.70

−

0.13

−

0.13

Sodium bicarbonate

1.08

1.08

1.03

1.03

Vitamin and mineral mix3

2.54

2.54

2.43

2.42

DM, %

60.9 ± 0.53

60.7 ± 0.32

61.0 ± 0.72

62.0 ± 1.50

OM

92.1 ± 0.60

91.6 ± 0.71

92.0 ± 0.84

92.0 ± 0.66

CP

15.2 ± 0.14

15.4 ± 0.21

16.1 ± 0.49

16.8 ± 0.35

9.52

9.73

9.82

10.3

Item
Ingredient, % of DM

NALM2

Chemical composition, % of DM

RDP4

95
RUP4

5.68

5.92

6.23

6.50

NDF

37.8 ± 1.37

37.0 ± 1.88

37.4 ± 1.06

38.2 ± 0.65

ADF

23.7 ± 0.85

23.4 ± 0.88

23.4 ± 0.84

24.0 ± 0.74

Starch

17.5 ± 0.57

19.0 ± 1.91

18.9 ± 0.99

16.6 ± 0.07

Ether extract

1.66 ± 0.61

1.91 ± 0.86

1.86 ± 0.39

1.68 ± 0.73

NFC5

37.4 ± 0.14

37.0 ± 0.21

36.7 ± 0.49

35.4 ± 0.35

1.67

1.67

1.68

1.68

RDP supply

2,342

2,443

2,494

2,616

RDP balance

-128

-27

24

146

RUP supply

1,397

1,499

1,595

1,651

RUP balance

-173

-71

25

81

MP supply

2,781

2,791

3,049

3,059

MP requirements

2,972

2,972

2,998

3,004

MP balance

-190

-181

50

55

dLys requirement

184

184

201

202

dLys supplied by the diet

191

191

209

209

Lys balance

7.0

7.0

8.0

7.0

dMet requirement

61

61

67

67

dMet supplied by the diet

55

55

60

60

dMet from Met derivative

0

15.6

0

15.6

-6.0

9.6

-7.0

8.6

NEL,4 Mcal/kg
Protein supply,6 g/d

Lys and Met balance,7 g/d

Met balance

96
dLys:dMet8

1

3.47

2.71

3.48

2.76

MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with

NALM; MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA
with NALM.
2

A developmental NALM product (CJ CheilJedang, Seoul, Korea) was a source of rumen-

protected Met, and it contained 78.0% Met.
3

Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of Cu

(from copper amino acid complex), 40,537.4 mg of Zn (from zinc amino acid complex),
38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co (from cobalt
carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1 IU of vitamin E,
and 295 mg of Rumensin (Elanco Animal Health, Greenfield, IN).
4

Based on tabular value (NRC, 2001).

5

NFC = 100 – CP – NDF – ether extract – ash.

6

All values were estimated using NRC (2001) based on actual DMI, milk yield, milk

composition, and BW of the cows throughout the trial.
7

Digestible Lys (dLys) and digestible Met (dMet) supply from the diets were estimated using

NRC (2001); supply of dMet from Met derivative was estimated with Met concentration and
absorption (67%) data provided the manufacturer. Requirements of dLys and dMet were
calculated as 6.6 and 2.2% (respectively) of MP requirements.
8

Diestible Lys from diet-to-digestible Met from diet and NALM ratio.
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Table 1-2. Intake, milk production, feed efficiency, and net energy utilization of lactating Holstein dairy cows
supplemented without or with N-acetyl-L-Met (NALM) at 2 different levels of MP
Diet1
MPD

Significance of effect2

MPA

−NALM

+NALM

−NALM

+NALM

SEM

MP

NALM

INT

24.6

25.6

25.4

25.4

1.34

0.67

0.46

0.44

Milk

39.3

39.7

41.3

42.0

2.60

< 0.01

0.48

0.81

3.5% FCM3

39.0

39.9

40.4

43.4

2.65

0.02

0.05

0.29

ECM4

38.7

39.7

40.2

42.9

2.51

0.02

0.06

0.35

Fat

3.44

3.52

3.34

3.70

0.121

0.65

0.02

0.10

True protein

2.77

2.82

2.78

2.83

0.083

0.82

0.21

0.92

Lactose

4.84

4.87

4.88

4.85

0.049

0.65

0.97

0.26

Fat

1.36

1.41

1.39

1.56

0.100

0.05

0.03

0.20

True protein

1.08

1.11

1.14

1.18

0.064

0.04

0.24

0.75

Lactose

1.91

1.93

2.02

2.04

0.128

< 0.01

0.53

0.95

Milk yield/DMI

1.59

1.55

1.61

1.66

0.075

0.03

0.83

0.10

3.5% FCM yield/DMI

1.58b

1.57b

1.57b

1.72a

0.083

0.06

0.09

0.06

Item
DM intake, kg/d
Yield, kg/d

Milk composition, %

Milk component yield,
kg/d

Feed efficiency

98
1.57b

1.55b

1.57b

1.70a

0.073

0.05

0.11

0.06

Initial, kg

704

698

702

704

21.7

0.56

0.66

0.26

Mean, kg

705

705

710

713

21.2

0.03

0.74

0.60

Gain, kg/d

0.06

0.30

0.40

0.40

0.345

0.24

0.51

0.51

Maintenance

10.9

10.9

11.0

11.0

0.25

0.03

0.73

0.57

BW gain

0.24

1.16

1.55

1.55

1.322

0.24

0.51

0.51

Milk

26.2

26.1

26.8

28.5

1.67

0.03

0.20

0.16

Total5

37.4

38.2

39.3

41.1

2.19

0.03

0.21

0.65

1.49

1.55

1.55

1.60

0.074

0.13

0.18

0.94

ECM yield/DMI
BW

Net energy utilization,
Mcal/d

NEL, Mcal/kg DMI

a-d

1

Means within a row with different superscripts differ (P < 0.05).

MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with NALM;

MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA with NALM.
2

MP = level of MP in the diet (MPD vs. MPA); NALM = supplementation of NALM (−NALM vs.

+NALM); and INT = interaction between MP and NALM.
3

3.5% FCM = [0.4324 × milk yield (kg/d)] + [16.216 × fat yield (kg/d)].

4

ECM = 0.327 × milk yield (kg/d) + 12.95 × fat yield (kg/d) + 7.2 × protein yield (kg/d).

5

Net energy used for maintenance, BW gain, and milk.
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Table 1-3. Plasma AA concentrations (µmol/L) of lactating Holstein dairy cows supplemented
without or with N-acetyl-L-Met (NALM) at 2 different levels of MP
Diet1
MPD

Significance of effect2

MPA

Item

−NALM

+NALM

−NALM

+NALM

SEM

MP

NALM

INT

His

10.1

11.6

10.2

9.7

5.60

0.51

0.70

0.48

Ile

85.3b

90.5b

102a

91.9b

9.39

< 0.01

0.35

< 0.01

Leu

119b

122b

144a

123b

12.5

< 0.01

0.02

< 0.01

Lys

61.2

65.8

68.0

65.0

17.61

0.40

0.83

0.29

Met

18.0b

19.6a

18.3ab

17.4b

0.85

0.06

0.49

0.01

Phe

71.3b

73.2ab

76.4a

70.6b

5.23

0.44

0.24

0.02

Thr

31.6

33.1

32.1

29.0

7.38

0.25

0.59

0.13

Val

248b

266b

283a

241b

23.3

0.74

0.43

0.05

Ala

196b

195b

200a

181b

14.3

0.36

0.04

0.07

Asp

37.9

49.8

46.9

38.1

9.48

0.77

0.75

0.03

Glu

24.8

23.3

24.2

22.6

2.50

0.47

0.09

0.99

Gly

198a

198a

188ab

168c

20.9

< 0.01

0.07

0.07

Pro

78.0ab

75.3bc

80.8a

70.3c

6.68

0.54

< 0.01

0.04

Tyr

138

166

168

159

42.2

0.35

0.44

0.13

EAA3

645b

682ab

720a

648b

21.6

0.34

0.42

0.01

NEAA4

793

707

694

638

64.3

0.19

0.27

0.82

a-c

Means within a row with different superscripts differ (P < 0.05).
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1

MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with NALM;

MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA with NALM.
2

MP = level of MP in the diet (MPD vs. MPA); NALM = supplementation of NALM (−NALM

vs. +NALM); and INT = interaction between MP and NALM.
3

Essential amino acid analyzed.

4

Nonessential amino acid analyzed.
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Table 1-4. Ruminal fermentation characteristics of lactating Holstein dairy cows supplemented without
or with N-acetyl-L-Met (NALM) at 2 different levels of MP
Diet1
MPD

Significance of effect2

MPA

−NALM

+NALM

−NALM

+NALM

SEM

MP

NALM

INT

Ruminal pH

6.26

6.21

6.35

6.39

0.101

0.03

0.95

0.48

Total VFA, mM

146

154

147

144

6.6

0.53

0.68

0.39

Acetate (A)

62.4

62.0

62.0

62.4

3.79

0.96

0.93

0.26

Propionate (P)

23.3

23.7

23.2

23.3

2.99

0.60

0.65

0.80

Butyrate

10.7

10.6

11.0

10.7

0.97

0.49

0.47

0.70

Valerate

1.57

1.66

1.47

1.62

0.403

0.30

0.09

0.61

Isobutyrate

0.79

0.89

0.95

0.87

0.128

0.27

0.88

0.14

Isovalerate

1.27b

1.27b

1.41a

1.20b

0.179

0.52

0.04

0.06

A:P

2.77

2.70

2.75

2.74

0.210

0.85

0.45

0.63

NH3-N,3 mg/100

9.34

9.05

9.28

9.82

1.425

0.70

0.89

0.65

2,540

2,649

2,954

2,837

237.7

< 0.01

0.96

0.16

Item

Individual VFA,
mol/100 mol

mL
MCP,4 g/d

a,b

1

Means within a row with different superscripts differ (P < 0.05).

MPD−NALM = diet deficient in MP (MPD) without NALM; MPD+NALM = MPD with NALM;

MPA−NALM = diet adequate in MP (MPA) without NALM; and MPA+NALM = MPA with NALM.
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2

MP = level of MP in the diet (MPD vs. MPA); NALM = supplementation of NALM (−NALM vs.

+NALM); and INT = interaction between MP and NALM.
3

Ammonia-N.

4

Microbial protein production (g/d) = ({[urinary total purine derivatives (allantoin + uric acid) − (0.385 ×

BW0.75)]/0.85} × 70 × 6.25)/(0.13 × 0.83 × 1,000) (Janicek et al., 2008).

Figure 1-1. Proposed mechanism of N-acetyl-L-Met (NALM) on its potential effects on milk fat and milk production. SAM = Sadenosyl-Met; VLDL = very low-density lipoprotein (Nelson and Cox, 2013)

CHAPTER 2

Effects of supplementing three different forms of rumen-protected lysine on
lactational performance of mid to late lactation dairy cows

ABSTRACT

The present study investigated lactational performance of dairy cows when
supplemented with N-acetyl-L-Lys (εNALL), N, -acetyl-L-Lys (diNALL), or
AjiPro-L (AP) as a source of rumen-protected Lys (RPLys) to a control diet. Control
cows (CL) were provided the basal diet formulated to contain 15.3% CP and supply
adequate MP (+ 10 g/d balance). Forty lactating Holstein dairy cows (151 ± 78.0 days-inmilk, on average) were assigned to treatments (n = 10) by parity and days-in-milk, and
the experiment was performed in a randomized complete block design. Cows were fed
the same CL diet for a 2-wk adaptation period. Cows were then randomly assigned within
blocks to 1 of the 4 experimental diets and fed assigned diets throughout the remaining 8
wk of the trial (entire study duration was 70 d). Developmental NALL, diNALL, and the
commercial RPLys product AP were supplemented to the CL diet at 51.5, 63, and 100
g/cow/d to provide 20 g/d of digestible Lys, respectively. Feeding the diNALL and the
AP diets decreased DMI. Milk yield was not altered by RPLys supplementation. Milk
composition (%) and milk component yields were not affected by RPLys
supplementation. In contrast, milk production efficiency (milk yield/DMI) increased with
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the diNALL diet in comparison to the CL diet. Body weight change was not affected by
RPLys supplementation. The diNALL diet shifted net energy partitioning (% energy
intake) toward milk production. Dietary treatments had similar plasma AA, N utilization,
and rumen NH3-N concentrations. Overall, results in the current study suggest that
diNALL and AP decreased DMI leading to improved milk production efficiency.
However, based on the current findings, the potential effects of RPLys on DMI regulation
warrant further investigation as stage of lactation and physiological changes occurring
through stage of lactation may have alter DMI.
Key Words: N-acetyl-L-lysine, feed efficiency, lactational performance, rumenprotected lysine

INTRODUCTION

Lysine is commonly considered the first limiting essential AA (EAA) in dairy cows
fed a corn-based ration or rations that include corn by-products, such as dried distillers
grains with solubles (Schingoethe et al., 2009). Lysine’s main biological role in dairy
cattle is to promote protein synthesis. Lysine may be used for weight gain in growing
dairy cattle, milk protein production in lactating dairy cows, incorporation into
mammalian tissues for structural integrity, or serve as a carbon backbone for carnitine
synthesis (NRC, 2001; Vaz and Wanders, 2002). However, for Lys products to exert their
biological effects in dairy cows, they must be able to avoid microbial degradation in the
rumen and supply post-ruminal Lys for small intestinal absorption.
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An effective method to increase post-ruminal Lys supply and improve post-ruminal
Lys absorptive efficiency is to feed rumen-protected Lys (RPLys). Inconsistent postruminal polymer degradation and high production costs have limited the development of
RPLys products (Swanepoel et al., 2010). However, since the early 1990s rumen stable
AA matrixes have been developed and numerous RPLys products have become available
for commercial use in animal agriculture (Robinson, 2009b). Available commercial
RPLys products use encapsulation, matrix technology, or a combination of both to protect
a Lys core from ruminal degradation (Ji et al., 2016). These RPLys products are often
coated by a series of lipid or fatty acid calcium-based salts (Ji et al., 2016). Wu and Papas
(1997) found that RPLys coating protection efficacy in the rumen depends on coating
composition, pellet surface smoothness, inner core pellet strength, and pellet solubility
and size. Recently, the production of Lys derivatives, a new form of RPLys may serve as
an alternative to physically protected lipid RPLys products.
The N-acetyl-L-Lys (NALL) is a Lys derivative produced via protection of the L-Lys
α-amino (Nα, ε-acetyl-L-Lys; diNALL) or ε-amino (Nε-acetyl-L-Lys; εNALL) group
with an N-acetyl group. The biological availability of N-substituted Lys products has
previously been described (Finot et al., 1978). The biological availability for diNALL
and εNALL is 0 and 50% in the rat, respectively (Neuberger and Sanger, 1943; Bjarnason
and Carpenter, 1969). According to Finot et al. (1978) the Lys derivatives which are
partially utilized as Lys sources in rats are Nε-formyl-L-Lys and εNALL. They belong to
the group of Nε-acyl-Lys and are negligibly hydrolyzed by homogenates of the intestinal
mucosa and liver, and only slightly so by the kidneys of the rat (Finot et al., 1978). Paik
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and Benoiton (1963) and Leclerc and Benoiton (1968) found that it is the renal ε-Lys
acylase which is responsible for Nε-formyl-L-Lys and εNALL hydrolysis. It is
anticipated that εNALL will be biologically available in lactating dairy cows, however,
there is no research reported on the effects of supplementing NALL in lactation diets on
production and ruminal fermentation in dairy cows.
The objective of the present study was to investigate lactational performance and
nutrient utilization by mid to late lactating dairy cows supplemented with 3 different
forms of RPLys. We hypothesized that supplementing RPLys to mid to late lactation
dairy cows would increase post-ruminal Lys supply and increase milk protein synthesis
and milk yield.

MATERIALS AND METHODS

The dairy cows used in the present study were cared for according to the Live Animal
Use in Research Guidelines of the Institutional Animal Care and Use Committee at Utah
State University. The study was conducted at the Caine Dairy Research Center
(Wellsville, UT), Utah State University from July to September, 2017.

Cows, Experimental Design, and Diets

Forty multiparous lactating Holstein dairy cows were used during the trial. Cows
were tested in mid to late lactation and began the experiment averaging 3.6 ± 1.21 parity,
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151 ± 78.0 DIM and producing 39.6 ± 6.89 kg milk/d. The experiment was performed as
a randomized complete block design. Cows were grouped into 10 blocks of 4 cows by
parity and DIM. Cows were fed the same control diet (CL) for a 2-wk adaptation period.
Cows were then randomly assigned within blocks to 1 of the 4 experimental diets and fed
assigned diets throughout the remaining 8 wk of the trial (entire study duration was 70 d).
Experimental diets were based on alfalfa hay, corn silage, and dried distillers grains with
solubles. Table 2-1 lists the chemical composition of the 4 dietary treatments. The control
diet was formulated to contain 15.3% CP and supply adequate MP (+ 10 g/d balance).
The dietary treatments fed in the study are as follows; 1) CL = normal CP (15.3%)
without RPLys, 2) NALL = normal CP with NALL (51.5 g/d), 3) diNALL = normal
CP with diNALL (63 g/d), and 4) AP = normal CP with AjiPro®-L (100 g/d).
The developmental NALL products from CJ CheilJedang (Seoul, South Korea) were
used as a supplemental source of RPLys in this study. N-acetyl-L-Lys and diNALL are
protected from rumen degradation with an N-acetyl group attached to either the α- or the
-amino group. The NALL and diNALL products were added at a rate of 51.5 and 63
g/d, respectively. The rate was determined for lactating dairy cows based on
manufacturer’s recommendation in order to supply 20 g of digestible Lys to the small
intestine. The recommendation of required digestible Lys and Met were assumed as 6.6
and 2.2% of the MP requirements, respectively (NRC, 2001). The RPLys products were
top-dressed onto corresponding experimental diets at each a.m. feeding. Diets were
formulated based on NRC (2001) recommendations to provide sufficient NEL, MP,
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vitamins, and minerals with an estimated intake of 25.0 kg/d to produce 36 kg/d of milk
with 3.5% fat and 3.0% true protein (Table 2-1).
Cows were housed individually in tie stalls fitted with rubber mattresses covered with
straw, allowing free access to water. Cows were individually fed twice daily for ad
libitum intake at a level of 110% expected daily intake with 60% of allotted feed fed at
0800 h and 40% fed at 1500 h. Feed offered and refused were recorded daily, and feed
samples were taken during each week of the trial to determine DMI. Cows were milked
twice daily at 0600 and 1600 h, and milk production was recorded throughout the entire
experiment.

Energy Partitioning Calculations

Energy partitioning was determined during sampling weeks using data of milk yield,
milk composition, and BW of experimental animals. Cows were weighed for 2
consecutive d after the a.m. milking and before the a.m. feeding at the end of weeks 2, 4,
6, 8 and 10. These weights were used to calculate the mean BW of cows for each
sampling week. Energy used for maintenance was calculated as BW0.75× 0.08 (NRC,
2001). Energy of BW change was assumed to be 5.114 Mcal/kg of gain or 4.924 Mcal/kg
of loss (NRC, 2001). Milk energy was calculated as (0.0929 × milk fat concentration) +
(0.0563 × milk true protein concentration) + (0.0395 × milk lactose concentration) (NRC,
2001). Estimated NEL value was calculated by total net energy utilization (maintenance,
BW gain, and milk) divided by DMI (Neal et al., 2014).
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Feed and Milk Samplings and Analyses

Samples of alfalfa hay, corn silage and dried distiller grains were taken weekly to
determine DM, and diets were adjusted accordingly for change in forage DM
concentration. Samples were ground to pass a 1-mm screen (standard model 4; Arthur H.
Thomas Co., Swedesboro, NJ), and stored for chemical analysis. Samples of TMR and
orts were collected from individual cows on d 3 and d 4, at the end of the adaptation
period and sampling weeks (3 through 10) composited, dried at 60°C for 48 h, and
ground as previously described. The DM concentrations of samples were used to
calculate intakes of DM and nutrients.
Analytical DM concentration of samples was determined by oven drying overnight at
105°C, and OM was determined by ashing at 550°C for 5 h (AOAC, 2000; method
942.05). Concentration of CP was determined using an automated N combustion analyzer
(Elementar, Analysensysteme GmbH, Hanau, Germany; AOAC, 2000; method 968.06).
Concentrations of NDF and ADF were sequentially determined using a fiber analyzer
(200/220, ANKOM Technology, Macedon, NY) according to the methodology supplied
by the company, which is based on the methods described by Van Soest et al. (1991).
Sodium sulfite was used in the procedure for NDF determination and pre-treated with
heat-stable amylase (Type XI-A from Bacillus subtilis; Sigma-Aldrich Corporation, St.
Louis, MO). Ether extract was measured using a fat analyzer (XT20, ANKOM
Technology; AOAC, 2000; method 2003.05). In addition, samples of TMR were
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analyzed for starch by Dairyland Laboratories, Inc. (Arcadia, WI) according to Knudsen
(1997).
Milk was sampled for 2 consecutive d (d 3 and 4) during the a.m. and p.m. milkings
each week. Individual milk samples were analyzed by the Rocky Mountain DHIA
Laboratory (Logan, UT) for fat, true protein, lactose, and MUN. Milk composition was
expressed on weighted milk yield of a.m. and p.m. samples. Milk fat and protein yields
were calculated by multiplying milk yield from the respective day by fat and true protein
concentration of the milk from an individual cow.

Blood Samplings and Analyses

Blood samples were collected immediately before the morning feeding and at 1400 h
into 10-mL EDTA plasma vacuum tubes from the coccygeal artery or vein on d 6 and 7
in each sampling week (4, 6, 8, and 10) and placed on ice. Blood samples were
centrifuged at 2,300 × g for 20 min, and plasma was collected and stored at ‒40°C for
subsequent AA analysis. The plasma samples were prepared for AA analysis using the
EZ:faast GC-FID Free (Physiological) AA Analysis kit (Phenomenex Inc., Torrance,
CA). Concentrations of plasma free AA were determined in accordance with the user
manual provided with the kit. Extraction of free AA from the plasma consisted of a
combination of solid-phase extraction, derivatization, and liquid/liquid extraction. The
organic phase containing the AA in question were analyzed using a GC (model 5890,
Hewlett-Packard Co, Avondale, PA) with a capillary column (30 m × 0.32-mm i.d., 1-μm
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phase thickness, Zebron ZB-FAAP; Phenomenex Inc., Torrance, CA) and flameionization detection.

Ruminal Fermentation Characteristics

Ruminal fluid samples were obtained using a Geishauser probe at 3 h after the
morning feeding on d 5 and 6 of each sampling week (4, 6, 8, and 10). The fluid was
collected with a solid, tube-like probe with rows of small holes on the end (Geishauser,
1993). The first 100 mL of ruminal fluid was discharged to avoid contamination from
saliva, and then 10 mL was collected for analysis. The pH of the ruminal fluid was
measured within 5 min of collecting the samples using a portable pH meter (Oakton pH
6; Oakton Instruments, Vernon Hills, IL). Five milliliters of the ruminal fluid were mixed
with 1 mL of 1% sulfuric acid and stored frozen (−40°C) for ammonia-N (NH3-N)
analysis. Concentration of NH3-N in the ruminal contents was determined as described by
Rhine et al. (1998), using a plate reader (MRXe; Dynex Technologies Inc., Chantilly,
VA). Another 5 mL of the ruminal fluid was collected and mixed with 1 mL of 25%
metaphosphoric acid, and then stored at −40°C for VFA content determination. Ruminal
VFA were separated and quantified using a GC (model 6890 series II; Hewlett-Packard
Co.) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZBFAAP; Phenomenex Inc., Torrance, CA) and flame-ionization detection. The oven
temperature was held at 170°C for 4 min, increased to 185°C at a rate of 5°C/min, then
increased by 3°C/min to 220°C, and held at this temperature for 1 min. The injector and
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the detector temperatures were 225 and 250°C, respectively, and the carrier gas was
helium (Eun and Beauchemin, 2007).

Statistical Analysis

Statistical analyses of all data except BW change, N excretion, AA and VFA were
conducted using the Proc Mixed procedure of SAS (version 9.4; SAS Institute Inc., Cary,
NC) with a repeated measures model that included the covariate mean for each trait for
each cow, plus block, treatment, week, and the interaction of treatment × week. A similar
approach was used for BW change, N excretion, AA and VFA data, except the covariate
was removed from the model. Overall, treatment differences were examined using least
squares means with the lowest standard error. Week and block were included in the final
statistical model for all analyses. The PDIFF option of SAS (version 9.4; SAS Institute
Inc., Cary, NC) was used to test treatment differences among least squares means, and the
SLICE option was used to analyze treatment differences among weekly treatment means.
Differences were considered significant at P ≤ 0.05, and trends were discussed at 0.05 <
P ≤ 0.10.

RESULTS AND DISCUSSION

Characteristics of Diet Composition and Treatment
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Ingredients and chemical composition of experimental diets are presented in Table 21. The CL diet had a CP content of 15.3%, which provided an adequate MP supply of
2,910 g/d (+ 10 g/d balance), whereas the RPLys supplemented diets provided an MP
supply of 2,930 g/d (+ 30 g/d balance) according to NRC (2001). Corn distillers grains
were added to the CL diet at an inclusion rate of 21% of DM in order to achieve a Lys
balance of – 20 g/d. High inclusion rates of corn distillers grains above 20% of DM have
been shown to increase the amount of rumen biohydrogenation intermediates (Hippen et
al., 2004) and may decrease milk fat concentration. Therefore, caution was taken to
ensure that the NDF concentration in the diets remained near NRC (2001)
recommendation of 25 to 33% of diet DM as total NDF. The RPLys supplemented diets
maintained a Lys balance of – 1 g/d (0 g/d Lys balance targeted) by providing 20 g of
metabolizable Lys to the diets based on manufacturers recommendation for each Lys
treatment. All diets supplied NEL in excess of requirement (NRC, 2001).
The concentrations of Lys and Met in MP was 6.6 and 2.2%, respectively. Digestible
Lys and Met concentrations in MP (dLys:dMet) were maintained at 3.05:1 for RPLys
supplemented diets and 2.73:1 for the CL diet. The dLys:dMet ratio for optimal milk and
milk protein yield is reported in the NRC as 3.0:1 (NRC, 2001), but ratios as low as
2.69:1 have been reported (Doepel et al., 2004; Van Amburgh et al., 2015).

Feed Intake, Productive Performance, and Net Energy Utilization
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Feeding the diNALL and the AP diets reduced intake of DM compared to the CL diet
(Table 2-2). Responses to supplementation of RPLys on feed intake in the literature are
limited. Paz et al. (2014) reported that RPLys supplementation did not affect DMI in
lactating dairy cows, which agrees with Blauwiekel et al. (1997) and Robinson et al.
(2011). Swanepoel et al. (2010) found that supplementation of RPLys did not influence
DMI in early lactating cows (77 ± 3.2 DIM); however, the mid lactation group (262 ±
6.70 DIM) had a tendency (P = 0.09) toward lower DMI with RPLys supplementation.
The mechanism by which RPLys reduces DMI in mid lactation cows is unknown, but the
authors suggested that RPLys possibly affected animal metabolism, which reduced
digestion in the lower digestive tract (Swanepoel et al., 2010).
A variety of factors such as forage quality, TMR nutrient balance, feed delivery,
feeding method, TMR palatability, ration DM content, environmental conditions, housing
facilities, and managerial practices can impact DMI (Allen and Bradford, 2009), which
might explain the lack of response seen with NALL supplementation. In the current
study, stage of lactation and week of trial may have altered DMI in cows fed the diNALL
and AP diets. This is because energy requirements decrease during mid lactation and
control of feed intake by gut distension gradually diminishes, while control by hepatic
oxidation increases (Allen and Bradford, 2009). Therefore, physiological changes
occurring through stage of lactation and the physical and chemical characteristics (NDF
concentration) of feeds beyond their nutrient composition can alter DMI (Allen and
Bradford, 2009).
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Supplementation of RPLys did not alter milk yield (Table 2-2). Milk, 3.5% FCM, and
ECM yields were not affected by dietary treatments. Swanepoel et al. (2010) observed
that dairy cows supplemented with RPLys at a rate of 41 g/cow/d did not affect milk
yield in early lactation. Paz and Kononoff (2014) did not detect a difference in milk yield
when RPLys was supplemented to diets with altering inclusion rates of low-fat dried
distillers grains (15 vs. 30% of diet DM). Furthermore, cows supplemented with RPLys
(37 g/cow/d) after peak lactation showed no improvement in milk yield (Bernard et al.,
2014). In contrast, Robinson et al. (2011) found a 2 kg increase in milk yield when
RPLys was supplemented to deliver 15 to 21 g of MP Lys. In the present study, there was
no improvement in milk yield in response to RPLys supplementation, thus indicating that
RPLys was not utilized in the mammary gland of mid to late lactating dairy cows for milk
production. The RPLys supplemental dosage rate, lack of a digestible Lys delivery to the
small intestine for absorption, or reduced DMI may be responsible for the absence of
production responses seen in the current study.
Milk composition (%) and milk component yields (kg/d) were not affected by dietary
treatments (Table 2-2). Swanepoel et al. (2010) reported reduced milk fat synthesis to
feeding a RPLys product to high producing dairy cows. Třináctý et al. (2009) fed RPLys
to lactating Holstein dairy cows (33.5 kg/d) and while milk protein concentration
increased, milk fat concentration and yield declined. A review of literature by Robinson
(2010) stated that RPLys supplementation generally results in minimal production
responses, possibly due to an AA imbalance or poor AA delivery to the intestinal
absorptive site. The productive benefits of RPLys supplementation on overall
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performance effects in lactating dairy cows can only be judged as negative (Robinson,
2010). However, increased Lys supply appear important in early lactation when MCP
synthesis is reduced because of lower DMI, to help drive milk and milk protein
production (Robinson et al., 2011). Stage of lactation (mid to late) or lack of a digestible
Lys deficiency in the diets supplemented with RPLys may be responsible for the absence
of production responses seen in the current study.
The diNALL diet reduced intake of DM and maintained milk yield resulting in better
feed efficiency for milk production compared to the CL diet (1.54 vs. 1.33; Table 2-2).
Wang et al. (2010) supplemented L-Lys-HCl at 0.50% DM to a control diet and detected
increased milk yield with no increase in DMI, improving feed efficiency to 1.34 vs. 1.27
for the control diet. As previously mentioned, the biological availability for diNALL and
εNALL is 0 and 50% in the rat based on growth rates (Neuberger and Sanger, 1943). The
improvement in feed efficiency for milk production with diNALL supplementation
demonstrate that, unlike in the rat, diNALL may be biologically available in lactating
dairy cows. Additionally, the increased feed efficiency observed in the current study
suggest that diNALL supplementation would be favorable in mid to late lactating cows,
but only when fed to a diet that has a digestible Lys deficit. Based on the current findings
the biological availabilities of diNALL and εNALL in lactating dairy cows warrant
further investigation.
No changes were seen in either BW gain or net energy utilization with
supplementation of RPLys in the diets (Table 2-2). However, feeding the diNALL diet
reduced BW gain relative to the CL diet, leading to an increased net energy partitioning
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for milk. No effect on BW gain due to diNALL supplementation suggests that energy
was primarily partitioned toward milk production rather than BW gain in mid to late
lactation in the current study.

Plasma AA Profiles

Plasma AA concentrations (EAA and NEAA) were not affected by RPLys
supplementation (Table 2-3). The plasma Lys concentrations observed in the current
study (Table 2-3) agree with Swanepoel et al. (2010), who did not detect a difference in
plasma Lys concentrations of mid lactating dairy cows supplemented with RPLys at 41
g/cow/d. Since, RPLys was supplemented to the CL diets, an increase in plasma Lys
concentration was expected. However, because digestible Lys requirements were met, the
absorbed Lys may have been used for biological functions other than milk production,
converted to metabolites or not utilized. Lysine is an AA with a high fractional extraction
rate by the mammary gland in ruminants (Manjarin et al., 2014). The primary metabolic
fate of Lys in the mammary gland is for milk and milk protein synthesis. Mabjeesh et al.
(2000) observed that the uptake of Lys in the mammary gland of dairy cows is greater
than milk Lys output. The plasma Lys concentration along with changes in production
parameters (i.e., milk yield) for the diNALL diet indicates that plasma Lys may have
been utilized for improved milk yield. Since, plasma AA profiles were not altered by
RPLys supplementation, further research is needed to determine the impact of Lys
derivative supplementation on plasma AA profiles in lactating dairy cows.
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Utilization of N

Intake of N in the current study followed DMI, meaning that cows fed the diNALL
and the AP diets consumed less N than those fed the NALL and CL diets (Table 2-4).
Supplementation of RPLys products do not often increase N intake because of either a
lower dietary CP or MP concentration in basal diets associated with RPLys or a
combination of RPAA supplementation (Leonardi et al., 2003; Broderick et al., 2009).
Lee et al. (2015) supplemented a MP-deficient diet (MP balance of −281 g/d; CP of
13.7% DM); with 100 g of RPLys/cow/d (estimated digestible Lys supply = 24 g/d) and
reported no increase in N intake compared to the MP-deficient diet. Supplementation of
RPLys had no effect on milk N excretion in the current study. Milk N efficiency is
primarily driven by feed N intake (Huhtanen and Hristov, 2009). Although the N intake
was reduced for the diNALL and the AP diets, no change in milk N excretion after
supplementation of RPLys resulted in milk N:N intakes that were similar across all diets
(0.32 on average). The N utilization efficiencies reported in the current study are similar
to the average N efficiencies (25 to 35%) reported in the literature (Hristov et al., 2004).
The lack of response in milk N to dietary treatments is related to DMI and milk yield
seen in the current study.
Concentrations of MUN and NH3-N were not affected by dietary treatments. Urea-N
(milk, serum, and urine) in cattle is derived from excess NH3-N absorbed through the
rumen wall from rumen CP degradation and deamination of AA (Linn and Olson, 1995;
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Wang et al., 2008). Wang et al. (2010) supplemented L-Lys-HCl at 0.50% of DM to a
control diet that was adequate in energy, but slightly limiting in MP and detected
increased urea-N concentration in serum, urine, and milk compared with the control diet.
In the present study, supplementation of RPLys maintained MUN and NH3-N
concentrations, indicating that the RPLys diets may have provided a more favorable AA
balance and resulted in less deamination of absorbed AA.
Urinary and fecal N excretion were not affected by dietary treatments. However,
manure N excretion (urinary N excretion, g/d + fecal N excretion, g/d) decreased for the
diNALL and the AP diets. Urinary and fecal N are directly correlated with DM and N
intakes (Huhtanen et al., 2008). Therefore, because of the reduced N intake of animals
fed the diNALL and the AP diets, manure N excretion decreased. The reduced manure N
excretion in the current study indicates the potential use of supplementing diNALL to
lactating dairy cows to aid in environmental N management on dairy farms, however
further lactation trials are needed to determine how NALL products impact N utilization
in lactating dairy cows.

Ruminal Fermentation Characteristics

Supplementation of RPLys in the NALL, the diNALL and the AP diets reduced
ruminal pH and ranged from 6.15 to 6.23, compared to the CL diet (pH = 6.42; Table 25). The mean ruminal pH from all dietary treatments were close to or above 6.2, so
RPLys influence on overall microbial composition may be negligible. The effects of
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RPLys supplementation on ruminal pH is not well defined in the literature. Recently, Lee
et al. (2015) determined that RPLys supplementation to an MP-deficient diet did not alter
ruminal pH in mid-lactation dairy cows.
Total and individual VFA concentrations were similar across dietary treatments.
According to Lee et al. (2015), rumen fermentation variables (total and individual VFA)
were not affected by RPLys supplementation to a MP-deficient diet. A previous study
performed by our group (Menchu, 2019), estimated the ruminal escape for the NALL
products used in the current study. The ruminal escape (% of dose) averaged 43.5 for
both NALL products, indicating that the NALL chemical structure is altered in the rumen
environment. The absence of response in VFA profiles to NALL and diNALL dietary
treatments, suggests that NALL lacks a ruminal mode of action and further research is
needed to understand the metabolism of NALL in the rumen.

CONCLUSIONS

Results of the current study show that feeding the diNALL diet in mid to late
lactation dairy cows decreased DMI, leading to greater feed efficiency compared to the
CL diet. Milk composition, milk component yields, AA, and VFA profiles were not
affected by RPLys supplementation. Net energy shifted toward milk production for the
diNALL treatment. Rumen-protected Lys supplementation did not alter utilization of N
by lactating Holstein dairy cows in the present study. These findings suggest that the
developmental NALL products may be biologically active in lactating dairy cows, with
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diNALL showing the most benefit to improve feed efficiency. However, further research
is needed to discover the role of Lys derivatives in lactating dairy cows on productive
performance, rumen metabolism, and bioavailability.
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Table 2-1. Ingredient and chemical composition of the experimental diets supplemented
with rumen-protected lysine fed to lactating Holstein dairy cows (n = 40)
Experimental diet1
CL

NALL

diNALL

AP

Alfalfa hay

19.6

19.5

19.5

19.5

Wheat straw

4.91

4.90

4.90

4.89

Corn silage

26.4

26.4

26.4

26.3

Corn grain (steam-flaked)

13.9

13.9

13.9

13.9

Corn distillers grain

21.0

21.0

21.0

20.9

Cottonseed, whole

4.86

4.84

4.84

4.83

Beet pulp, shreds

6.54

6.53

6.53

6.52

Lysine supplement2

−

0.20

0.25

0.40

Sodium bicarbonate

0.63

0.63

0.63

0.63

Vitamin and mineral mix3

2.11

2.10

2.10

2.09

DM, %

57.6 ± 1.88

58.1 ± 1.93

57.8 ± 2.74

58.2 ± 2.80

OM

91.2 ± 0.38

91.3 ± 0.48

91.7 ± 1.22

91.1 ± 0.58

CP

15.3 ± 0.20

15.4 ± 0.25

15.4 ± 0.51

15.4 ± 0.36

RDP4

8.58

8.64

8.64

8.64

RUP4

6.72

6.76

6.76

6.76

Item
Ingredient, % of DM

Chemical composition, % of DM
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NDF

34.6 ± 1.98

34.2 ± 2.46

34.3 ± 1.65

34.2 ± 2.99

ADF

18.6 ± 1.37

18.0 ± 1.36

18.0 ± 0.90

18.0 ± 1.64

Starch

19.5 ± 0.65

19.4 ± 1.02

19.4 ± 0.99

19.5 ± 0.54

Ether extract

3.38 ± 1.06

4.58 ± 0.91

3.96 ± 1.39

4.10 ± 1.29

NFC5

37.9 ± 2.56

37.1 ± 3.21

38.0 ± 3.10

37.4 ± 3.43

1.74

1.74

1.74

1.74

MP supply

2,910

2,930

2,930

2,930

MP requirement

2,900

2,900

2,900

2,900

10

30

30

30

dLys requirement

192

193

193

193

dLys supplied by the diet

172

172

172

172

0

20

20

20

Lys balance

-20

-1

-1

-1

dMet requirement

64

64

64

64

dMet supplied by the diet

63

63

63

63

Met balance

-1

-1

-1

-1

dLys:dMet8

2.73

3.05

3.05

3.05

NEL,4 Mcal/kg
Protein supply,6 g/d

MP balance
Lys and Met balance,7 g/d

dLys from Lys supplement
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1

CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea); diNALL=

Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control + AjiPro®-L v2
(Ajinomoto, Japan).
2

Developmental NALL products (NALL and diNALL) (CJ CheilJedang, Seoul, Korea)

and a commercial RPLys product (AjiPro®-L v2) (Ajinomoto, Japan) were used as the
sources of rumen-protected lysine.
3

Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of

Cu (from copper amino acid complex), 40,537.4 mg of Zn (from zinc amino acid
complex), 38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co
(from cobalt carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1
IU of vitamin E, and 295 mg of Rumensin (Elanco Animal Health, Greenfield, IN).
4

Based on tabular value (NRC, 2001).

5

NFC = 100 – CP – NDF – ether extract – ash.

6

All values were estimated using NRC (2001) based on actual DMI, milk yield, milk

composition, and BW of the cows throughout the trial.
7

Digestible Lys (dLys) and digestible Met (dMet) supply from the diets were estimated

using NRC (2001); supply of dLys from RPLys products were estimated by data provided
the manufacturer. Requirements of dLys and dMet were calculated as 6.6 and 2.2%
(respectively) of MP requirements.
8

Digestible Lys from diet-to-digestible Met from diet ratio.
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Table 2-2. Dry matter intake, productive performance, body weight (BW) change, and
net energy utilization of mid to late lactation Holstein dairy cows supplemented with
rumen-protected lysine
Diet1
CL

NALL

diNALL

AP

SEM

P

26.8b

26.1ab

24.7a

24.8a

0.41

< 0.01

Milk

36.4

36.6

37.1

35.6

1.16

0.83

3.5% FCM

36.2

36.5

35.8

35.6

1.83

0.98

ECM

36.5

36.9

36.5

35.7

1.62

0.96

Fat

3.74

3.39

3.32

3.30

0.178

0.29

True protein

3.05

3.00

2.98

3.05

0.101

0.95

Lactose

4.88

4.72

4.79

4.85

0.055

0.17

Fat

1.29

1.26

1.22

1.23

0.086

0.91

True protein

1.09

1.09

1.11

1.04

0.034

0.50

Lactose

1.77

1.76

1.78

1.73

0.061

0.92

Item
Intake, kg/d
DM
Yield, kg/d

Milk composition, %

Milk component yield,
kg/d

Dairy efficiency
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Milk yield/DMI

1.33b

1.46ab

1.54a

1.46ab

0.046

0.02

3.5% FCM yield/DMI

1.33

1.44

1.49

1.46

0.070

0.42

ECM yield/DMI

1.35

1.45

1.51

1.47

0.061

0.30

Initial, kg

745

758

730

735

18.9

0.36

Mean, kg

769

772

730

746

18.8

0.35

Gain, kg/d

1.74

1.08

0.10

1.02

0.661

0.39

Maintenance

11.7

11.7

11.2

11.4

0.21

0.35

BW gain

8.89

5.50

0.51

5.22

3.38

0.39

Milk

25.9

24.4

24.1

24.1

1.75

0.88

BW gain + milk

34.7

29.9

24.6

29.3

3.03

0.15

Total2

46.4

41.6

35.9

40.8

3.05

0.13

NEL,3 Mcal/kg of DMI

1.74

1.56

1.43

1.62

0.113

0.29

Maintenance

27.1

29.3

34.6

29.0

2.52

0.20

BW gain

12.3

10.3

-10.5

10.7

9.23

0.27

Milk

60.6

60.4

75.8

60.3

7.18

0.35

BW gain + milk

72.9

70.7

65.4

71.0

2.52

0.20

BW

Calculated net energy
values, Mcal/d

Net energy partitioning,
% energy intake
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a-b

1

Means within a row with different superscripts differ (P < 0.05).

CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea);

diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control +
AjiPro®-L v2 (Ajinomoto, Japan).
2

Net energy used for maintenance, BW change, and milk.

3

Calculated NEL = calculated total net energy, Mcal/d ÷ DMI (kg/d).
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Table 2-3. Plasma AA concentrations (µmol/L) of mid to late lactation Holstein dairy
cows supplemented with rumen-protected lysine
Diet1

1

Item

CL

NALL

diNALL

AP

SEM

P

Arg

48.9

53.1

48.8

54.2

3.09

0.49

His

51.0

49.9

49.7

47.2

2.70

0.78

Ile

88.7

86.8

80.5

88.4

5.61

0.71

Leu

206

197

181

191

12.6

0.58

Lys

71.6

78.7

66.5

77.6

4.71

0.24

Met

20.7

20.7

20.3

20.5

1.04

0.99

Phe

44.0

43.5

41.0

43.7

1.77

0.60

Val

217

202

192

207

14.2

0.67

EAA2

748

731

678

731

42.6

0.68

Ala

251

237

247

235

10.6

0.65

Gly

232

218

231

221

16.6

0.92

Ser

81.9

81.5

77.7

81.2

5.12

0.72

Tyr

55.9

55.3

51.6

57.6

3.58

0.68

NEAA3

621

609

607

595

28.1

0.93

CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea);

diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control +
AjiPro®-L v2 (Ajinomoto, Japan).
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2

Essential amino acid analyzed.

3

Nonessential amino acid analyzed.
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Table 2-4. Utilization of N by mid to late lactation Holstein dairy cows supplemented
with rumen-protected lysine
Diet1
Item

CL

NALL

diNALL

AP

SEM

P

N intake, g/d

613b

611b

583a

580a

10.1

0.04

Milk N,2 g/d

189

184

185

188

10.6

0.99

Milk N:N intake3

0.31

0.30

0.32

0.33

0.017

0.75

MUN, mg/100 mL

11.2

11.1

11.3

11.6

0.33

0.74

NH3-N4, mg/100 mL

11.4

11.1

11.9

11.3

0.48

0.70

Urinary N excretion,5 g/d

224

223

216

225

9.40

0.90

Fecal N excretion,6 g/d

201

204

182

167

12.0

0.12

Manure N excretion,7 g/d

424b

427b

398a

392a

12.0

0.10

a-b

1

Means within a row with different superscripts differ (P < 0.05).

CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea);

diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control +
AjiPro®-L v2 (Ajinomoto, Japan).
2

Milk N (kg/d) = milk true protein (kg/d)/6.38 + MUN (kg/d).

3

Efficiency of use of feed N to milk N.

4

Ruminal ammonia-N.

5

Predicted using the equation: 0.026 × MUN, mg/100 mL × BW, kg (Wattiaux and Karg,

2004).
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6

Predicted using the equation: N intake, g/d – urinary N excretion, g/d – milk N, g/d.

7

Manure N, g/d = urinary N excretion, g/d + fecal N excretion, g/d.
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Table 2-5. Ruminal fermentation characteristics of mid to late lactation Holstein dairy
cows supplemented with rumen-protected lysine
Diet1
CL

NALL

diNALL

AP

SEM

P

Ruminal pH

6.42a

6.23b

6.18b

6.15b

0.06

0.02

Total VFA, mM

96.5

98.2

97.0

98.2

5.5

0.53

Acetate (A)

57.5

56.5

57.9

58.4

1.03

0.59

Propionate (P)

25.4

28.4

26.4

26.8

0.89

0.15

Butyrate

10.4

10.1

9.6

9.8

0.44

0.19

Valerate

1.53

1.57

1.52

1.50

0.07

0.60

Isobutyrate

0.87

0.83

0.86

0.92

0.05

0.22

Isovalerate

0.83

0.84

0.70

0.74

0.07

0.38

2.35

2.05

2.24

2.25

0.10

0.25

Item

Individual VFA, mM

A:P

a,b

1

Means within a row with different superscripts differ (P < 0.05).

CL= control diet; NALL = Control + NALL (CJ CheilJedang, Seoul, Korea);

diNALL= Control + diNALL (CJ CheilJedang, Seoul, Korea); and AP = Control +
AjiPro®-L v2 (Ajinomoto, Japan).
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CHAPTER 3

Bioavailability and lactational performance of dairy cows supplemented with Nacetyl-L-methionine at different doses

ABSTRACT

The present study investigated the bioavailability and lactational performance of dairy
cows supplemented with N-acetyl-L-Met (NALM) at different doses. Six lactating dairy
cows (75  20.1 d-in-milk) were blocked by parity and d-in-milk. The experiment was
performed as a replicated 3 × 3 Latin square design. Within each square, cows were
randomly assigned to a sequence of 3 diets during each of the three 13-d periods (10 d of
treatment adaptation and 3 d of data collection and sampling). The 3 dietary treatments
are as follows: basal diet (15.7% CP) without NALM (control); control diet with 30 g/d
of supplemented NALM (30NALM), and control diet with 60 g/d of supplemented
NALM (60NALM). The NALM was rumen dosed for 11 d and then abomasally infused
on d 12 and d 13 for quantification of NALM bioavailability (BA). Supplementation of
NALM did not affect dry matter intake, milk production parameters, or feed efficiency.
Supplementation of NALM led to a quadratic trend (P = 0.06) toward increases in plasma
Arg, Gly, and Met concentrations and quadratic increases in plasma His and Ser
concentrations. Rumen NALM dosing led to a quadratic increase in the baseline mean
plasma Met concentration. Abomasal infusion with NALM increased the area under the
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curve (AUC) versus control and both linear and quadratic increases in AUC were
observed with NALM dosing. The mean AUC per Met unit (µM × h/L ÷ Met (g)) for the
control, 30NALM, and 60NALM were 4.68, 5.89, and 5.07, which corresponded to a Met
BA (AUC per Met unit ÷ AUC per Met unitControl) of 100, 139, and 115%, respectively.
The absence of plasma NALM and increases in plasma Met for both ruminal and
abomasal NALM dosing in the current study suggests that NALM supplemented by
either rumen placement or abomasal infusion to lactating dairy cows may have been
deacetylated before entering the central circulation. In the current study, BA estimation
by plasma Met was greater for NALM doses, indicating NALM improved plasma Met
concentrations relative to the control. The absence of NALM in plasma, liver, milk, and
muscle reveals that the N-acetyl group is cleaved from NALM prior to reaching central
circulation and should be considered as a safe and effective BA rumen-protected Met
source in lactating dairy cows.
Key Words: N-acetyl-L-methionine, bioavailability, lactational performance, area under
the curve

INTRODUCTION

Protein nutrition of dairy cows in recent years has shifted from the simple use of
dietary CP towards meeting the ammonia and AA needs of ruminal fermentation for
MCP synthesis (Schwab and Broderick, 2017), while providing specific bypass AAs.
Strategic balancing of individual AA in MP has also been used as a method to maximize
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lactational performance, meet AA requirements of the cow, and deliver consistent postruminal AA, while minimizing total dietary CP supply (Lee et al., 2012a). When excess
CP is fed and the AA profile within the CP supply does not match animal AA
requirements, increases in environmental N excretion will result (Liu et al., 2017).
Because Lys and Met have traditionally been recognized as the most limiting AA for
lactating dairy cows (Schwab et al., 1992), research has focused on Met and Lys dietary
supply in order to maximize milk production and milk component synthesis. However,
balancing rations for only Lys and Met requirements may not improve productive
responses, because additive effects of other AAs may be overlooked. Therefore,
balancing rations for EAA requirements of dairy cows (not just Lys and Met) and for
multiple-limiting AA may help to reduce overfeeding of protein, improve post-ruminal
AA absorptive efficiency, reduce N excretion, and improve lactational performance (Liu
et al., 2017).
Protection of free AAs from ruminal degradation dates to the 1960s when researchers
began to understand the importance of balancing AA in order to meet dairy cow AA
requirements (Schwab and Broderick, 2017). Numerous physically protected (coated or
encapsulated) and chemical forms (Met analogues) of rumen-protected Met (RPMet)
have been developed to escape ruminal degradation and provide post-ruminal digestible
Met (dMet) for intestinal absorption (Schwab and Ordway, 2003). Production responses
to supplemental RPMet products have been inconsistent and the biological mechanisms
contributing to these responses are difficult to determine. However, infusing or
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supplementing cows with RPMet products generally result in increased milk fat and
protein yields (Zanton et al., 2014).
Recently, a new form of RPMet, a Met derivative, N-acetyl-L-Met (NALM) has been
shown to increase milk fat composition and yield (Fagundes et al., 2018).
Supplementation of NALM to early and mid-lactation dairy cows improved milk yield
(Liang et al., 2019; Amaro et al., 2019). The studies note that NALM supplementation at
30 g/d resulted in the highest milk yield and these studies represent the initial attempts to
measure production responses to supplemental NALM in lactating dairy cows.
The NALM is a Met derivative produced by chemical protection of the L-Met αamino group with a N-acetyl group. In monogastric animals, the L-Met from NALM is
metabolically equivalent to free L-Met (Rotruck and Boggs, 1975). Several animal
studies conclude that the bioavailability (BA) of L-Met and NALM are similar based on
feeding studies measuring growth rates and weight gain (Boggs et al., 1975; Young
Jenkins et al., 1978; Friedman and Gumbmann, 1987). To date, there is no research
reported on the effects of supplementing NALM to lactating dairy cows on BA.
Therefore, the objective of this study was to evaluate the BA and lactational performance
of lactating dairy cows supplemented with NALM at 2 different doses. We hypothesized
that Met supply from abomasal infusion of NALM would increase plasma Met
concentration and the BA of NALM would be greater for each NALM dose compared to
the control.
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MATERIALS AND METHODS

The dairy cows used in the present study were cared for according to the Live Animal
Use in Research Guidelines of the Institutional Animal Care and Use Committee at Utah
State University. The study was conducted at the Caine Dairy Research Center
(Wellsville, UT), Utah State University from March to May, 2019.

Cows, Experimental Design, and Diets

Three multiparous and three primiparous lactating Holstein dairy cows fitted with a
rumen cannula were used in the trial. Cows began the experiment averaging 75 ± 20.1
DIM with 32.7 ± 5.28 kg/d of milk yield. The experiment was performed in a replicated 3
× 3 Latin square design. Within each square, cows were randomly assigned to a sequence
of 3 diets during each of the three 13-d periods (10 d of treatment adaptation and 3 d of
data collection and sampling). A washout period of 7 d was assigned before the start of
subsequent periods to avoid carryover effects. Within each square, cows were randomly
assigned to a sequence of 3 dietary treatments: basal diet (15.7% CP) without NALM
(control); control diet with 30 g/d of supplemented NALM (30NALM), and control diet
with 60 g/d of supplemented NALM (60NALM; Table 3-1).
The developmental NALM product from CJ CheilJedang (Seoul, South Korea) was
used as the supplemental source of RPMet in this study. The NALM product was in
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powder form, and contained Met concentration of 78.0%, with 99.5% purity. The NALM
product was added at a rate determined for cows to consume 30 and 60 g/cow/d of Met in
order to supply 15.6 and 31.2 g of dMet to the small intestine according to
manufacturer’s recommendation, respectively. The rates were also based on previous
research (Liang et al., 2019) and the 30 g/cow/d rate tested by Fagundes et al., (2018).
The recommendation of required digestible Lys and Met were assumed as 6.6 and 2.2%
of the MP requirements, respectively (NRC, 2001; Table 3-2). The NALM product was
placed through the rumen cannula at the liquid phase just under the rumen fiber mat daily
at 0700 h during the 10 d of treatment adaptation and 1 d of data collection and sampling.
Diets were formulated based on the NRC recommendations to provide sufficient NEL,
ME, MP, minerals, and vitamins with an estimated DMI of 25.0 kg/d to produce 40 kg/d
of milk with 3.8% fat and 3.0% true protein (NRC, 2001; Table 3-2). The basal diet was
also formulated to balance Lys (2.0 g/d) and Met (0 g/d) recommendations according to
NRC (2001). Cows were housed individually in tie stalls fitted with rubber mattresses
covered with straw, allowing free access to water. Cows were individually fed twice daily
for ad libitum intake at a level of 110% expected daily intake with 60% of allotted feed
fed at 0600 h and 40% fed at 1500 h. Feed offered and refused was recorded daily, and
feed samples were taken during the sampling week to determine DMI. Cows were milked
twice daily at 0600 and 1600 h, and milk production was recorded throughout the entire
experiment.

146

Feed and Milk Samplings and Analyses

Samples of alfalfa hay and corn silage were taken weekly to determine DM, and diets
were adjusted accordingly for change in DM concentration. Samples were ground to pass
a 1-mm screen (standard model 4; Arthur H. Thomas Co., Swedesboro, NJ), and stored
for chemical analysis. Samples of TMR and orts were collected from individual cows on
d 11 to d 13, composited by period, dried at 60°C for 48 h, and ground as previously
described. The DM concentrations of samples were used to calculate intakes of DM and
nutrients.
Analytical DM concentration of samples was determined by oven-drying overnight at
105 °C. Concentration of CP was determined using an automated N combustion analyzer
(Elementar, Analysensysteme GmbH, Hanau, Germany; AOAC, 2000; method 968.06).
Concentrations of NDF and ADF were sequentially determined using a fiber analyzer
(200/220, ANKOM Technology, Macedon, NY) according to the methodology supplied
by the company, which is based on the methods described by Van Soest et al. (1991).
Ether extract was measured using a fat analyzer (XT20, ANKOM Technology; AOAC,
2000; method 2003.05). In addition, samples of TMR were analyzed for starch by
Cumberland Valley Analytical Services (Waynesboro, PA).
Milk was sampled for 3 consecutive d (d 11 to 13) during the a.m. and p.m. milkings
each period. Individual milk samples were analyzed by the Rocky Mountain DHIA
Laboratory (Providence, UT) for fat, true protein, lactose, and milk urea nitrogen (MUN).
Milk composition was expressed on weighted milk yield of a.m. and p.m. samples. Milk
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fat and protein yields were calculated by multiplying milk yield from the respective day
by fat and true protein concentration of the milk from an individual cow. A subset of milk
samples from d 11 to d 13 of each period were freeze-dried, composited by cow, and
stored for NALM and Met analysis by Bio Research Institute, CJ CheilJedang (Suwon,
South Korea).

BA, AA, and Plasma NALM Analyses

To determine the BA of NALM, 15.6 g (30 g oral equivalent) or 31.2 g (60 g oral
equivalent) of NALM was suspended in 1 L of water and bolus infused into the
abomasum over 5 min at 0700 h on d 12 and 13 of each sampling period. An infusion line
(Nalgene 980® braided clear PVC tubing; 6.4 mm i.d., 2.3 mm wall; Fisher Scientiﬁc,
Waltham, MA) containing a distal flange (Spires et al., 1975) was passed through the
sulcus omasi and placed in the abomasum via the abomasal orifice with an insertion and
delivery device as described by Gressley et al., (2006). Infusion line placement was
assured by hand to confirm the flange was in the abomasum and not the omasum. After
the NALM bolus administration, the infusion line was rinsed with 250 mL of water to
ensure full delivery of the NALM dose to the abomasum. Control infusion consisted of
1.25 L of water bolus infused into the abomasum.
Indwelling catheters were placed in the jugular vein after the a.m. milking on d 11 of
each sampling period and catheter placement altered each period. Catheters were
removed after the final blood sampling on d 13 of each period. Blood samples were
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collected on d 11 at 0, 2, 4, 6, 8, and 10 h after rumen NALM dosing into 10-mL EDTA
plasma vacuum tubes. The blood samples taken on d 11 were used to establish individual
basal plasma Met concentration for each test animal before abomasal infusions on d 12
and d 13. Blood samples were collected on d 12 at 0, 1, 2, 3, 4, 5, 7, 9, 11, 13, 15 h and
on d 13 at 0, 2, 4, 6, 8 and 10 h after NALM abomasal infusion into 10-mL EDTA
plasma vacuum tubes. Samples were placed on ice and centrifuged at 2,300 × g for 20
min, after each sampling timepoint, and plasma was collected and stored at ‒40°C for
subsequent plasma Met, NALM, and AA analyses. The plasma samples were prepared
for AA and NALM analysis by filtration using an Amicon Ultra-0.5 Centrifugal Filter
Unit (3KDa cutoff; Cat # UFC5003BK, Millipore, Burlington, MA) to remove plasma
proteins. Flow-through samples were analyzed for Met and NALM using UPLC
(Shimadzu Nexera, Seoul, South Korea).
Methionine BA of the NALM dose was determined from the plasma Met area under
the curve (AUC) with respect to time for d 12 and 13 of each sampling period. The AUC
was numerically estimated using the trapezoidal rule after subtraction of the mean of the
pre-infusion concentrations from all values. The AUC was then expressed per gram of
total Met concentration in the diet (AUC per Met unit). The ratio of the NALM dose (30
g or 60 g) AUC per Met unit over the control AUC per Met unit represented the Met BA
of the NALM dose to the control. The NALM dose abomasally infused was adjusted for
ruminal loss (33%), Met content (78%), purity (99.5%), and therefore the resulting AUC
per Met Unit was expressed over the control for Met BA estimation of NALM. The
control Met BA is assumed to be 100%, because the dMet (total Met in the basal diet)
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supplied in the control diet is available to the animal for absorption. Results of BA were
expressed as the mean percentage of the amount of Met supplied by NALM.

Liver and Muscle Biopsies

Liver and muscle biopsy samples were collected on d 12 of each sampling period post
a.m. feeding. Liver biopsies were collected by the paracostal, percutaneous needle biopsy
method as described by Mølgaard et al. (2012). Muscle biopsies were collected by
surgical excision of a 1 cm3 M. longissimus dorsi sample, dorsal to the last rib under local
anesthesia as described by Bradley (1978). Liver and muscle biopsy samples were freezedried and stored for tissue NALM and Met analysis by Bio Research Institute, CJ
CheilJedang.

Tissue and Milk NALM and Met Analyses

Freeze-dried muscle (approximately 50 mg) and liver samples (liver sample was used
in its entirety) were weighed and added to a lysis buffer consisting of 100 mM perchloric
acid for muscle (700 µL) and liver (200 µL) and soaked at 4°C for 20 min. A tissue
homogenizer pestle (Biomasher II® Closed System Disposable Tissue Homogenizer,
NIPPI Inc., Tokyo, Japan) was used to crush the tissue samples and then the suspension
was centrifuged at 13,000 × g for 15 min. The supernatant was collected and pH adjusted
to 4.5 with KOH and filtered. Flow-through was collected and analyzed for NALM and
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Met concentrations using a UPLC (Shimadzu Nexera) system as described by Hyde et al.,
(2004). Freeze-dried milk samples were dissolved in water (25 w%, 37°C) and then
filtered using an Amicon Ultra-0.5 Centrifugal Filter Unit (3KDa cutoff; Cat #
UFC5003BK, Millipore). Flow-through samples were analyzed for Met and NALM using
UPLC (Shimadzu Nexera).

Statistical Analysis

Data were analyzed as a replicated 3 × 3 Latin square using the Proc Mixed procedure
of SAS (version 9.4; SAS Institute Inc., Cary, NC). Data for intake, milk production, and
AUC were analyzed with a model that included fixed effects of period and treatment.
Cow nested within square and square were random effects. Data for AA were analyzed
using the model described above except that time was included as a repeated option. For
each variable analyzed, 3 covariance structures (autoregressive order 1, compound
symmetry, and unstructured covariance) were evaluated. The covariance structure that
resulted in the lowest values for the Akaike information criterion and the Schwartz
Bayesian criterion was used (Littell et al., 1998). Kenward-Roger's option was used to
calculate the denominator degrees of freedom. Means were separated by use of
orthogonal polynomial contrasts: 1) control vs. NALM treatments, 2) linear effect of
increasing NALM, and 3) quadratic effect of increasing NALM. Least square means are
reported throughout. Differences were considered significant at P ≤ 0.05, and trends were
discussed at 0.05 < P ≤ 0.10.
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RESULTS AND DISCUSSION

Characteristics of Diet Composition and Treatment

Ingredients and chemical composition of the basal diet are presented in Table 3-1.
Energy and protein supply and AA balance of the basal diet supplemented with NALM
are presented in Table 3-2. The basal diet was formulated to contain 15.7% CP and
provide adequate MP supply (60 g/d). All diets provided MP supply in excess of
requirements. Additionally, all diets were isoenergetic and supplied NEL and ME in
excess of requirement (NRC, 2001). Lysine and Met requirements were met for the basal
diet (2.0 g/d and 0 g/d balance) by dietary addition of canola meal, dried distillers grains
with solubles, and blood meal, respectively. The Met balance for NALM supplemented
diets were 15.6 and 31.2 g/d for the 30NALM and 60NALM, respectively.
The NRC (2001) model recommends that dLys and dMet concentrations in MP for
maintenance and optimal milk protein production approximate to 7.2 and 2.4%,
respectively. Common dietary strategies to achieve ideal Lys and Met concentrations
include feeding diets with greater CP concentration or supplementing RPLys and RPMet
products to diets with lower CP concentration to balance dLys and dMet in MP. Feeding
higher CP diets can result in excess ruminal AA supply, greater N excretion in the
environment, reduced N efficiency, and increase feed costs, which is economically
unfavorable to dairy producers.
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An alternative approach to optimize milk protein production is to maintain dLys and
dMet in MP closer to 6.6 and 2.2%, respectively, for a targeted dLys:dMet in MP
(efficiency for AA use) close to 3.0:1 (Schwab et al., 2003). Van Amburgh et al. (2015)
updated the CNCPS model (version 6.5) and reported optimal ratios of dLys:dMet in MP
closer to 2.69:1. The authors stated that to maximize milk protein yield, the calculated
estimates from breakpoint analysis in the updated CNCPS model for Lys and Met (% of
MP) were 7.00 and 2.60%, respectively, and to maximize milk protein content, 6.77 and
2.85 (% of MP), respectively (Van Amburgh et al., 2015). In the current study,
supplementing 30 g/d (30NALM; manufacturer’s recommended dose) and 60 g/d of
NALM decreased the dLys:dMet in MP to 2.46:1 and 2.05:1 (Table 3-2), respectively. In
addition, the dLys and dMet in MP were 6.53 and 2.66%, respectively, for the 30NALM
diet. Furthermore, the dLys and dMet in MP were 6.49 and 3.17%, respectively, for the
60NALM diet. Supplementation of 30 g/d NALM improved the dMet in MP, which
suggests a more favorable Met concentration in the diet for animal and production
utilization. However, increasing the supplemental NALM dose to 60 g/d reduced the
dLys and increased the dMet in MP, leading to suboptimal dLys:dMet in MP.

Feed Intake, Productive Performance, Feed Efficiency, and Milk Urea Nitrogen

Intake, milk production, feed efficiency, and MUN data are presented in Table 3-3.
Although primary production parameters were measured in the present study, caution
needs to be taken when interpreting the data due to the short trial length. Overall, feed
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intake, productive performance, and feed efficiency were not affected by NALM
supplementation, however MUN linearly decreased with NALM supplementation. The
basal diet was formulated to provide adequate MP and the dLys and dMet in MP were not
limiting, which may partly explain the lack of response to treatments. A common in vivo
technique to measure BA of AA in lactating dairy cows is the production response
approach (Schwab et al. 2001; Fleming et al., 2019). Whitehouse et al. (2017) suggested
the major limitation for the production response approach is to maintain dietary AA (Met
or Lys) deficiency, in all animals, over all treatment dosages administered, so that
linearity in milk protein concentration or yield is detected. Although the production
response approach was not used in the current study, the absence of positive milk protein
response to increasing NALM doses further supports that the basal diet was adequate in
dMet, which was expected. The lack of negative production parameter effects serves to
indicate that supplementation at 60NALM was still a safe concentration for the animals.
Liang et al. (2019) reported that NALM supplemented at rates of 0, 15, 30 and 60 g/d
to mid lactation dairy cows improved milk yield in a quadratic manner, with 30 g/d of
NALM seeming to be the optimal supplementation rate for milk yield under the
experimental conditions. Amaro et al. (2019) found that milk yield of early lactating
Holstein dairy cows tended to be greater (P = 0.07) with intermediate concentrations (15
and 30 g/d) of NALM compared to control animals. The authors noted that NALM
supplementation at 30 g/d resulted in the highest numerical milk yield (Amaro et al.,
2019), which is in agreement with Liang et al. (2019). Based on limited data in the
literature, NALM supplementation to either early or mid-lactation dairy cows has failed
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to exhibit beneficial effects on milk protein concentrations (Amaro et al., 2019; Liang et
al., 2019). However, Fagundes et al. (2018) reported that NALM supplementation at 30
g/d increased milk fat concentration and yield and 3.5% FCM yield in MP-deficient (-190
g/d) and MP-adequate diets (50 g/d). The basal diet fed in the current study was similar in
MP (60 g/d) to that fed by Fagundes et al. (2018); however, each square within the Latin
square design consisted of 21-d periods versus 13-d periods for the current study,
respectively. Therefore, the short trial length in the present study, along with a 7-d
washout period may not have allowed animals to adapt to NALM supplementation to
exhibit changes in production parameters.
Liang et al. (2019) noted that MUN concentrations were not affected by oral NALM
supplemented at rates of 0, 15, 30 and 60 g/d to mid lactation dairy cows. Milk urea
nitrogen can be used as an indicator of N utilization efficiency in dairy cows. Variation in
MUN is related to the protein:energy ratio of the diet consumed. With adequate energy in
the diet, MUN can be indicative of protein status. All diets in the current study were
balanced to be isoenergetic and supplied NEL and ME in excess of requirement (Table 32). The linear decrease in MUN concentrations due to NALM dosing was unexpected,
however once NALM reaches the small intestine it is deacetylated into the physiological
isomer L-Met that is systemically available for use by the body. Although it appears that
NALM dosing improved N utilization efficiency through reduced MUN content, milk
true protein was similar among NALM dosage rates. Lack of milk true protein change
suggests the free useable Met from NALM dosing may have been utilized for other
biological processes within the body. Additional research is needed to determine if
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NALM supplementation alters N utilization of early to mid-lactation dairy cows by oral
supplementation, as abomasal infusion of RPAAs is not a practical means of supplying
RPAAs to lactating dairy cows.

Plasma AA Profiles and NALM

Supplementation of NALM led to a quadratic trend (P = 0.06) toward increases in
plasma Arg, Gly, and Met and quadratic increases in plasma His and Ser concentrations
(Table 3-4). Alternatively, NALM supplementation linearly decreased plasma AA
concentrations of Leu, Phe, and Val and trends were observed for linear decreases in Ile
and Ala concentrations. Although plasma Met increased linearly, there was an overall
linear trend (P = 0.08) toward lower plasma EAA concentration. Total NEAA
concentration was not affected by supplementation of NALM. Recently, Liang et al.
(2019) described that NALM supplemented at rates of 0, 15, 30, and 60 g/d to mid
lactation dairy cows displayed quadratic increases in plasma Met concentration, with 30
g/d NALM resulting in the highest plasma Met concentration compared to the control
treatment (36.7 vs. 31.1 µM). In contrast, Fagundes et al. (2018) found that early to midlactation dairy cows supplemented with 30 g/d NALM to MP-adequate diets had no
effect on plasma Met concentration, which was an unexpected finding to the authors.
Plasma Met concentrations provide a qualitative measure of post-ruminal delivery
and absorption of Met from RPMet products (Blum et al., 1999). Furthermore, plasma
AA concentrations can also indicate the balance between AA supply in the diet and
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utilization (Meijer et al., 1995). However, the ability of NALM to be absorbed as L-Met
from the small intestine is dependent on the enzyme acylase I, which hydrolyzes NALM
to L-Met (Giardina, 1997; Baxter et al., 2002). The acylase I enzyme is found in the
intestine, liver, and kidney of mammalian tissues and has a high affinity for sulfur and
neutral AA derivates (Giardina et al., 1997). No NALM could be detected in either portal
or vena caval plasma in young pigs dosed with NALM by a gastrostomy tube (382 mg/kg
BW), suggesting deacylation of NALM in the intestinal lumen or mucosal cells (Daabees
et al., 1984). In addition, no NALM was detected in the plasma of adult subjects or 1year-old infants after oral loading (0.0605 mmoles/kg BW) with NALM (Stegink et al.,
1980; Stegink et al., 1982). The absence of plasma NALM (Table 3-5) and subsequent
increase in plasma Met concentration with NALM dosing in the current study suggests
that NALM supplemented by either rumen placement or abomasal infusion to lactating
dairy cows is deacylated before entering the central circulation.
In this study, NALM supplementation linearly decreased plasma branched-chain AA
(BCAA; Ile, Leu and Val) and EAA concentrations. Appuhamy et al. (2011) reported that
jugular infusion of a combination of L-Lys and L-Met led to a 17% reduction in plasma
Ile concentration compared to control cows. Blum et al. (1999) noted that plasma
concentrations of Val, Ile, and total BCAA were reduced, but only in cows fed a polymer
coated RPMet product. Similarly, Fagundes et al. (2018) observed decreased plasma
BCAA and total EAA concentrations, but only in a diet supplemented with NALM that
was adequate in MP, which was similar to the diet and findings of the current study. In
addition, Varvikko et al. (1999) abomasally infused DL-Met to early, mid and late
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lactation cows. The authors found that the concentration of total BCAA and each
individual BCAA (Ile, Leu, and Val) in plasma decreased linearly with abomasal infusion
of DL-Met (Varvikko et al., 1999).
The NALM supplementation in the current study most likely increased BCAA
catabolism or tissue uptake, since EAAs that are not removed by the liver or peripheral
tissues return to general circulation (Arriola Apelo et al., 2014). Branched-chain amino
acids make up roughly 50% of the EAA in milk proteins (Mackle et al., 1999). Feeding
RPMet products may result in increased milk protein synthesis or yield, because Met is a
limiting EAA in dairy cows. Likewise, increased milk protein yield can enhance
mammary gland BCAA uptake, leading to decreased plasma BCAA concentrations. Milk
protein yield was not altered by NALM supplementation in our trial, thus suggesting that
NALM dosing did not alter BCAA metabolism in the mammary gland. Branched-chain
AAs and Met are important in portal drained viscera energy generation in ruminants
(Lobley et al., 2003), and dietary energy deficiencies can alter AA partitioning towards
greater oxidation and energy generation (Lapierre et al., 2006). All diets in the present
study supplied ME and NEL in excess of requirements according to NRC (2001).
Therefore, it is unlikely that the BCAAs were used for additional energy generation in
tissues after NALM dosing. It appears that NALM supplementation to lactating dairy
cows increases plasma Met concentration and alters individual plasma BCAA profiles;
however, more research is needed to understand the mechanisms involved in BCAA
metabolism and potential nutrient interactions with NALM dosing.
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BA and Kinetic Parameters

Bioavailability and kinetic parameter results of NALM dosing are presented in Table
3-5. The mean basal plasma Met concentration was 25.4 µM for the control diet, which is
similar to observed values in the literature for lactating dairy cows (Appuhamy et al,
2011; Arriola Apelo et al, 2014). Rumen NALM dosing led to a quadratic increase in the
mean plasma Met concentration on d 11 of sampling after 10 d of rumen dosing. The
mean plasma Met was 39.7 µM and 39.5 µM for the 30NALM and the 60NALM
supplemented cows, respectively. The values reported in the current study were greater
than literature values reported for diets supplemented with other types of RPMet products
(Lee et al., 2015; Giallongo et al., 2016) and jugular infusion of L-Met to lactating dairy
cows (Appuhamy et al, 2011), but similar to values seen with diets supplemented with
NALM (Liang et al., 2019). Increased mean plasma Met after rumen NALM dosing
suggests that NALM is deacetylated and free Met is absorbed into the central circulation
for utilization by the animals.
Peak time and Met height after abomasal infusion of NALM did not differ among
treatments (Table 3-5). Plasma Met concentrations increased over the first 3 h after
abomasal infusion of NALM and returned to basal concentrations by 8 h post dosing
(Figure 3-1). Daabees et al. (1984) noted when equimolar amounts of L-Met and NALM
were supplemented to young pigs, the portal and venal caval peak plasma Met
concentrations were lower for NALM compared to L-Met. However, peak time after
dosing for both portal and vena caval plasma Met concentrations was greater (90 min) for
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NALM versus portal (45 min) and vena caval (60 min) plasma Met concentrations after
L-Met dosing (Daabees et al., 1984). In humans, peak time after oral administration was
delayed for NALM compared to L-Met (Stegink et al., 1980). Peak time after
intraruminal supplementation (50 g/d Met equivalent) with either the isopropyl ester of 2hydroxy-4-(methylthio)-butanoic acid or polymer coated RPMet product in non-lactating
dairy cows, averaged 4 h and 22 h 25 min, respectively (Graulet et al., 2005).
The mean plasma Met concentrations after abomasal infusion of each cow on d 12
and 13 for each period were used to determine the AUC (Table 3-5). Abomasal infusion
with NALM led to an increased AUC versus control and both linear and quadratic
increases in AUC were observed with NALM dosing. The resulting AUC values were
expressed as the AUC per Met unit (i.e., AUC divided by the total dMet concentration in
each diet) in order to adjust for varying Met doses in the diets. The mean AUC per Met
unit (µM × h/L ÷ Met (g)) for the control, 30NALM, and 60NALM diets were 4.68, 5.89,
and 5.07, which corresponded to a Met BA (AUC per Met unit ÷ AUC per Met unitControl)
of 100, 139, and 115%, respectively. N-acetyl-L-Met has been shown to be BA and
capable of replacing the dietary requirement for Met in humans, rats, and swine, but had
not been studied in dairy cattle (Boggs et al. 1975; Rotruck and Boggs 1975; Zezulka and
Calloway, 1976; Stegink et al. 1980, 1982; Daabees et al. 1984). In the current study, BA
estimation by plasma Met appearance was higher for NALM doses, indicating NALM
improved plasma Met concentrations relative to the control. These results indicate that
NALM is also capable of replacing dietary Met in lactating dairy cattle. However, further
studies are warranted to evaluate the BA and kinetic parameters of NALM in lactating
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dairy cows relative to unprotected forms of Met (L-Met) and RPMet products with
known BA values in the literature. To our knowledge, this is the first time the Met
derivative, NALM has been shown to increase plasma Met concentrations and serve as a
RPMet source for lactating dairy cows.

Residue Potential

Residue potential in lactating Holstein dairy cows supplemented with NALM is
summarized in Table 3-6. No NALM was detected in milk, liver, or muscle samples after
rumen placement or abomasal infusion. In humans, existing authorizations for NALM
have been approved in Germany for use in dietetic foods (BGBI, 1988) and in 1978, the
United States approved NALM as a source of L-Met food additive (Federal Register,
1978). Smith et al. (2011) described that the extraction efficiency of N-acetylated AAs is
known to be poor which can lead to a lack of detection of NALM. Therefore, tissue Met
concentrations were quantified to verify the NALM analysis method by intracellular
disruption and tissue Met release. Milk Met concentration was not altered by NALM
supplementation. Methionine extraction by the mammary gland, unlike Lys, closely
matches the amounts required for milk protein synthesis (Bequette et al., 1998).
Therefore, no improvement in milk protein yield due to NALM supplementation would
explain the lack of change in milk Met after NALM dosing. Liver and muscle Met
concentrations increased with NALM supplementation, resulting in both linear and
quadratic effects for increased liver Met concentration and a linear trend (P = 0.10) for
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increased muscle Met concentration. The liver is responsible for Met metabolism
(Brosnan and Brosnan, 2006) and liver Met removal in dairy cows is related to total liver
inflow and blood flow, rather than net portal absorption (Lapierre et al, 2005; Arriola
Apelo et al, 2014). Additionally, hepatic Met removal varies with the source of RPMet
supplemented to lactating dairy cows. Common RPMet products contain equimolar
mixtures of D- and L- isomers; however, D-Met is not physiologically functional in the
dairy cow and must be converted to L-Met before it can be incorporated into mammalian
proteins (Lapierre et al., 2005; Lapierre et al., 2012). Since, NALM only contains the Lisomer of Met, it can be utilized directly for protein synthesis after deacetylation, without
conversion to any other isoforms. Liver and muscle Met increased after NALM dosing,
demonstrating that free Met from the NALM source was absorbed, delivered to the liver,
and was able to be utilized by peripheral tissues (i.e, muscle). Furthermore, in lactating
dairy cows, the primary net user of post-liver Met supply is the mammary gland for milk
protein synthesis (Lapierre et al., 2005). Elevated Met concentrations in liver and muscle
after NALM supplementation, could be explained by the lack of response to milk protein
yield seen in the current study. The absence of NALM residue in plasma (Table 3-5),
liver, milk, and muscle reveal that the N-acetyl group is cleaved from NALM prior to
reaching central circulation and can be considered as a safe and effective RPMet source
in lactating dairy cows.

CONCLUSIONS
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The current study evaluated the BA and lactational performance of dairy cows
supplemented with NALM at 2 different doses. Overall, production parameters were not
influenced by NALM supplementation, which was not surprising given the short study
periods. Plasma Met increased with NALM dosing, while individual BCAA
concentrations decreased. Bioavailability by plasma appearance of Met for NALM
treatments was higher for the 30NALM dose compared with the 60NALM and the
control, suggesting that optimal supplementation rate for NALM would be 30 g/cow per
day. Residue of NALM was not detected in plasma, milk, liver, or muscle samples. This
is the first attempt to measure the BA of the Met derivative in lactating dairy cattle and
the findings suggest that NALM is deacetylated before reaching central circulation,
increases plasma Met concentrations, and supplies lactating dairy cows with a source of
RPMet. However, further studies are needed to evaluate the comparative BA of NALM
in lactating dairy cows relative to unprotected forms of Met (L-Met) and RPMet products
with known BA values in the literature.
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Table 3-1. Ingredients and chemical composition of the basal diet
Item

% of DM

Ingredient
Alfalfa hay

30.0

Wheat straw

1.77

Corn silage

26.5

Corn grain (steam-flaked)

15.9

Distillers dried grains with solubles

3.54

Cottonseed, whole

3.54

Canola meal

7.07

Blood meal

1.06

Beet pulp, shreds

6.19

Fat supplement1

1.77

Sodium bicarbonate

0.53

Yeast supplement2

0.18

Vitamin and mineral mix3

1.94

Chemical composition
DM, %

60.5

CP

15.7

RDP4

9.33

RUP4

6.37
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1

NDF

32.9

ADF

22.9

Starch

17.7

Sugar

6.00

Ether extract

3.98

NFC5

37.3

Ash

10.0

Rumen-protected dry fat supplement (Nurisol®, WLT Distributors Inc., Winnipeg, MB,

Canada).
2

Diamond V XP® (Cargill Inc., Cedar Rapids, IA).

3

Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of

Cu (from copper amino acid complex), 40,537.4 mg of Zn (from zinc amino acid
complex), 38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co
(from cobalt carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1
IU of vitamin E, and 295 mg of Rumensin (Elanco Animal Health, Greenfield, IN).
4

Based on tabular value (NRC, 2001).

5

NFC = 100 – CP – NDF – ether extract – ash.
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Table 3-2. Energy and protein supply and AA balance of the basal diet supplemented with
N-acetyl-L-Met (NALM) at 2 different doses
Diet1
Item

Control

30NALM

60NALM

NEL, Mcal/kg

1.65

1.65

1.65

ME, Mcal/d

66.2

66.2

66.2

ME, Mcal/kg

2.58

2.58

2.58

MP supply

2,940

2,955

2,975

MP requirements

2,880

2,880

2,880

60

75

95

dLys requirement

191

191

191

dLys supplied by the diet

193

193

193

Lys balance

2.00

2.00

2.00

dMet requirement

63.0

63.0

63.0

dMet supplied by the diet

63.0

63.0

63.0

dMet from Met derivative

0.00

15.6

31.2

Total dMet in the diet

63.0

78.6

94.2

dMet balance

0.00

15.6

31.2

Energy supply2

Protein supply,2 g/d

MP balance
Lys and Met balance,3 g/d
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dLys:dMet4

1

3.06

2.46

2.05

Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d

of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented
NALM.
2

All values were estimated using NRC (2001) based on actual DMI, milk yield, milk

composition, and BW of the cows throughout the trial.
3

Digestible Lys (dLys) and digestible Met (dMet) supply from the diets were estimated

using NRC (2001); supply of dMet from Met derivative was estimated with Met
concentration (78%) and absorption (67%) data provided by the manufacturer.
Requirements of dLys and dMet were calculated as 6.6 and 2.2% of MP requirements,
respectively.
4

Lys from diet-to-digestible Met from diet and dMet from NALM.
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Table 3-3. Intake, milk production, feed efficiency, and milk urea nitrogen of lactating
Holstein dairy cows supplemented with N-acetyl-L-Met (NALM) at 2 different doses
Diet1
Item
DMI, kg/d

Contrast2

Control 30NALM 60NALM SEM

NALM

L

Q

20.4

20.7

20.3

1.55

0.96

0.83 0.65

Milk

30.9

31.3

30.9

1.79

0.84

0.99 0.69

3.5% FCM3

33.2

33.5

32.6

2.27

0.94

0.85 0.85

ECM4

32.7

33.0

32.0

2.35

0.91

0.69 0.64

Fat

3.98

3.96

3.87

0.157

0.77

0.69 0.91

True protein

2.85

2.87

2.77

0.086

0.75

0.47 0.51

Lactose

4.74

4.73

4.73

0.136

0.77

0.75 0.98

Fat

1.23

1.23

1.19

0.088

0.89

0.80 0.86

True protein

0.87

0.90

0.85

0.076

0.98

0.65 0.42

Lactose

1.47

1.47

1.46

0.103

0.99

0.87 0.77

1.53

1.52

1.54

0.144

0.87

0.75 0.82

Yield, kg/d

Milk composition, %

Milk component yield,
kg/d

Feed efficiency
Milk yield/DMI
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3.5% FCM

1.65

1.63

1.63

0.096

0.81

0.82 0.93

ECM yield/DMI

1.62

1.60

1.60

0.086

0.83

0.83 0.96

MUN, mg/100 mL

12.3

11.2

10.7

1.19

0.05

0.02 0.42

yield/DMI

1

Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d

of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented
NALM.
2

NALM = control vs. NALM treatments; L = linear effect of increasing NALM

supplementation; Q = quadratic effect of increasing NALM supplementation.
3

3.5% FCM = [0.4324 × milk yield (kg/d)] + [16.216 × fat yield (kg/d)].

4

ECM = 0.327 × milk yield (kg/d) + 12.95 × fat yield (kg/d) + 7.2 × protein yield (kg/d).
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Table 3-4. Plasma AA concentrations (µmol/L) of lactating Holstein dairy cows
supplemented with N-acetyl-L-Met (NALM) at 2 different doses
Diet1

1

Contrast2

Item

Control

30NALM

60NALM

SEM

NALM

L

Q

Arg

42.9

46.9

42.0

2.1

0.55

0.76

0.08

His

38.9

42.5

37.4

1.66

0.61

0.52

0.03

Ile

74.8

74.8

67.2

3.16

0.33

0.09

0.32

Leu

136

128

113

5.2

0.02

< 0.01

0.57

Lys

58.2

59.2

54.7

2.51

0.68

0.32

0.37

Met

16.0

21.6

22.1

1.07

< 0.01

< 0.01

0.06

Phe

42.2

40.3

36.4

1.56

0.05

0.01

0.61

Val

209

202

183

7.8

0.10

0.02

0.49

EAA3

617

616

556

24.3

0.30

0.08

0.33

Ala

190

179

170

7.78

0.11

0.07

0.97

Gly

194

224

211

9.48

0.05

0.23

0.07

Ser

54.4

65.6

57.6

2.52

0.02

0.37

< 0.01

Tyr

40.5

41.4

37.3

1.51

0.54

0.14

0.18

NEAA4

479

510

475

20.6

0.59

0.89

0.19

Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d

of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented
NALM.
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2

NALM = control vs. NALM treatments; L = linear effect of increasing NALM

supplementation; Q = quadratic effect of increasing NALM supplementation.
3

Essential AA analyzed.

4

Nonessential AA analyzed.
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Table 3-5. Determination of bioavailability and kinetic parameters in lactating Holstein dairy
cows supplemented with N-acetyl-L-Met (NALM) at 2 different doses
Diet1
Item
Basal plasma Met

Control

Contrast2

30NALM 60NALM

SEM

NALM

L

Q

25.4

39.7

39.5

2.55

< 0.01

< 0.01

0.04

2:35

2:45

3:15

0.50

0.52

0.38

0.79

45.4

65.4

84.1

13.0

0.16

0.12

0.97

295

463

479

20.5

< 0.01

< 0.01

< 0.01

4.68

5.89

5.07

0.24

0.01

0.14

< 0.01

100

139

115

0.07

< 0.01

0.09

< 0.01

ND5

ND

ND

-

-

-

-

concentration (BPC), µM
Peak time after abomasal
infusion, h
Peak Met height after
abomasal infusion, µM
Area under the curve (AUC),
µM × h/L
AUC per Met unit,3 (µM ×
h/L)/Met (g)
Met bioavailability of
NALM,4 %
Plasma NALM concentration

1

Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d

of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented
NALM.
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2

NALM = control vs. NALM treatments; L = linear effect of increasing NALM

supplementation; Q = quadratic effect of increasing NALM supplementation.
3

AUC per Met unit = area under the curve ÷ total dMet concentration in the diet (g).

4

Bioavailability = (AUC per Met unit ÷ AUC per Met unitControl) × 100.

5

ND = Not detected.
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Table 3-6. Residue potential in lactating Holstein dairy cows supplemented with N-acetyl-LMet (NALM) at 2 different doses
Diet1
Item

Contrast2

Control 30NALM 60NALM SEM NALM

L

Q

-

-

Milk NALM, (µM)

ND2

ND

ND

-

-

Milk Met, (µM)

8.17

6.42

10.3

2.67

0.59

Liver

ND

ND

ND

-

-

-

-

Muscle

ND

ND

ND

-

-

-

-

Liver

15.6

25.4

22.9

1.16

< 0.01

0.01 0.01

Muscle

9.18

13.1

13.7

1.27

0.08

0.10 0.36

0.58 0.41

Tissue NALM, (µM)

Tissue Met, (µg/g)

1

Control = basal diet without NALM supplementation; 30NALM = control diet with 30 g/d

of supplemented NALM; and 60NALM = control diet with 60 g/d of supplemented
NALM.
2

ND = Not detected.
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Figure 3-1. Plasma Met concentration (µM) versus time plot for lactating Holstein dairy cows
abomasally infused with N-acetyl-L-Met (NALM) at 2 different doses
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CONCLUSIONS

Amino acid and protein nutrition in lactating dairy cows remain a topic of great
interest to researchers and the dairy industry. Substantial progress has been made over the
years in the development of rumen-protected forms of lysine and methionine. Lysine and
methionine have traditionally been identified as the most limiting essential amino acids
for lactating dairy cows. As more complex feeding models are developed, the
incorporation of a multiple-limiting amino acid model that includes branched-chain
amino acids (i.e., isoleucine, leucine, and valine) and additional essential amino acids,
(i.e, histidine, lysine, and methionine) if not all 10 essential amino acids could help to
reduce protein overfeeding, improve post-ruminal amino acid supply, decrease nitrogen
excretion, and improve lactational performance.
This dissertation investigated the use of acetylated methionine and lysine derivatives
as a source of rumen-protected amino acids for lactating dairy cows. Acetylated amino
acid derivatives are a free amino acid molecule with a chemical blocking group (acetyl
group) added to the either the ε-amino or α-amino group. Chapter 1 focused on
investigating production responses and ruminal fermentation characteristics of lactating
dairy cows when supplemented with N-acetyl-L-Methionine as a source of rumenprotected methionine in metabolizable protein-deficient and -adequate diets. Improving
the total balance of amino acids in metabolizable protein has been one strategy used to
optimize lactational performance, while reducing the amount of dietary crude protein fed
in lactating dairy cow rations. Previous studies have evaluated the use of rumen-protected
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methionine to improve lactational performance in dairy cows, but have obtained
inconsistent findings due to various feeding, physiological and complex inter-organ
metabolism of methionine by the rumen, liver, and mammary gland. Our objective was to
investigate lactational performance and nutrient utilization of early to mid-lactating dairy
cows supplemented without or with a developmental N-acetyl-L-methionine in
metabolizable protein-deficient or -adequate diets. Overall, the results demonstrated that
N-acetyl-L-methionine exerted minor influence on ruminal metabolism, but increased
milk fat concentration, which was an unexpected finding, possibly due to accelerated
fatty acid delivery from the liver to the mammary gland, resulting in sizable increases in
milk fat yield and feed efficiency.
In chapter 2, the objective was to investigate lactational performance and nutrient
utilization by mid to late lactating dairy cows supplemented with three different forms of
rumen-protected lysine (2 developmental lysine derivatives and 1 commercially available
lysine supplement). Results of the study demonstrate that feeding the Nα, ε-acetyl-Llysine supplemented diet in mid to late lactation dairy cows decreased dry matter intake
and maintained milk yield, leading to greater feed efficiency compared to the control diet.
These findings suggest that the developmental N-acetyl-L-lysine products (Nα, ε-acetylL-Lysine and Nε-acetyl-L-Lysine) may be biologically active in lactating dairy cows,
with Nα, ε-acetyl-L-lysine showing the most benefit to improve feed efficiency and
increase milk yield. However, further research is needed to discover the role of lysine
derivatives on productive performance, ruminal metabolism, and bioavailability in
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lactating dairy cows as this was the first attempt to evaluate the use of lysine derivatives
in lactating dairy cows.
In chapter 3, the objective of the study was to evaluate the bioavailability and
lactational performance of lactating dairy cows supplemented with N-acetyl-Lmethionine at 2 different doses (30 and 60 g/d). To date, there had been no research
reported on the effects of supplementing N-acetyl-L-methionine on bioavailability and
safety to lactating dairy cows. Overall, production parameters were not influenced by Nacetyl-L-methionine supplementation, which was not surprising given the short study
periods. Plasma methionine increased with N-acetyl-L-methionine dosing, while
individual branched chain amino acid concentrations decreased, which was an
unexpected finding. Bioavailability by plasma appearance of methionine for N-acetyl-Lmethionine treatments was higher for the 30 g/d N-acetyl-L-methionine dose compared
with the 60 g/d N-acetyl-L-methionine and control dose, suggesting that the optimal
supplementation rate for N-acetyl-L-methionine is 30 g/cow/d. N-acetyl-L-methionine
was not detected in plasma, milk, liver or muscle samples. This again was the first
attempt to measure the bioavailability of the methionine derivative in lactating dairy
cattle and the findings suggest that N-acetyl-L-methionine is deacetylated before reaching
central circulation, increases plasma methionine concentrations, and supplies lactating
dairy cows with a safe bioavailable source of rumen-protected methionine. Although
there were differences observed between studies in lactational performance (chapter 1-3),
the overall major findings of these studies indicate that acetylated methionine is safe for
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use in lactating dairy cows and both methionine and lysine derivatives should be
considered as a source of rumen-protected amino acids for lactating dairy cows.
The daily profit per lactating dairy cow being fed with rumen protected methionine
has been estimated to be around 30 cents (Cho et al., 2007; Chen et al., 2011). Dairy
nutritionists commonly report a return on investment of 2.5:1 or higher when rations are
balanced for rumen protected lysine and methionine in metabolizable protein (Schwab,
2012). Additionally, increases in income over feed cost approaching 40 to 50 cents per
cow per day from precision balancing for rumen degradable protein and rumen
undegradable protein, while balancing for lysine and methionine have been described by
dairy nutritionists (Schwab, 2012). The concept of the multiple-limiting amino acid
model may be profitable based on the values above through precision feeding, however
the environmental impacts of reducing nitrogen excretion by lysine and methionine
derivative supplementation should not be overlooked.
Consumers of dairy products are aware of the environmental impacts of feeding and
raising livestock animals. Animal agriculture has been identified as a major source of
nitrogen pollution to water resources. Animal wastes can contribute to nitrogen pollution
of the environment as ammonia volatilized to the air, nitrate leached into ground water,
and nitrogen that runs off to surface water. Improvement of nitrogen utilization efficiency
by lactating dairy cows fed with amino acid derivatives could decrease nitrogen losses
from farms and help to reduce the negative environmental impacts of livestock animals.
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Although considerable advancements have been made in amino acid nutrition, future
works need to focus on the development of products and technologies that promote
animal health (i.e., improved immunity) through balanced feeding allowing for lower
protein diets and increased microbial protein synthesis. Further works could include the
use of acetylated amino acid derivative mixtures supplemented to lactating dairy cows.
Additionally, future works should focus on the “real-life” estimates of potential
reductions in nitrogen excretion by supplementing amino acid derivatives through
improving the amino acid profile reaching the small intestine. Future research needs to
focus on longer term feeding periods during various stages of lactation (i.e., early, mid or
late). The study durations should be extended to measure responses with larger sample
sizes and explore the biological and commercial significance of the dietary treatments.
This could also allow researchers to pinpoint when acetylated amino acid derivatives
exert the greatest effects to dairy cows during lactation. It will also aid dairy farmers on
deciding the optimal time to feed acetylated amino acid derivatives to lactating dairy
cows to maximize animal health, reduce environmental nitrogen excretion, and increase
profits.
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Utah State University School of Veterinary Medicine

PROFESSIONAL TRAINING
2017
Liver Biopsy Wet Lab
Course Instructor: Jeffery Hall, DVM, Ph.D., Diplomat ABVT
2013

Milk Quality/LactoCorder Training
Veterinarian’s Outlet Dublin, Texas
Course Instructor: Ynte Schukken DVM, Ph.D., MS
Cornell University College of Veterinary Medicine: Quality Milk
Production Services

2013

Ovum Pickup (OPU) in the bovine
California Polytechnic State University, San Luis Obispo, CA
Course Instructors: Joy Altermatt DVM, MS, DACT
Fernando Campos-Chillon DVM, MS, Ph.D., DACT

PROFESSIONAL EXPERIENCE
2017-2019
Clinical Veterinary Internship
Utah State University School of Veterinary Medicine
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Clinical Veterinary Services Team
4815 Old Main Hill
Logan, Utah 84322-4815
Duties: On-call responsibilities of one weeknight each week and
one weekend a month. Oversight of research animals.
Participation in small ruminant surgeries and routine visits to
livestock operations (Dairy, Beef, Small Ruminant, Swine).
Participation in classroom/laboratory teaching with undergraduate,
graduate and veterinary students.
2011-2013

Veterinary Assistant
Westside Veterinary Services, Inc.
1531 E. Pacheco Blvd.
Los Banos, CA 93635
Duties: Accompanied veterinarians to on-farm calls, administered
injections, pregnancy palpation via portable ultrasound, milk
quality investigation, routine timing, teat scoring, parlor audits,
lameness evaluations, nutrition diagnostics and dairy records
analysis.

2012-2013

Associate
Ani-Tech Production Solutions
Duties: Assisted with graphing pulsators, vacuum measurements,
CIP evaluations, NMC milking system evaluations and
troubleshooting increased mastitis incidence on dairy farms.

2012-2013

Hospital Manager
Red Top Jerseys
21519 Rd 4, Chowchilla, CA 93610
Duties: Diagnosing and treatment of sick animals. Developed
treatment protocols and trained employees in the use of an on-farm
milk culture system. Employee on-farm training of
ultrasonography to determine herd pregnancy status.

PUBLICATIONS
• Journal Articles
*indicates corresponding author
1. Fagundes, M. A., S.Y. Yang, J.-S. Eun*, J. O. Hall, J.O. Moon and J.S. Park.
2018. Influence of supplementing a methionine derivative, N-acetyl-Lmethionine, in dairy diets on production and ruminal fermentation by lactating
cows during early to mid lactation. J. Dairy. Sci. 101:7082-7094.
•

Abstracts in Peer-Refereed Conference Proceedings
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1. Eun, J.-S., M. A. Fagundes, D. Vyas, J. S. Park, and J. O. Moon. 2019.
Gastrointestinal availability of a methionine derivative, N-acetyl-L-methionine,
and its impacts on lactational performance and nitrogen metabolism of dairy
cows. Abstract accepted to International Symposium on Ruminant Physiology.
2. Sharp, S., M. A. Fagundes, J.-S. Eun, J. O. Hall, J. S. Park, and J. O. Moon.
2018. Ruminal escape and duodenal appearance of N-acetyl-L-methionine in
lactating dairy cows. J. Dairy Sci. 101 (Suppl. 2):320. (Abstr.)
3. Fagundes, M. A.*, S. A. Blaser, S. Y. Yang, J.-S. Eun, and J. O. Moon. 2016.
Effects of supplementing a rumen-protected methionine on lactational
performance of Holstein dairy cows during early and mid lactation. Journal of
Animal Science 94(supplement5):349.
• Oral Conference Presentations
*indicates presenting author
1. Fagundes, M. A.*, S. A. Blaser, S. Y. Yang, J.-S. Eun, and J. O. Moon. 2016.
0728 Effects of supplementing a rumen-protected methionine on lactational
performance of Holstein dairy cows during early and mid lactation. Conference:
2016 ADSA-ASAS JAM, Salt Lake City. Volume: 99 (E-suppl. 1). (ADSA
Production Division Graduate Student Oral Competition: PHD).

PROFESSIONAL AFFILIATIONS
American Veterinary Medical Association
American Association of Bovine Practitioners
Academy of Dairy Veterinary Consultants
American Dairy Science Association
American Society of Animal Science
Dairy Cattle Reproductive Council
National Mastitis Council

